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ABSTRACT 
Long lifespan of evolutionary higher organisms including humans is associated with 
the challenge to maintain viability of post mitotic cells, such as neurons, for decades. 
Autophagy is increasingly recognized as an important prosurvival pathway in oxidative 
and proteotoxic stress conditions. Autophagy degrades cytosolic macromolecules in 
response to starvation and is involved in the selective degradation of damaged/toxic 
organelles, such as mitochondria. With age autophagy function declines, and is also 
compromised in several neurodegenerative diseases. We identified a novel role for 
autophagy in the maintenance of mitochondrial health, specifically respiratory complex 
I. Intriguingly, galactose-induced cell death of autophagy deficient cells was rescued 
by preventing ROS production at complex I or bypassing complex I-linked respiration. 
We propose that aberrant ROS production via complex I in response to autophagy 
deficiency could be pathogenic and result in neurodegeneration and preventing this 
could be an interesting therapeutic target. 
Furthermore, we found that vertebrates have evolved mechanisms to induce 
autophagy in response to oxidative stress. This involves the oxidation of the autophagy 
receptor p62, which promotes autophagy flux and the clearance of autophagy cargo, 
resulting in increased stress resistance in mammalian cells and survival under stress 
in flies. In addition, we obtained data revealing an important role for redox-regulated 
cysteines in NDP52 for the degradation of mitochondria via mitophagy and tools were 
created to study the role of other autophagy receptors in autophagy initiation and 
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1 CHAPTER 1: INTRODUCTION 
1.1 Autophagy 
Autophagy is a broad term referring to different pathways for bulk degradation of 
cytosolic components and organelles. Three types of autophagy are known: chaperone 
mediated autophagy, microautophagy and macroautophagy. In chaperone mediated 
autophagy a chaperone protein binds first to its cytosolic target substrate and then to 
a receptor on the lysosomal membrane where the unfolding of the protein occurs. The 
unfolded cytosolic target protein is then translocated directly into the lysosome for its 
degradation (Massey et al., 2004). Microautophagy translocates cytoplasmic materials 
into the lysosome or vacuole for degradation by either direct invagination, protrusion, 
or septation of the lysosomal or vacuolar membrane (Mijaljica et al., 2011). Finally, 
macroautophagy is characterised by the formation of a cytosolic double-membrane 
vesicle, the autophagosome. During macroautophagy, cytoplasmic proteins, 
organelles or other materials are surrounded by phagophores, which expand and close 
to form autophagosomes. These autophagosomes fuse with lysosomes (or vacuoles) 
to form autolysosomes, in which the cytoplasmic cargos are degraded by resident 
hydrolases. The resulting degradation products are then transported back into the 
cytosol for reuse through the activity of membrane permeases (Figure 1.1) (Klionsky, 
2007). Macroautophagy is the most widely studied and best characterised process and 
is commonly referred to as autophagy (this term will also be used hereafter). 
Autophagy is orchestrated by a set of autophagy-related (ATG) genes, which were 






Figure 1 Diagram of the bulk autophagy pathway. 
Deprivation of growth promoting stimuli (such as amino acids, growth factors and ATP) activate autophagy 
via mTORC1 (mammalian Target Of Rapamycin Complex 1) and the ULK1 (Unc-51-Like autophagy 
activating Kinase 1) complex, which regulate autophagosome biogenesis. The formation of an 
autophagosome starts with the recruitment of Atg9 positive vesicles to the PAS (Pre-Autophagosomal 
Structure) and the formation of a phagophore, which surrounds cytosolic cargo. The local production of 
PI3P (Phosphoinositol 3-Phosphate) by the class III PI3K (Phosphoinositide 3-Kinase) complex promotes 
the formation of the autophagosomal membrane and the LC3 (Microtubule-associated protein 1A/1B-Light 
Chain 3) and Atg12-Atg5-Atg16L1 ubiquitin-like conjugation systems is important for elongation of the 
phagophore. The formed autophagosome matures by fusing with endosomes to form the amphisome and 
with the lysosome to form the autolysosome. The sequestered cargo is degraded by the lysosomal 
proteases and recycled. 
1.1.1 Autophagy initiation 
Autophagosomes are double-membraned vesicles that sequester cytosolic proteins 
and organelles for lysosomal degradation. Different membrane sources have been 
proposed to be the origin of the autophagosomal membrane, of which the ER-
mitochondrial contact site seems to be one of the main origins of the phagophore, 
followed by further expansion using membranes from the plasma membrane, 
endoplasmic reticulum (ER), recycling endosomes, mitochondria and the ER-Golgi 
intermediate compartment (Lamb et al., 2013, Bento et al., 2016, Yla-Anttila et al., 
2009, Hailey et al., 2010, Hamasaki et al., 2013, Ge and Schekman, 2014, Hayashi-
Nishino et al., 2009).  
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Autophagosome biogenesis is initiated by the recruitment of the mATG9 (mammalian 
Atg9) positive vesicles to the PAS (phagophore assembly site) and the formation of a 
phagophore (Mari et al., 2010). In yeast, the transmembrane protein Atg9 is a substrate 
of the kinase Atg1 (mammalian ULK1/2), and in yeast its phosphorylation is essential 
for the recruitment of Atg18 (mammalian WIPI-1, 2, 3, 4, WD repeat domain 
phosphoinositide-interacting proteins) and Atg8 (mammalian LC3A, B, C; GABARAPs; 
Gate-16). Upon autophagy induction, Atg1 and Atg13 assemble with tetrameric Atg17 
(mammalian FIP200, FAK family kinase Interacting Protein of 200 kDa) into a complex 
and this complex promotes the binding of Atg9 to Atg17, which is the first scaffolding 
protein to arrive at the PAS and was found to have membrane tethering activity 
(Papinski et al., 2014, Rao et al., 2016, Suzuki et al., 2015). 
In mammals, the ULK1 (Unc-51 Like autophagy activating Kinase 1) complex, 
consisting of the kinase ULK1 (or the orthologue ULK2, which has a redundant function 
(Lee and Tournier, 2011)), the scaffold FIP200, ATG13 and Atg101 transduces the 
upstream signals from mTORC1 (mammalian Target Of Rapamycin Complex 1) and 
AMPK (5’ Adenosine Monophosphate-activated Protein Kinase) to initiate autophagy 
by phosphorylating Beclin1 and Atg14L, which are part of the class III PI3K (PI3 
Kinase) complex (Figure 1) (Russell et al., 2013, Park et al., 2016). This complex 
consists of Beclin 1, the PI (phosphatidylinositol) kinase Vps34 (vacuolar protein 
sorting 34), Vps15 and Atg14L (Park et al., 2016) and promotes the local production 
of PI3P (phosphatidylinositol 3-phosphate), thereby promoting the formation of the 
autophagosomal membrane (Papinski and Kraft, 2016). The PI3P rich membrane 
patches recruit PI3P-binding proteins, such as WIPI family members and DFCP1 
(Double FYVE-Containing Protein 1) (Axe et al., 2008) (Figure 1). Recently, it was 
shown that WIPI2 interacts with Atg16L1 and recruits the Atg12-Atg5-Atg16L1 to the 
phagophore (Dooley et al., 2014). 
1.1.2 The two ubiquitin-like conjugation systems 
The elongation of the phagophore is coordinated by two ubiquitin-like conjugation 
systems, consisting of an E1-like activating enzyme, an E2-like conjugating enzyme 
and an E3-like ligase. The first conjugation system involves a group of ubiquitin-like 
proteins from the mammalian Atg8-like family. The Atg8 family can be subdivided in 
three families; the LC3 (Microtubule-associated protein 1A/1B-Light Chain 3), 
GABARAP (γ-aminobutyric acid receptor-associated protein) and GATE-16 (Golgi-
associated ATPase enhancer of 16 kDa) family. These ubiquitin-like proteins can be 
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modified with the lipid PE (phosphatidylethanolamine) and thus exists in two forms, a 
soluble and membrane bound form (for example LC3-I and II, respectively), of which 
the membrane bound form can be incorporated into the phagophore- and 
autophagosomal membrane (Kabeya et al., 2000, Kabeya et al., 2004). For example 
proLC3, in order to be lipidated needs to be modified by Atg4B to become LC3-I, this 
is followed by a reaction with Atg7 and the E2-like enzyme Atg3 (Tanida et al., 2004), 
resulting in the conjugation of LC3-I with PE to form LC3-II (Figure 2) (Kabeya et al., 
2000). In mammals, LC3B is the most prevalent form and often used as a marker for 
autophagosomes. LC3 is mainly cytosolic and nuclear localised, and recently it was 
found that upon starvation LC3 is redistributed from the nucleus to the cytosol. This 
redistribution requires deacetylation of LC3 by Sirtuin 1, which promotes the interaction 
with the nuclear protein DOR and the cytosolic protein Atg7. DOR shuttles LC3 out of 
the nucleus to the cytosol, where LC3 is able to bind Atg7 (Huang et al., 2015). 
The other ubiquitin-like conjugation system involves the E1-like enzyme Atg7 and the 
E2-like enzyme Atg10, which conjugate the ubiquitin-like protein Atg12 to Atg5. This 
conjugate then forms a complex with Atg16L1, which acts as an E3-like ligase that 
promotes the elongation of the phagophore by recruiting Atg3, which is essential for 
LC3 lipidation (Figure 2) (Hanada et al., 2007). During the entire autophagy cycle, LC3-
II remains on the inner autophagosomal membrane, and eventually is degraded in the 
autolysosome by the lysosomal hydrolases. The LC3-II that is present at the outer 
membrane is removed by Atg4B (Nakatogawa et al., 2012). On the contrary, as soon 
as formation of the autophagosome is completed, Atg12-Atg5-Atg16L1 complex is 
removed from the autophagosomal membrane. Deletion of the essential autophagy 
gene Atg5 results in a block in autophagy and therefore is often used to model 
autophagy-deficient conditions (Komatsu et al., 2005, Mizushima et al., 2001).  
Till very recently it was thought that the Atg8 family is required for the formation and 
elongation of autophagosomes and the recruitment of autophagy receptors and their 
cargo, however Nguyen et al. showed that in cells in which all three LC3 isoforms and 
the three GABARAP isoforms were knocked out, autophagosomes were still formed, 
(Nguyen et al., 2016b). They convincingly showed that instead of being important for 
autophagosome formation, the Atg8 proteins have a crucial role in the fusion of 
autophagosomes with lysosomes. Their results were confirmed in another study where 
knockout of Atg3, Atg5 and Atg7 blocking conjugation of PE to Atg8 proteins does not 
prevent formation of autophagosomes (Tsuboyama et al., 2016) (Figure 2). 
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Another surprising finding was that mitochondria still recruit to the autophagosome in 
cells lacking the 6 Atg8 proteins, showing that Atg8 family members are not essential 
for this process either and other proteins can provide a link between the cargo and the 
autophagosome (Nguyen et al., 2016b).  
 
Figure 2 Diagram of the two ubiquitin-like conjugation systems in autophagy. 
First Atg4B cleaves ProLC3 to form LC3-I, which reacts with Atg7 and Atg3, resulting in the conjugation to 
PE (phosphatidylethanolamine) to form LC3-II. Atg7 and Atg10 conjugate Atg12 to Atg5, which forms a 
complex with Atg16L1. This complex recruits Atg3 to the phagophore and thereby promotes LC3-I 
lipidation. 
1.1.3 Autophagosome maturation 
The final step of autophagosome biogenesis is the maturation step, which involves the 
fusion with endosomes and lysosomes to form amphisomes and autolysosomes 
respectively. Generally, autophagosomes fuse with endosomes before the final 
maturation into autolysosomes (Filimonenko et al., 2007). These steps involve several 
vesicle fusion events, which are mediated by different proteins, such as Rab GTPases, 
membrane-tethering factors and cytoskeleton-related proteins. The timing of the fusion 
with lysosomes is of essential importance, for the autophagosome has to be closed. 
The actual closure of autophagosomes is poorly understood, potentially Atg2A and 
Atg2B are implicated in this process, because knock-down of these proteins result in 
the accumulation of unclosed autophagosomes (Velikkakath et al., 2012). At the 
moment it is not completely clear how the fusion machinery recognises a closed 
autophagosome. Removal of LC3-II from the outer autophagosomal membrane by 
Atg4B has been suggested to be a signal (Kirisako et al., 2000). When 
autophagosomes are closed, using actin filaments and microtubules they move 
towards the perinuclear region, where the lysosomes reside and there fusion can take 
place (Fass et al., 2006, Jahreiss et al., 2008, Monastyrska et al., 2009). The Vps34 
complex containing UVRAG (UV Radiation Resistance Associated Gene protein) and 
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Atg14L is directly associated with autophagosome maturation (Zhong et al., 2009, Di 
Bartolomeo et al., 2010), whilst binding of Rubicon to this complex negatively regulates 
maturation (Zhong et al., 2009, Kang et al., 2011).  
Membrane tethering factors facilitate the docking and fusion process by acting as a 
bridge between two different membranes. The HOPS (homotypic fusion and protein 
sorting) complex, consisting of Vps11, Vps6, Vps18, Vps33A, Vps39 and Vps41, via 
its interaction with the autophagosomal SNARE (Soluble NSF Attachment protein) 
Receptor) syntaxin 17, promotes the autophagosome-lysosome fusion, together with 
the GTPase Rab7 (Huotari and Helenius, 2011, Jager et al., 2004, Hyttinen et al., 
2013). LC3 recruits PLEKHM1 (Pleckstrin homology domain containing protein family 
member 1) to the autophagosome, where it interacts with the HOPS complex and Rab7 
(Nguyen et al., 2016b, McEwan et al., 2015). PLEKHM1 was suggested to function as 
an endolysosomal adapter platform that functions in the final maturation of 
autophagosomes and also mediates autophagosome-lysosome fusion (McEwan and 
Dikic, 2015, McEwan et al., 2015).  
Recently it was shown that lipids also play and essential role in governing 
autophagosome maturation. It was found that the inositol polyphosphate 5-
phosphatase INPP5E regulates the fusion of autophagosomes with lysosomes. At the 
lysosomes, INPP5E dephosphorylates PI(3,5)P2 (Phosphatidylinositol 3,5-
bisphosphate), which competes with actin filaments for cortactin binding. By 
decreasing the PI(3,5)P2 levels, INPP5E promotes actin polymerisation at the 
lysosome, which allows autophagosome-lysosomes fusion (Hasegawa et al., 2016, Li 
et al., 2016). 
Finally, different membrane anchored snares have been linked to autophagosome 
maturation, which are reviewed in (Wang et al., 2016d). After this step, the 
autophagosomal cargo can be degraded by lysosomal hydrolases. 
1.1.4 Autophagy regulation via mTORC1 signalling 
Autophagy can be highly up-regulated under starvation and is mostly considered 
nonspecific, thus degrading proteins and other cytosolic macromolecular components 
that are not specifically targeted for degradation. The nutrient sensor mTORC1, which 
was first discovered in yeast and later in flies, is one of the key upstream autophagy 
signalling pathways (Noda and Ohsumi, 1998, Scott et al., 2004). The key mTOR 
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protein exists in two multimeric complexes, mTORC1 and mTORC2, of which 
mTORC1 regulates autophagy initiation. The mTORC1 complex consists of 5 subunits, 
including the scaffold raptor (regulatory associated protein of mTOR), the kinase 
inhibitors DEPTOR (DEP domain containing mTOR-interacting protein), PRAS40 
(Proline-Rich Akt Substrate of 40 kDa), mLST8 (mTOR complex subunit LST8 (Lethal 
with SEC13 protein 8)) and the protein kinase mTOR (Laplante et al., 2012). mTORC1 
integrates a wide variety of anabolic and catabolic signals, such as growth factors, 
nutrients (amino acids), cellular energy (high AMP/ATP ratio) and oxygen levels to 
control protein, nucleotide, lipid synthesis, lysosome biogenesis and autophagy 
(Goberdhan et al., 2016). Growth factor signalling through PI3K and Akt (Protein 
Kinase B) mainly signal via the TSC (Tuberous Sclerosis Complex)-Rheb (Ras 
homolog enriched in brain) signalling axis to activate mTORC1 (Petiot et al., 2000, 
Cantley, 2002, Inoki et al., 2002). Amino acids, mainly leucine, but also arginine, 
glutamine and serine, regulate mTORC1 activity via different mechanisms. Recently 
different proteins were identified to be specific amino acids sensors; Sestrin2 as a 
leucine sensor (Saxton et al., 2016); SLC38A9 (SoLute Carrier family 38 member 9) 
as a putative arginine sensor (Wang et al., 2015); CASTOR1 (Cytosolic Arginine 
Sensor for mTORC1 subunit 1) as an arginine sensor (Chantranupong et al., 2016). 
Arginine was also shown to be able to regulate mTORC1 via the TSC complex (Carroll 
et al., 2016). The TSC2 subunit of this complex acts as a GAP (GTPase Activating 
Protein) on the small GTPase Rheb, promoting the hydrolysis of GTP to GDP, resulting 
in mTORC1 inhibition (Zhang et al., 2003). Finally, low cellular energy levels (low 
AMP/ATP ratio) can be sensed by AMPK, which negatively regulates mTORC1, but 
also can promote autophagy directly via the ULK1 and Beclin 1 phosphorylation (Kim 
et al., 2011, Zhang et al., 2016). 
Active mTORC1 results in the phosphorylation of the downstream translation 
regulators S6K1 (p70-S6 Kinase 1), eIF4E (eukaryotic Initiation Factor 4E) and 4E-
BP1 (4E-Binding Protein 1) (Laplante and Sabatini, 2012). In addition to regulation of 
protein synthesis, mTORC1 regulates autophagy via several mechanisms. Firstly, 
activated mTORC1 can interact with the ULK1-Atg13-FIP200 complex and 
phosphorylate ULK1 and Atg13, thereby inhibiting autophagy at an early stage 
(Hosokawa et al., 2009, Jung et al., 2009, Ganley et al., 2009). Secondly, recently 
UVRAG was identified as a mTORC1 substrate, its phosphorylation negatively 
regulates autophagy at a later stage by affecting autophagosome and endosome 
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maturation (Kim et al., 2016). Thirdly, mTORC1 negatively regulates autophagy at the 
transcriptional level by phosphorylating TFEB (Transcription Factor EB), which 
prevents its translocation to the nucleus and inhibits the transcription of autophagy and 
lysosomal related genes (Martina et al., 2012). Finally, mTOR can regulate autophagy 
at the post-transcriptional level via Dcp2 (Decapping mRNA 2). In nutrient rich 
conditions, mTOR phosphorylates Dcp2, allowing the degradation of autophagy 
related mRNA transcripts (Hu et al., 2015). These different pathways identified to date 
regulate the autophagy signals downstream of mTORC1. 
1.1.5 Autophagy regulation by reactive oxygen species (ROS) 
In addition to starvation, several other stressors can activate autophagy. For example, 
ROS has been shown to modulate autophagy. At high levels ROS are detrimental for 
the cell, but lower levels have been shown to act as signalling molecules. For example, 
ROS has been shown to increase Beclin1 expression (Chen et al., 2008), as well as 
p62 expression via the Nrf2 (Nuclear factor (erythroid-devided2)-like 2) antioxidant 
pathway (Jain et al., 2010). Also ROS can impinge on the mTOR signalling pathway 
and thereby indirectly modulate autophagy (Yoshida et al., 2011, Alexander et al., 
2010). A more direct regulation of autophagy by ROS was demonstrated by a direct 
redox regulation of ATG4. It was shown that hydrogen peroxide inactivates ATG4 by 
oxidising a catalytic cysteine, resulting in the promotion of LC3 lipidation (Scherz-
Shouval et al., 2007). So far, ATG4 is the only direct ROS substrate identified in the 
autophagy pathway and as ROS accumulate with age and in age-related diseases, it 
would be interesting to investigate if there are more direct targets in the autophagy 
machinery that can be redox regulated.  
1.2 Selective autophagy 
In addition to bulk autophagy degradation, selective forms of autophagy have recently 
been described. Selective autophagy is commonly associated with its housekeeping 
roles in the maintenance of cellular homeostasis. An important role of selective 
autophagy is evident in the context of many neurodegenerative diseases for the 
clearance of aggregate-prone proteins (aggrephagy) and selective degradation of 
organelles, for example mitochondria (mitophagy). Other targets of selective 
autophagy include peroxisomes (pexophagy), ER (reticulophagy), ribosomes 
(ribophagy), bacteria (xenophagy), viruses (virophagy) and nuclear envelope 
(nucleophagy (Bjorkoy et al., 2005, Kim et al., 2008, Novak and Dikic, 2011, Geisler et 
al., 2010, Zheng et al., 2009, Orvedahl et al., 2010, Bernales et al., 2006, Mochida et 
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al., 2015). Growing evidence suggests that adaptor proteins, such as p62, OPTN 
(optineurin), NDP52 (Nuclear Dot Protein 52 kDa), TAX1BP1 (TAX1 Binding Protein 
1) and NBR1 (Neighbor Of BRCA1 gene 1 protein) act as shuttle proteins that transport 
ubiquitinated proteins to the autophagosome via interactions with both ubiquitin and 
the autophagic component LC3-II (Johansen and Lamark, 2011, Lazarou et al., 2015). 
1.2.1 Ubiquitin as a degradation signal for selective autophagy 
Ubiquitin (Ub) has a major role in selective autophagy, as unwanted or aberrantly 
folded proteins are tagged with Ub signals and are recognised by autophagy receptors. 
Ubiquitinated proteins can be degraded either by the proteasome or via autophagy 
depending on the Ub signal. Ub can form a wide variety of homo- and heterotypic Ub-
chains on protein substrates, resulting in a distinct cellular responses (Akutsu et al., 
2016). Ub is a small protein and can be covalently attached with its C-terminus to a 
protein substrate or to itself. Three different enzymes are required for this process: an 
E1 ubiquitin-activating enzyme, an E2 ubiquitin-conjugating enzyme and an E3 
ubiquitin-ligating enzyme (Figure 3) (Clague et al., 2015). Ub can be ligated to one or 
multiple lysines (K) with one Ub molecule (mono-ubiquitination) or Ub chains 
(polyubiquitination). Ub has 7 lysine residues and in order to form a chain they can be 
conjugated through different lysines (K6, K11, K27, K29, K33, K48 and K63) or a N-
terminal methionine (M1). These options present enormous possibilities to assemble 
a specific chain. Furthermore, chains can be branched, the length can vary and Ub 
can be post-translationally modified (acetylation and phosphorylation), giving even 
more diversity (Akutsu et al., 2016). The fate of ubiquitinated proteins depends on the 
nature of the Ub modification. Different Ub modifications are specifically recognised by 
different Ub-binding proteins, resulting in a specific cellular response. Ub modifications 
can also alter a protein’s enzymatic activity, localisation or stability (Husnjak and Dikic, 
2012). Most research has been done on K48- and K63-linked Ub chains, however, 
more recently also other previously considered atypical chains have been studied in 
more detail (Akutsu et al., 2016). For example, K11-linked poly-Ub chains have been 
implicated in cell cycle control and Beclin 1 function, whereas linear M1-linked chains 
have been linked to NF-Κβ (Nuclear Factor kappa-light-chain-enhancer of activated B 
cells signalling) (Shimizu et al., 2015, Jin et al., 2016, Wickliffe et al., 2011). 
K48-poly-Ub chains are the canonical signal for proteasomal degradation, whilst 
proteins marked with K63-poly-Ub participate in cellular signalling pathways and 
autophagy (Tan et al., 2008). Recently it has become apparent that autophagy 
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receptors can recognise different Ub modification, depending on the ubiquitin binding 
domain, which will be discussed in more detail in section 1.3.1.  
 
Figure 3 Schematic diagram of the ubiquitin-conjugation system. 
The ubiquitination process involves three types of enzymes: ubiquitin-activating (E1), ubiquitin-
conjugating (E2) and ubiquitin-ligating (E3) enzymes, which recognises the substrate. Deubiquitinating 
enzymes (DUBs) can remove the Ub residue from the substrate. 
1.3 Autophagy receptors 
Autophagy receptors are poorly conserved from yeast to humans, in contrast to the 
core autophagy machinery, however functional homologs are present. Also as a gene 
group, autophagy receptors are not very conserved compared to the autophagy genes 
(Till et al., 2015, Tumbarello et al., 2015). In this section, a subset of autophagy 
receptors, p62, NBR1, OPTN, NDP52 and TAX1BP1 will be discussed, which all have 
been implicated in selective autophagy and share structural and functional similarities 
(Johansen and Lamark, 2011).  
In order to bind to ubiquitinated cargo these autophagy receptors contain an ubiquitin 
binding domain. In addition, some of them have the ability to oligomerise and they all 






Figure 4 Schematic diagram of the domain structure of p62, NBR1, OPTN, NDP52 and TAX1BP1. 
The Ubiquitin binding domains are depicted in purple, PB1 domains in red, CC domains in blue, LC3-binding 
domains in green, ZZ domain in orange, KIR domain in yellow and the SKICH domain in grey. p62 also 
contains nuclear localisation signals, depicted in black.  
1.3.1 Ubiquitin binding domains (UBDs) 
Ub modifications are recognised by a variety of Ub binding domains. These domains 
are functionally and structurally diverse, reflecting the variation in Ub signals (Rahighi 
and Dikic, 2012). The most common UBD fold into α-helices, such as the UBA (Ub 
Associated) and the UBAN (UBD in Abin proteins and NEMO) domain. p62 and NBR1 
both contain a UBA domain at the C-terminus. p62 binds mono-and poly-Ub and the 
UBA-domain of p62 can form homodimers in vitro and this inhibits Ub binding. Several 
mutations in the p62 UBA-domain, resulting in the loss of its ability to bind ubiquitin, 
have been shown to be to be associated with Paget disease (Section 1.4.1) (Rea et 
al., 2013). The UBA-domain structure of NBR1 has been solved and has been 
compared to the p62 UBA-domain. Surprisingly, even though both UBA-domains are 
very similar, the UBA-domain of NBR1 has a higher affinity for Ub (Walinda et al., 
2014). Walinda et al. observed that the p62 residue S403 which can be 
phosphorylated, resulting in an increased affinity for ubiquitin, is replaced by a 
hydrophobic residue in NBR1, which might increase the affinity for Ub (Walinda et al., 
2014, Matsumoto et al., 2011). OPTN contains an UBAN-domain located within the C-
terminal CC (Coiled Coil) domain, which is an ubiquitin-binding domain shared among 
OPTN, NEMO (NF-Kβ Essential Modulator) and ABIN1-3 (A20-Binding Inhibitor of NF-
Κβ) (Wagner et al., 2008, Husnjak and Dikic, 2012). In NEMO and ABINs the UBAN-
domain has been demonstrated to have an important role in the regulation of NF-Κβ 
signalling (Wagner et al., 2008). In general, UBAN-domains form a coiled coil, which 
has specificity for linear Ub chains (Rahighi et al., 2009, Dikic and Dotsch, 2009). 
Interestingly, a missense mutation in the OPTN UBAN-domain (E478G) has been 
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associated with ALS (Amyotrophic Lateral Sclerosis) (Maruyama et al., 2010) (Section 
1.4.2). 
Another group of UBDs contain zinc fingers, such as the UBZ (Ubiquitin-Binding ZnF) 
domain, which is present in NDP52 and TAX1BP1. In NDP52, the UBZ-domain 
contains two zinc fingers, which recently have been characterised in more detail. The 
first ZZ-domain (ZF1) is at amino acid (aa) 392-413, which is an unconventional 
dynamic CysCysCysHis (CCCH) zinc domain, whereas the second ZZ-domain (ZF2) 
at amino acid 414-446 is a ubiquitin-binding CCHH zinc finger (Xie et al., 2015). The 
ZF2 can recognise mono-Ub and different linkage types poly-Ub chains. Both the ZF1 
and ZF2 are involved in binding to myosin VI, which has been shown to be important 
for autophagosome maturation during xenophagy (Verlhac et al., 2015a, Tumbarello 
et al., 2012, Morriswood et al., 2007, Xie et al., 2015). TAX1BP1 has two C-terminal 
UBZ-domains, of which the crystal structures have been determined (Ceregido et al., 
2014). The second UBZ-domain was shown to be required for Ub binding and binds 
with high-affinity to K63-linked chains (with a higher affinity than NDP52 and OPTN) 
and also is able to bind to linear tetra-ubiquitin. Finally, in contrast to NDP52 and 
OPTN, TAX1BP1 can bind K48-linked chains as well (Tumbarello et al., 2015). A 
combination of both UBZ1 and UBZ2 domains is important for Myosin VI binding. It 
was suggested that TAX1BP1 first binds with a lower affinity to ubiquitin, followed by 
binding to Myosin VI on the out membrane of the autophagosome (Tumbarello et al., 
2015).  
1.3.2 PB1 domain 
p62 and NBR1 contain a PB1 (Phox and Bem1) domain at the N-terminus. The p62 
PB1 domain has oppositely charged surfaces and enables p62 to oligomerise. It can 
oligomerise with itself, and can also form heterodimers with the PB1 domain of other 
proteins, like aPKCs (atypical Protein Kinase C), MEK5 (MAPK/ERK Kinase 5) and 
NBR1 (Lamark et al., 2003). The rear end acidic cluster of the p62 PB1 domain 
interacts with MEKK3 (MAPK Kinase Kinase 3)(Nakamura et al., 2010). All these 
interactions allow p62 to participate in different signalling pathways. For example, the 
interaction with aPKCs plays an important role in NF-Κβ signalling (Sanz et al., 2000). 
Self-oligomerisation of p62 via PB1 domain is also essential for its role in degradation 
of autophagic substrates (Ichimura et al., 2008). Recently, it was established that the 
PB1 domain and part of the linker domain between the PB1 and ZZ domains drive the 
formation of p62 filaments. The PB1 domain functions as a helical scaffold, promoting 
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oligomerisation. This oligomerisation and formation of p62 filaments is proposed to 
present multiple LC3 binding sites to promote growth of the phagophore onto the 
filaments (Ciuffa et al., 2015). The region between the PB1 and ZZ domains is an 
unstructured region that is rich of basic and acidic residues. A charge-reversal mutant 
affects p62 aggregation, suggesting that this electrostatic bridge stabilises the PB1 
domain (Ciuffa et al., 2015).  
In NBR1 the PB1 domain enables NBR1 to interact with p62 and mutation D50R 
prevents this interaction (Kirkin et al., 2009). Unlike p62, NBR1 does not oligomerise 
via its PB1 domain, because it lacks the N-terminal basic charge cluster (Kirkin et al., 
2009). Therefore, it could be hypothesised that NBR1 binding to p62 inhibits the 
formation of p62 oligomers. 
NBR1 uses the N-terminal CC domain to form oligomers and uses PB1 domain to bind 
to titin (also known as connectin), which is a very large filamentous protein (about 4000 
kDa) found in the striated muscle (Lange et al., 2005; Müller et al., 2006). 
In a recently published study, it was shown that autophagy receptors without the ability 
to oligomerise reside on the outer membrane, whilst oligomerised receptors reside on 
the inner membrane of the autophagosome, resulting in their degradation. Therefore, 
not the LC3 binding, but the ability to oligomerise in addition to LC3 binding determines 
if a protein is an autophagy substrate (Hirano et al., 2016). 
1.3.3 CC domain  
A coiled coil is a common structural motif in proteins in which 2-7 alpha-helices are 
coiled together. NBR1 contains two CC domains and the second one is important for 
dimerisation (Kirkin et al., 2009). It has been hypothesised that the dimerisation via the 
CC domain is not sufficient to induce formation of large NBR1-positive protein 
aggregates and that this step thus is dispensable for NBR1-dependent selective 
autophagy (Shi et al., 2014). OPTN contains two CC domains and its structure is 
predicted to be over 70% coiled-coiled. A Leucine-zipper (LZ domain) is located within 
the N-terminal CC domain, and the UBAN-domain is located within the C-terminal CC 
domain. The N-terminal domain is required for TBK1 (TANK1 Binding Kinase 1) 
binding, which serves as an important component of multiple signalling pathways, such 
as NF-Κβ, but also a role for TBK1 in autophagy is emerging. The kinase TBK1 
phosphorylates OPTN at S177 (Wild et al., 2011, Lazarou et al., 2015), which promotes 
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LC3 binding, as well as S473 and S513 which results in an increased selectivity and 
stronger binding for OPTN to poly-Ub chains (Lazarou et al., 2015). 
Leucine zippers consist of a periodic repetition of a leucine residue at every seventh 
position (heptad repeat) and forms α-helix, which facilitates dimerisation and in some 
cases higher oligomerisation of proteins. Leucine zippers are known to be sites for 
protein-DNA or protein-protein interaction. The function of the OPTN LZ domain (aa 
143-164) has not been studied in detail, but it was shown to be partially required for 
Rab8 and transferrin receptor binding (Park et al., 2010). Finally, the C-terminal CC 
domain of OPTN has been shown to bind to mutant Huntingtin and mutant SOD1 
(SuperOxide Dismutase 1) aggregates in an ubiquitin-independent manner (Korac et 
al., 2013).  
The middle region of NDP52 consists of a CC domain, which is important for 
dimerisation of NDP52 and binding to leucine rich repeat and LRSAM1 (Leucine rich 
Repeat and Sterile Alpha Motif containing 1), an E3 Ub ligase that has been implicated 
in xenophagy (Huett et al., 2012). Interestingly, a mutation in the NDP52 CC domain 
has been linked to Crohn’s disease, which is an inflammatory bowel disease that is 
potentially caused by impaired autophagy (Ellinghaus et al., 2013). TAX1BP1 contains 
3 CC domains, of which the second CC domain (aa 320-420) is required for TRAF6 
(TNF Receptor Associated Factor 6) binding (Ling and Goeddel, 2000). The role of the 
other CC domains is not known, but potentially could promote the formation of higher 
order structures (Woolfson et al., 2012).  
1.3.4 LC3-binding motifs 
In order to degrade the bound cargo, the autophagy receptors need to bind to LC3-II. 
The canonical LC3-binding motifs (LIR) consist of a sequence with a core motif 
corresponding to W/F/Y-XX-L/I/V (where X can be any amino acid). In p62, the LIR 
motif (amino acid 335-341) is critical for the interaction of p62 with LC3 for autophagic 
degradation. p62 binds all Atg8 family members: LC3A, B and C and GABARAP, 
GABARAPL1 and GABARAPL2 (Pankiv et al., 2007, Rogov et al., 2017) in its soluble 
and insoluble form and the PB1 domain is not essential for this interaction (Kraft et al., 
2016, Wurzer et al., 2015). Intriguingly, p62 mutations linked to ALS-FTLD have been 
mapped to the LIR motif (Rea et al., 2014). OPTN also contains a typical LIR motif (W-
V-E-I) similar to p62, and it is required for LC3 recruitment to damaged mitochondria 
and the degradation of Salmonella (Wong and Holzbaur, 2014, Wild et al., 2011). 
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NBR1 has a non-canonical LIR motif (C-LIR) that consists of 8 amino acids (SEDYIIIL) 
N-terminal of its C-terminal CC domain (Waters et al., 2009), which binds specifically 
to GABARAPL1. The structure of the NBR1 LIR motif with GABARAPL1 revealed that 
the 4 hydrophobic residues (YIII) of NBR1 are important for this interaction (Rozenknop 
et al., 2011; Klionsky and Schulman, 2014). 
NDP52 has a typical LIR motif in the SKICH domain, however, this domain does not 
mediate NDP52 binding to LC3, because it is not accessible for binding. Instead, a C-
LIR motif is present in the linker region between the SKICH and CC domains (von 
Muhlinen et al., 2012), which binds to LC3C specifically. The C-LIR motif comprises of 
L-V-V, which is different from the canonical LIR motif, which comprises of W-I-G-I. The 
main difference between the two motifs is that the C-LIR motif selectively binds to 
LC3C, whereas the LIR motif interacts with all members of the LC3 family as well as 
LC3 homologs GABARAP, GABARAPL1, and GABARAPL2 (von Muhlinen et al., 
2012). In addition, recently another LIR-like motif was identified, which is present in the 
CC domain and is essential for NDP52-mediated autophagosome maturation, but not 
for targeting of bacteria to autophagosomes (Verlhac et al., 2015a). The C-LIR motif 
of TAX1BP1 can bind to LC3B, LC3C, GABARAPL1 an L2. It was shown that there is 
no preference in binding to LC3B or LC3C, which is in contrast to NDP52 and OPTN, 
which both have a higher affinity for LC3C (Tumbarello et al., 2015). 
Clearly, some specificity exists in binding to the different Atg8 family members, 
however the mechanism of this specificity remains to be understood and also the 
biological and functional significance of binding to these different Atg8 family members 
is not known.  
1.3.5 ZZ domain 
ZZ-type zinc finger (ZZ) domain can bind two zinc ions and are thought to be involved 
in protein-protein interactions. The p62 ZZ domain mediates the interaction with RIP 
(Receptor-Interacting serine/threonine-Protein Kinase 1, also called, RIP1 or RIPK1), 
which is implicated in p38MAPK signalling (Festjens et al., 2007; Yu et al., 2009). 
Through its ZZ domain p62 can also directly interact with AMPA (α-Amino-3-hydroxy-
5-Methyl-4-isoxazolePropionic Acid) receptor subunits and thereby recruit the AMPA 
receptor for phosphorylation by aPKC and thereby regulating synaptic plasticity (Jiang 
et al., 2009). Recently, the p62 ZZ domain was shown to be required for recognition of 
N-terminal arginylated ER proteins destined for degradation via autophagy (Cha-
Chapter 1 
16 
Molstad et al., 2016, Cha-Molstad et al., 2015). OPTN and NBR1 also contain a ZZ 
domain, however the function remains to be determined.  
1.3.6 NLS and NIS signals 
Interestingly, p62 and OPTN have been shown to localise to the nucleus in certain 
conditions. In unstressed cells p62 is primarily found in the cytoplasm, but due to its 
two nuclear localisation signals and an export signal (NLS1, NLS2 and NES), p62 can 
shuttle between the nucleus and cytoplasm. This is an active process and happens at 
a high rate (Pankiv et al., 2010). In the nucleus, p62 is found to localise to PML 
(ProMyelocytic Leukaemia) bodies and protein aggregates in vitro and in vivo 
(Pikkarainen et al., 2011). Furthermore, p62 was found to be dynamically associated 
with DNA damage foci, where it interacts with filamin A. p62 promotes the proteasomal 
degradation of filamin A and RAD51 (RAD51 recombinase) in the nucleus, resulting in 
a slower DNA repair (Hewitt et al., 2016). OPTN migrates to the nucleus upon oxidative 
stress, however nuclear localisation signals have not been identified (De Marco et al., 
2006). 
1.3.7 SKICH domain 
NDP52 and TAX1BP1 contain an N-terminal SKICH domain, which resembles an IG-
fold lacking the 8th β-sheet (Gurung et al., 2003). The NDP52 SKICH domain is 
responsible for the interaction with Nap1 (Thurston et al., 2009) and phosphorylated 
tau (Jo et al., 2014). The crystal structure of the TAX1BP1 SKICH domain was 
determined and revealed that this domain contains some conserved surface exposing 
aromatic residues, but the function remains unknown (Yang et al., 2014). Thus far, the 
biological function of the NDP52 and TAX1BP1 SKICH domain remains to be 
understood. 
1.3.8 KIR domain and Nrf2 signalling 
In addition to the different domains that have been implicated in the role of these 
receptors in autophagy, p62 also contains a KIR domain (Keap1 Interaction Region), 
which is important for the Nrf2 antioxidant pathway. Keap1 is an adaptor of the Cul3-
ubiquitin E3 ligase complex responsible for Nrf2 degradation. p62 binds to Keap1 
(Kelch-like ECH-associated protein 1) via its KIR domain, targets it for degradation, 
followed by the translocation of Nrf2 to the nucleus, where it activates genes that are 
important for the antioxidant response (Komatsu et al., 2010).  
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The Nrf2/Keap1 pathway is recognised as the main cellular defence mechanism 
against oxidative and electrophilic stresses. Nrf2 (Nuclear factor erythroid 2-related 
factor 2) is a transcription factor that mainly regulates the transcription of genes that 
are known as AREs (antioxidant response element genes) (Chorley et al., 2012), 
including antioxidant and phase II detoxification genes (Itoh et al., 1997, Thimmulappa 
et al., 2002). Under normal condition, Nrf2 is constitutively degraded by the UPS, 
because its binding partner Keap1 recruits the Cullin3 E3 ligase, which ubiquitinates 
Nrf2 and targets it for degradation by the proteasome (Zhang et al., 2004). In response 
to electrophiles or ROS Keap1 is inactivated through modification of its cysteines, it 
changes conformation which disrupts its binding to Nrf2. As a result, Nrf2 is stabilised 
and translocates to the nucleus, where it activates its target genes (Kobayashi et al., 
2006).  
p62 is involved in the Nrf2 antioxidant response pathway by facilitating the degradation 
of Keap1. p62 interacts with the Nrf2 binding site of Keap1, sequesters it and sends it 
for degradation by autophagy (Taguchi et al., 2012). Accumulated p62, in response to 
a block in autophagy, competes with the interaction between Nrf2 and Keap1, and 
enables Nrf2 to translocate to the nucleus and induce gene expression (Komatsu et 
al., 2010, Kwon et al., 2012). In response to stress serine 351 of the KIR-domain of 
p62 is phosphorylated, which increases the affinity for Keap1 and activates Nrf2. 
Interestingly, it was shown that this phosphorylation is mTORC1-dependent, linking 
the Keap1-Nrf2 system to nutrient signalling and autophagy (Ichimura et al., 2013). 
Furthermore, p62 contributes to a positive feedback loop, because Nrf2 signalling 
results in the induction of p62 gene transcription (Jain et al., 2010). 
1.4 Autophagy receptors in disease 
1.4.1 p62 in disease 
In the past years, mutations in p62 have been identified in patients with ALS and FTLD 
(FrontoTemporal Lobar Degeneration). Before those mutations were identified, p62 
was already linked to ALS. p62 was shown to form aggregates in ALS patients as well 
as in a mutant SOD1 mouse model (Gal et al., 2007, Mizuno et al., 2006). Moreover, 
p62 colocalises with FUS (FUsed in Sarcoma) and TDP-43 (TAR DNA-binding Protein 
43) in ubiquitin-positive inclusions in spinal cords from patients with sporadic and 
familial ALS (non-SOD1) (Deng et al., 2010) and p62 overexpression prevents TDP-
43 aggregation and promotes TDP-43 degradation in an autophagy and proteasomal 
manner (Brady et al., 2011). p62 promotes SOD1 aggregation in a motoneuron-like 
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cell line (Gal et al., 2007), where it binds SOD1 directly in an ubiquitin-independent 
manner. The p62 PB1 domain and a region between the ZZ domain and the TB 
(TRAF6 Binding) domain are essential for this interaction (Gal et al., 2009).  
As mentioned before, mutations in p62 have been identified in both familial and 
sporadic cases of ALS-FTD (FrontoTemporal Dementia) (Fecto et al., 2011, Rea et al., 
2014, Yang et al., 2015). ALS associated mutations in p62 are distributed in different 
domains throughout the protein (Figure 5) (Rea et al., 2014). A subset of mutations 
were found in the LIR motif, of which L341V was studied functionally, and it was shown 
that LC3B binding was impaired (Goode et al., 2016). Another subset of mutations 
locating to the PB1 domain, could affect p62 oligomerisation and thus possibly LC3 
binding. Additionally, many mutations reside in the UBA domain, and all mutants tested 
had impaired Ub binding (Rea et al., 2009). Interestingly most mutations identified in 
the UBA domain that are associated with ALS and/or FTLD, have been found in PDB 
(Paget’s Disease of Bone) patients as well (Rea et al., 2014). PDB is a common bone 
disorder characterised by enhanced resorption of bone as a result of overactivity of 
osteoclasts. A mouse with the P394L mutation (human P392L equivalent, the most 
frequent PDB mutation) developed a bone disorder similar to PDB patients 
(Daroszewska et al., 2011), no ALS or FTD related phenotype was mentioned, but 
most likely also not studied, because at the time p62 mutations had not been 
associated with ALS or FTD. The study does suggest that p62 mutations can play a 
causal role is PDB development and does not necessarily need an environmental 
trigger. It would be of interest to study the functional effect of all the different p62 
mutations. The PB1, LIR and UBA domain mutations have predictable effects on p62 
functioning in selective autophagy.  
Intriguingly, in addition to mutations in the ZZ, TB, KIR domain and the nuclear export 
signal, also mutations in unstructured regions and outside the known domain 
structures have been identified in ALS and/or FTLD (Figure 5). How these mutations 
effect function and result in the disease phenotype is unknown and of high importance 





Figure 5 Summary of p62 mutations found in ALS (Amytrophic Lateral Sclerosis) and FTD 
(Frontotemporal Dementia) patients. 
p62 diagram showing all ALS and FTD related p62 mutations identified to date (Rea et al., 2014, Yang et al., 
2015). In red, orange, blue, green, yellow and purple are the mutations locating to the PB1, ZZ, TB, LIR, KIR 
and UBA domain respectively. Mutations R312G, S318P, S318S and E319K occur in the nuclear export 
signal. Mutations visualised in bold (A33V, K238E, E274D, S318S, E319K and P392L) are mutations found 
in ALS and FTLD and the mutations in italic (R110C, V259L, R312G, K344E, A381V and P387L) were only 
found in FTLD cases, but not ALS. Mutations A381V, P387L, A390X, P392L, G411S, G425R have been 
reported in PDB (Paget’s Disease of Bone) previously (Rea et al., 2013).  
1.4.2 OPTN in disease 
Mutations in OPTN have been associated with the neurodegenerative diseases ALS, 
FTD and POAG (Primary Open-Angle Glaucoma) (Rollinson et al., 2012, Iguchi et al., 
2013, Pottier et al., 2015) (Cirulli et al., 2015, Rezaie et al., 2002). In POAG patients, 
retinal ganglion cells degenerate, which results in irreversible blindness. The cause of 
this genetic disease is not clear, several genes have been linked to the disease, 
however no common pathways were identified (Fingert, 2011). Since mutations in 
OPTN were identified, and also mutations in TBK1 were linked to the disease, selective 
autophagy dysfunction could be involved in POAG pathogenesis. Most of the OPTN 
mutations are missense singly copy mutations, which likely are dominant. One 
mutation, E50K, was shown to inhibit autophagy and endocytic recycling of the 
transferrin receptor (Nagabhushana et al., 2010, Chalasani et al., 2014). Furthermore, 
in neuronal cells differentiated from iPSCs (induced pluripotent stem cells) derived 
from POAG patients carrying the E50K mutation, revealed that the E50K mutant forms 
insoluble aggregates, which was suggested to contribute to the pathogenesis 
(Minegishi et al., 2013). This could potentially explain why the E50K mutant does not 
translocate to the nucleus upon H2O2 induced cell death (De Marco et al., 2006). The 
E50K mutation also resulted in enhanced TBK1 binding and it was shown that the 
insolubility of E50K OPTN was dependent of TBK1 (Minegishi et al., 2013). However, 
POAG associated mutant E50K did not affect mitophagy, suggesting that this is not 
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involved in the disease pathogenesis (Lazarou et al., 2015). However, more point 
mutations, distributes throughout the protein, have been identified in POAG patients, 
and these might have different effects on protein function (Sirohi and Swarup, 2016).  
Mutations in OPTN were first shown to cause autosomal recessive ALS, however later 
also heterozygous mutations were reported in familiar ALS cases (Maruyama et al., 
2010, van Blitterswijk et al., 2012). Mutations in OPTN were also associated with FTLD 
and these mutations were predicted to be highly pathogenic and result in loss of 
function and reduced protein levels (Pottier et al., 2015). In a minority of sporadic ALS 
patients, protein inclusions were shown to be positive for OPTN (Osawa et al., 2011, 
Hortobagyi et al., 2011).  
1.4.3 NDP52 in disease 
NDP52 is associated with intracellular Aβ (Amyloid peptide β)-plaques and 
neurofibrillary tangles in an Alzheimer’s mouse model (Kim et al., 2014) and has also 
been associated with hyper-phosphorylated tau in Alzheimer’s patients. NDP52 was 
also suggested to play a role in the degradation of hyper-phosphorylated tau (Jo et al., 
2014). 
As mentioned before, a mutation in NDP52 was found in Crohn’s disease patients. The 
V248A mutation impairs the regulatory function of NDP52 to inhibit NF-Kβ (Ellinghaus 
et al., 2013). It would be interesting to assess if the V248 variant also affects 
autophagy, especially xenophagy. A link between autophagy and Crohn’s disease was 
established previously, as mutations in core autophagy genes, ATG16L1, LRRK2 
(Leucine Rich Repeat Kinase 2), IRGM (Immunity-Related GTPase family M protein) 
and ULK1 were identified (Massey and Parkes, 2007, Chauhan et al., 2016, Chauhan 
et al., 2015, Henckaerts et al., 2011).  
1.5 Mitophagy 
The degradation of mitochondria via autophagy (also called mitophagy) mediates the 
clearance of damaged mitochondria, as well as mitochondria in a specific context, such 
as during erythrocyte maturation or to eliminate sperm-derived mitochondria after 
fertilisation. Mitophagy is one of the most studied selective autophagy pathways in the 
last years, because of the association of mitochondrial function with the development 
of neurodegenerative disease. In particular, mutations in two proteins PINK1 (PTEN-
INduced putative Kinase 1) and Parkin have been associated with Parkinson’s disease 
(Kitada et al., 1998, Valente et al., 2004), therefore the role of these two proteins have 
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been investigated in great detail. PINK1 is a serine/threonine kinase, which when the 
mitochondrial membrane potential (Δψm) is high, binds to PGAM5 (PhosphoGlycerate 
Mutase family member 5) in the IMM (Inner Mitochondrial Membrane). On the contrary, 
when mitochondria are damaged and the Δψm is low, PINK1 accumulates on the OMM 
(Outer Mitochondrial Membrane), where it recruits and phosphorylates Parkin, an E3 
ubiquitin-ligating enzyme, resulting in its activation (Figure 6) (Shiba-Fukushima et al., 
2014, Kondapalli et al., 2012). PINK1 phosphorylates Ub and Parkin has a high affinity 
for this pS65-Ub, resulting in recruitment of Parkin to the OMM (Kane et al., 2014, 
Kazlauskaite et al., 2014, Koyano et al., 2014, Ordureau et al., 2015). Binding of Parkin 
to pS65-Ub also results in a conformational change, resulting in Parkin activation 
(Okatsu et al., 2015, Wauer et al., 2015). Parkin then conjugates Ub onto OMM 
proteins, predominantly K48- and K63-linked chains, which also get phosphorylated by 
PINK1, thus recruiting more Parkin and resulting in a positive feed-forward loop 
(Ordureau et al., 2014). Also other Ub chains were identified, including K6- and K11-
linked chains, showing the variety of Ub chains on the mitochondria. Recently, two 
different mitochondrial anchored DUBs (DeUBiquitylases), USP30 (Ubiquitin-Specific 
Protease 30) and USP15 were found to negatively regulate PINK1/Parkin dependent 
mitophagy (Bingol et al., 2014, Cunningham et al., 2015, Cornelissen et al., 2014). 
The K48-linked chains most likely promote the extraction of OMM proteins and 
subsequent degradation by the proteasome (Tanaka et al., 2010, Yoshii et al., 2011). 
The K63-linked Ub chains were found to be mainly important for the recruitment of 
autophagy receptors to the damaged mitochondrion. p62, NBR1, TAX1BP1, NDP52 
and OPTN recruit to mitochondria during PINK1/Parkin induced mitophagy. Making 
use of HeLa PentaKO cells (CRISPR (Clustered Regularly Interspaced Short 
Palindromic Repeats) knock-out for OPTN, NDP52, p62, TAX1BP1 and NBR1) and re-
expressing the different autophagy receptors showed that primarily OPTN and NPD52 
and, to a smaller extent TAX1BP1, are required but functionally redundant for 
mitophagy (Wong and Holzbaur, 2014, Lazarou et al., 2015, Heo et al., 2015). It was 
shown that the expression patterns of the different receptors was different. In the brain 
OPTN is highly expressed, p62 expression is lower, and NDP52 is not detectable. 
Whilst, for example in the small intestine, moderate to high NDP52 and p62, and 
undetectable OPTN expression was observed (Lazarou et al., 2015). 
Furthermore, it was shown that OPTN and NDP52 have a higher affinity for pS65-Ub 
chains, however this was not detected in vitro suggesting that other factors or 
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modifications in vivo are required (Nguyen et al., 2016a). One of these modifications 
could be phosphorylation of the receptors, as OPTN, p62, NDP52 and TAX1BP1 can 
be phosphorylated by TBK1 (Figure 6) during mitophagy, and phosphorylation of 
OPTN resulted in an increased affinity for all Ub chains (Matsumoto et al., 2015, Heo 
et al., 2015, Moore and Holzbaur, 2016, Richter et al., 2016). TBK1 depletion or 
expression of ALS-associated OPTN or TBK1 mutations blocked the efficient 
degradation of mitochondria, suggesting that phosphorylation of OPTN by TBK1 is 
essential (Moore and Holzbaur, 2016). 
The role of p62 in mitophagy is controversial. Several reports indicate an essential role 
for p62 (Lee et al., 2010a, Geisler et al., 2010, de Castro et al., 2013, Pimenta de 
Castro et al., 2012). Others report that p62 is not essential, but has a role in 
mitochondrial clustering to prepare them for degradation (Lazarou et al., 2015, 
Narendra et al., 2010). Interestingly, it was thought that autophagy receptors recruit 
the autophagosomal membrane and machinery to the damaged mitochondrion. 
However, recently it became apparent that the autophagosomal membrane is built at 
the OMM upon mitophagy induction (Itakura et al., 2012, Lazarou et al., 2015). ULK1 
and Atg9 are recruited to the OMM to initiate the formation of the autophagosome. In 
HeLa PentaKO cells ULK1, DFCP1 and WIPI1 failed to recruit to the mitochondria, 
suggesting that these receptors are essential for the recruitment of the key proteins 
involved in autophagy initiation (Figure 6). Furthermore, NDP52 and OPTN were 
shown to be essential for ULK1 and DFCP1 recruitment. However, LC3 lipidation was 
not affected upon mitophagy induction in PentaKO cells, suggesting that the 
recruitment of key components of autophagy initiation and LC3 lipidation are 
independently regulated (Lazarou et al., 2015, Nguyen et al., 2016b). After the 
recruitment of ULK1-, DFCP1- and Atg9- positive vesicles to mitochondria, LC3 is 
recruited, which promotes fusion of the autophagosome with the lysosome (Figure 6) 
(Itakura et al., 2012, Nguyen et al., 2016b). It would be interesting to assess if 
mitophagy makes use of all the other canonical autophagy components in order to 
complete mitochondrial degradation. 
PINK1/Parkin dependent mitophagy has been studied in great detail, because it has 
been extensively implicated in human disease, especially neurodegeneration. 
However, alternative mitophagy pathways have been identified as well. Furthermore, 
it is under debate if mitochondrial defects due to mitophagy dysfunction caused by loss 
of PINK1 or Parkin are responsible for the loss of dopaminergic neurons in Parkinson’s 
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disease. This is mainly based on the fact that in conditional adult Parkin knockout mice, 
which show a clear loss of dopaminergic neurons, neither mitophagy defects nor 
mitochondrial accumulation was observed (Stevens et al., 2015). Instead it was shown 
that PINK1 and Parkin are involved in the degradation of PARIS, which is a pathogic 
Parkin substrate. In the case of loss of PINK1 or Parkin, PARIS accumulates and 
transcriptionally represses PGC1α (PPARγ (Peroxisome Proliferator-Activated 
Receptor-γ) Coactivator-1α) and this has shown to result in degeneration of 
dopaminergic neurons (Lee et al., 2017, Shin et al., 2011). Thus, it remains to be 
determined to what degree PINK1/Parkin-mediated mitophagy is involved in the 
development of Parkinson’s disease. 
 
Figure 6 Schematic diagram showing PINK1/Parkin dependent mitophagy. 
Upon loss of the mitochondrial membrane potential (Δψm), PINK1 accumulates at the mitochondrial 
membrane, where it phosphorylates Parkin and ubiquitin (Ub). Parkin ubiquitinates outer mitochondrial 
membrane proteins, resulting in the recruitment of the kinase TBK1 and autophagy receptors. This is 
followed by the recruitment of Atg9, ULK1 and WIPI1, promoting the formation of an autophagosomal 
membrane around the mitochondrion. The autophagy receptors directly bind to LC3, which promotes 
fusion with lysosomes in order to complete degradation. 
1.6 Xenophagy 
The degradation of bacteria (xenophagy) is a process that is very similar to the 
degradation of mitochondria, which can be explained by the fact that mitochondria are 
of bacterial ancestry. Xenophagy is an innate immune mechanism against bacterial 
infection and is essential to restrict cytosolic growth of a wide variety of bacteria, like 
Salmonella enterica serovar Typhimurium, Mycobacterium tuberculosis, Listeria 
monocytogenes or Group A Streptococcus (Gutierrez et al., 2004, Py et al., 2007, 
Nakagawa et al., 2004, Castrejon-Jimenez et al., 2015, Birmingham et al., 2006). 
Especially the protection of the gut epithelium against bacteria depends on xenophagy, 
because mice lacking Atg5 in enterocytes suffer from infections and mutations in 
NDP52 have been associated with Crohn’s disease (an inflammatory bowel disease) 
(Ellinghaus et al., 2013, Benjamin et al., 2013).  
Chapter 1 
24 
Upon infection, gram-negative bacteria enter epithelial cells via actin-rich membrane 
ruffles and reside in a vacuole where they are unnoticed by the host defence 
machinery. In these vacuoles the bacteria do not cause much damage, however 
occasionally bacteria escape into the cytosol, where they can rapidly proliferate and 
be detrimental to the cell. As a protective mechanism, upon escaping the vacuole, the 
bacteria become immediately ubiquitinated, resulting in the recruitment of autophagy 
receptors p62, OPTN, NDP52, TAX1BP1 and NBR1, which similar to mitophagy result 
in the recruitment of LC3 and subsequent degradation via autophagy (Randow and 
Youle, 2014, Gomes and Dikic, 2014).  
In case of Salmonella, which is the most widely studied pathogen infection, a second 
“eat me” signals has been reported. In addition to ubiquitination of the bacteria upon 
escape into the cytosol, damage of the Salmonella-containing vacuole can be 
recognised as well. Galectin 8 binds glycans and provides a signal, which results in 
the recruitment of NDP52 and TBK1 (Figure 7) (Thurston et al., 2012).  
In addition, recently it was found that WIPI1 and WIPI2 are recruited to cytosolic 
bacteria in a TBK1 dependent manner and that loss of WIPI2, but not WIPI1, restricted 
xenophagy (Figure 7). This implicates that the autophagosomal membrane is built 
around the bacteria, similar to what recently was observed during mitophagy. It would 
be interesting to assess if similar to mitophagy, ULK1 is also recruited to cytosolic 
Salmonella in a TBK1 dependent manner and if other canonical autophagy proteins 




Figure 7 Schematic diagram showing the xenophagy pathway. 
Upon infection, Salmonella enters the epithelial cell and resides in a vacuole. When the vacuole gets 
damaged, galectin 8 binds to glycans and the autophagy receptor NDP52 and the kinase TBK1 get recruited. 
If Salmonella escapes the vacuole it gets ubiquitinated by LRSAM1 and Parkin, followed by the recruitment 
of TBK1 and different autophagy receptors. This is followed by the recruitment of WIPIs and LC3 and 
subsequent degradation via autophagy.  
1.7 Aggregate formation and degradation 
Selective autophagy has an essential role in the maintenance of proteostatic balance, 
because it is involved in the selective degradation of protein aggregates. Protein 
misfolding and aggregation can be toxic for the cell and can lead to cell death. 
Molecular chaperones can disentangle protein aggregates and promote correct protein 
folding (Kim et al., 2013b). In case molecular chaperones are not sufficient to prevent 
the formation of protein aggregates, soluble smaller aggregates can be cleared via the 
proteasome, whilst bigger insoluble aggregates or aggresomes are degraded via 
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autophagy (Kirkin et al., 2009, Stefani and Dobson, 2003, Ravid and Hochstrasser, 
2008, Finley, 2009, Piwko and Jentsch, 2006, Hjerpe et al., 2016). Inefficient protein 
quality control results in the generation of insoluble aggregates, which contribute to 
many diseases and have also been associated with ageing (Kopito, 2000, Hyttinen et 
al., 2014). Especially in neurodegenerative diseases protein inclusions are a common 
feature, for example hyper-phosphorylated tau-containing neurofibrillary tangles and 
Aβ containing plaques accumulate in Alzheimer’s disease, α-synuclein in Lewy bodies 
in Parkinson’s disease, polyQ (poly-glutamine) mutants of huntingtin form aggregates 
in Huntington’s disease and TDP-43 positive aggregates accumulate in FTD and ALS 
(Winslow et al., 2010, Imarisio et al., 2008, Ravikumar et al., 2002, Hsu et al., 2000, 
Kuusisto et al., 2001). Suppression of autophagy in neuronal cells in mice causes 
neurodegeneration in mice, which is associated with an accumulation of Ub positive 
inclusions (Hara et al., 2006). Autophagy dysfunction in neurodegenerative diseases 
is discussed in more detail in section 1.12. 
1.7.1 The role of p62 in the formation and degradation of protein aggregates 
Most neurodegenerative disease-associated protein aggregates are positive for Ub, 
several heat shock proteins and the autophagy receptor p62 (Zatloukal et al., 2002). 
p62 has a dual and complicated role in this process, since it is involved in aggregate 
formation as well as degradation. p62 is an aggregate prone protein by itself, as it has 
the ability to oligomerize via its PB1 domain and this promotes the formation of p62 
positive inclusions (Bjorkoy et al., 2005). In mice, deficient autophagy results in the 
accumulation of p62 positive aggregates. Interestingly, depletion of p62 in this 
background dramatically reversed this phenotype in hepatocytes and neurons, 
showing its opposing role (Komatsu et al., 2007). In Drosophila melanogaster it was 
shown that Ref(2)P (Refractory to sigma P, the fly homolog for p62) was involved in 
aggregate formation as well (Nezis et al., 2008).  
p62 was the first autophagy receptor that was shown to be required for the clearance 
of Ub positive aggregates (Pankiv et al., 2007) and loss of p62 in mice caused the 
accumulation of neurofibrillary tangles, resulting in an Alzheimer’s disease like 
phenotype (Wooten et al., 2008). In flies loss of Ref(2)P causes a delay in the 
autophagy-dependent degradation of polyQ aggregates (Saitoh et al., 2015). Because 
p62 is involved in aggregate formation and degradation, in some conditions and tissues 
loss of p62 results in more aggregates as is the case for polyQ proteins in a fly and 
mouse model for neurodegeneration (Saitoh et al., 2015, Doi et al., 2013) and other 
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cases p62 depletion results in less aggregates (Bjorkoy et al., 2005, Komatsu et al., 
2007). 
1.7.2 Molecular mechanism of aggrephagy 
In the last decade, a lot of work has been done to identify molecular mechanisms of 
the clearance of protein aggregates. For example, it has been shown that the formation 
of K63-linked Ub chains promote the clearance of inclusions associated with 
neurodegenerative diseases via autophagy (Tan et al., 2008), however not much is 
known about the role of different Ub-linked chains and Ub-ligating enzymes concerning 
aggrephagy. Similar to mitophagy and xenophagy, autophagy receptors are recruited 
to the ubiquitinated aggregates via their ubiquitin binding domains. It was shown that 
NBR1 and p62 locate in a complex on Ub positive inclusions and both can bind LC3. 
Furthermore, it was shown that NBR1 can function independently of p62 (Kirkin et al., 
2009). OPTN also recruits to p62 positive inclusions via its ubiquitin binding domain. 
TBK1, which localises to aggregates as well, was shown to phosphorylate OPTN 
(Korac et al., 2013), which most likely promotes Ub binding, as was shown to happen 
during mitophagy (Matsumoto et al., 2015, Heo et al., 2015, Moore and Holzbaur, 
2016, Richter et al., 2016). Interestingly, OPTN and p62 can also bind to SOD1 
aggregates in a ubiquitin-independent manner (Korac et al., 2013, Gal et al., 2009), 
which is of importance, since in ALS patients SOD1 aggregates negative for ubiquitin 
were observed (Allen et al., 2003, Osawa et al., 2011).  
After autophagy receptors are recruited, it was proposed that Alfy (Autophagy-Linked 
FYVE protein), by binding to p62 and NBR1, can acts as a scaffold that can recruit the 
autophagosomal membrane and machinery to p62/NBR1 positive aggregates via a 
direct interaction with Atg5 and PI3P (via its lipid binding domain called FYVE) (Figure 
8). Alfy, which is a large 400 kDa protein, resides in the nucleus, and its translocation 
to the cytosol depends on p62 (Clausen et al., 2010). Potentially, Alfy binds to p62 
and/or NBR1 on aggregates and recruits the Atg5-Atg12-Atg16L1 complex to the 
aggregate, where it can lipidate LC3, which can be recruited via the LC3 binding 
domains of p62 and NBR1 (Deretic, 2010). This would promote the fusion with 
lysosomes in order to degrade the aggregate. Furthermore, it was shown that Alfy does 
not affect starvation induced bulk autophagy (Clausen et al., 2010), but it would be 
interesting to asses if it has a role in other selective autophagy pathways. 
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In addition to the well-known autophagy receptors, recently Tollip was shown to 
degrade polyQ aggregates in a ubiquitin-dependent manner via a CUE-domain, which 
has a higher affinity for mono- and poly- Ub chains than the UBA-domain of p62 (Lu et 
al., 2014). Interestingly, Tollip interacts with p62 and NBR1 and a double knockdown 
of Tollip and p62 is even more toxic than single knockdowns in response to polyQ 
expression, suggesting that there is no functional redundancy (Lu et al., 2014). 
Since the aggregation of specific proteins is thought to underlie age-related 
neurodegenerative diseases, elimination of these aggregates via autophagy has been 
proposed as a strategy to ameliorate these diseases (Eisele et al., 2015, Rubinsztein 
et al., 2012). Therefore, more research needs to be done in order to identify potential 
targets for specific intervention.  
 
Figure 8 Schematic diagram showing the aggrephagy pathway. 
Misfolded and aggregates proteins are ubiquitinated by an unknown Ub-ligase. The formed poly-Ub chains 
result in the recruitment of autophagy receptors and TBK1. Alfy and LC3 bind to the different autophagy 
receptors and Alfy binds to Atg5 and PI3P, thereby recruiting the autophagosomal membrane and 
machinery, and promoting subsequent degradation via autophagy.  
To summarise, it is clear that the selective degradation of different cargo via autophagy 
all have common themes, but there are also distinct differences. It is not clear if the 
cargo and the use of certain autophagy receptors also result in the usage of different 
or similar autophagy machinery as in bulk autophagy. Furthermore, still more research 
needs to be done to identify ligases and deubiquitinating enzymes that are involved in 
decorating the cargo with different Ub chains and how their activity is regulated. What 
are the roles of the different autophagy receptors, why do they have redundant 
functions during mitophagy, but functionally distinct roles in xenophagy? Potentially, 
the artificial model that has been used in the last decade to study mitophagy is not 
good enough to detect their specific roles. It would be of interest to study mitophagy in 
an in vivo setting in mice or other organisms using the different tools that have recently 
become available (McWilliams 2016, Sung 2016, Sun 2016). 
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1.8 Redox signalling 
1.8.1 ROS formation 
ROS are a damaging, highly reactive by-product of mitochondrial respiration, oxidative 
protein folding and other aerobic metabolic reactions, but can also be formed upon 
exposure of cells to environmental agents such as UV, smoke, drugs (such as 
paraquat) and xenobiotics (Halliwell and Cross, 1994). In the last years, it has been 
established that less-reactive ROS, in particular H2O2, can act as signalling molecules 
(Veal and Day, 2011), however when levels are too high they can be damaging to 
(mitochondrial) DNA, proteins and lipids (Sies, 2017). In the case of ROS produced by 
mitochondria, it can result in mitochondrial dysfunction and even more ROS 
generation, resulting in a vicious cycle. Because of their damaging role, but also their 
role in redox signalling, ROS are implicated in ageing and the pathology of many 
conditions, such as cancer, inflammatory, cardiovascular and neurodegenerative 
diseases (Halliwell, 2007, Gutteridge and Halliwell, 2000, Winterbourn, 2008). 
In addition to the ROS formed by external cues and internal by-products of inefficient 
mitochondrial respiration, it has now become clear that cells can generate ROS as a 
regulated physiological process (Nathan, 2003). In addition to mitochondria, enzymes 
such as NOXs (NADPH OXidases), xanthine oxidase, nitric oxide synthase and 
peroxisomal proteins generate ROS (Halliwell, 2007). When these processes are 
dysregulated aberrant ROS is formed, which causes pathology. Cells have several 
defensive mechanisms in place to cope with these high ROS levels, these will be 
discussed in section 1.8.4. 
1.8.2 Redox sensitive cysteines 
The side chain of a cysteine residue contains a terminal thiol (-SH) group (Figure 9). 
This thiol group can be a target of oxidation by ROS resulting in different post-
translational modifications, among these are reversible S-nitrosylation (SNO), 
sulfhydration (SSH), S-glutathionylation (RS-SG), disulphide bonds (RS-SR’), 
sulfenylation (SOH) and largely irreversible modifications such as as sulfinic acid 
(SO2H) and sulfonic acid (SO3H).  
Cysteines are the least common amino acid, yet often is found as a highly conserved 
residue within functional domains and catalytic sites (Marino and Gladyshev, 2010). 
Not all cysteines are equally sensitive to be oxidised and the formation of one of these 
post-translational modifications depends on different factors, like the reactivity of the 
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cysteines (pKa), the charge of the nearby amino acid residues, hydrogen bonding and 
steric factors. The pKa value refers to the tendency of a thiol group to be deprotonated 
over a range of pH values and the actual pKa is the pH when 50% of the sites are 
protonated. For cysteines this value is approximately 8.5, however, reactive cysteines 
often have a lowered pKa due to other factors, such as a protein environment (positively 
charged residues) that stabilises the negatively charged thiol group (Lutolf et al., 2001, 
Poole, 2015). With a lowered pKa the thiol group is deprotonated at physiological pH, 
which enhanced its reactivity. Recently, algorithms have been made to predict which 
cysteines within a protein are likely to be oxidised, with an accuracy between 70-80% 
correct predictions (Wang et al., 2016c). 
1.8.3 Redox signalling via disulphide bond formation 
The oxidation of cysteines can act as a redox switch to modulate cell signalling, protein 
folding and enzymatic function (Antelmann and Helmann, 2011, Paulsen and Carroll, 
2013). The formation of disulphide bonds (also called disulphide bridges or S-S bonds) 
involves the coupling of two thiol groups and are usually formed from the oxidation of 
the sulfhydryl (-SH) groups of cysteines (Figure 9). The cysteines can be located within 
one protein, resulting in an intermolecular disulphide bond, which often attributes to 
stabilising the secondary structure of a protein. On the other hand, a disulphide bond 
can be formed between two peptides locating in two different proteins, which is called 
an intermolecular disulphide bond. Intermolecular disulphide bonds can promote the 
formation of hetero- or homo- protein dimers or oligomers. 
 
Figure 9 Diagram showing the formation of disulphide bonds between two cysteines. 
On the left the structure of the sulphur-containing (yellow) amino acid cysteine is depicted. Cysteines are 
very reactive and are important for the formation of disulphide bonds, depicted on the right. Free thiols 
upon oxidation can form disulphide bonds, which are reversible and can be reduced by for example the 
thioredoxin system.  
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As mentioned before, not all cysteines are as reactive as others are. H2O2 reacts with 
the thiol groups, but only a minority of proteins have cysteines with low pKa, and thus 
are likely to be targets for oxidation. Prxs (Peroxiredoxins) are a family of proteins that 
contain thiolates with very reactive cysteines and thus reduce H2O2. The rate constant 
of Prxs is very high and they are highly abundant, therefore most H2O2 in the cell reacts 
with these proteins (Wood et al., 2003). GSH (Glutathione) also reacts with a small 
proportion of H2O2 and other proteins are considered non-competitive, based on 
kinetics and abundance (Winterbourn, 2008). Several mechanisms have been 
suggested for how redox-regulated proteins can compete with Prx. For example, 
localisation can play a role, where redox-regulated proteins face extremely high H2O2 
concentrations, making direct oxidation feasible. Prxs can also be inactivated by a 
phosphorylation, thereby allowing the accumulation of H2O2 and oxidation of redox-
regulated proteins (Woo et al., 2010). Another theory (called the floodgate theory) 
involves the inactivation of Prxs by hyperoxidation to sulfinic acids, which is a mainly 
irreversible modification, thereby allowing other redox-regulated proteins to be oxidised 
by H2O2 (Wood et al., 2003). Furthermore, redox regulated proteins can be indirectly 
oxidised by H2O2 via Prxs; this mechanism involves a physical interaction between the 
Prx and the redox regulated protein, for example Prx2 and STAT3 (Signal Transducer 
and Activator of Transcription 3), which allows the transfer of oxidising equivalents 
between the two (Sobotta et al., 2015). Interestingly, Prx1 was also shown to interact 
with several redox-regulated proteins, including PTEN (Phosphatase and TENsin 
homolog) and ASK1 (Apoptosis Signalling Kinase 1), resulting in thiol-disulphide 
exchange (Cao et al., 2009, Jarvis et al., 2012, Turner-Ivey et al., 2013), this potentially 
could be a common redox-signalling pathway, however more research is required 
(Latimer and Veal, 2016). 
1.8.4 The antioxidant system 
To prevent that ROS reach damaging levels, ROS can be buffered by the antioxidant 
system. These antioxidants also serve an essential role in redox signalling, because 
they can reduce disulphide bonds to a free thiol, which is essential for redox-regulated 
proteins to function as a switch to regulate protein function.  
Primary enzymes, such as glutathione peroxidase, SOD and catalase and Prxs protect 
the cells against oxygen radicals. SOD is a metalloenzyme that promotes the 
dismutations of superoxide to oxygen and H2O2 (Figure 10). There are three human 
superoxide dismutases; the cytosolic and mitochondrial SOD1; mitochondrial SOD2 
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and secretory SOD3. The produced H2O2 can be reduced by glutathione peroxidase 
or catalase.  
Glutathione peroxidase, which needs selenium as a cofactor, reduces peroxides to 
water or alcohol (Figure 10). This reaction involves GSH, which is an abundant 
tripeptide and upon oxidation forms a disulphide bridge, resulting in dimerization. The 
oxidised dimer is also called to GSSG (Hansen et al., 2009). The secondary enzymes 
do not neutralise ROS directly, but play a supportive role. In the case of glutathione 
peroxidase, GR (Glutathione Reductase) is the secondary enzyme, as it reduces 
GSSG, which then is ready to react with free radicals again (Figure 10) (Deponte, 
2013). Peroxisomal catalase is another enzyme important for the reduction of H2O2, 
which in this case is converted to water and molecular oxygen (Figure 10). The 
previously mentioned Prxs also scavenge H2O2 and thus function as an antioxidant. 
Humans have 6 Prx isoforms, which have a different cellular distribution (Rhee et al., 
2001). 
Trx (Thioredoxin) is a highly conserved protein family that reduces target proteins, 
including Prxs and GSSG. In order to do so, it transfers a disulphide bond to its reactive 
cysteine pair to form an intermolecular disulphide bond, which then can be reduced by 
Trx-reductase (Figure 10) (Lee et al., 2013). Humans have two Trx isoforms, a 
cytosolic expressed Trx 1 and a mitochondrial expressed Trx 2. 
These key cellular antioxidants in concert regulate redox homeostasis. Dysregulation 
of any of these components results in an impaired redox signalling and oxidative stress, 
which has been implicated in ageing and various diseases, such as cancer, 





Figure 10 Diagram of the antioxidant system. 
Enzymes involved in the first line of defence to protect against oxygen radicals (red). The primary enzymes: 
SOD (SuperOxide Dismutase), GPx (Glutathione Peroxidase), and Prx (Peroxiredoxin) and catalase 
converts O2- into H2O. Secondary enzymes involved GR (Glutathione Reductase) and TrxR (Thioredoxin 
Reductase), which reduce GSSG (oxidised glutathione) and oxidised Trx (S-S) respectively.  
1.9 Autophagy deficiency and mitochondrial dysfunction 
Mitochondria are known to be the powerhouse of the cell and are responsible for 
aerobic ATP production. Furthermore, these double-membraned organelles are 
involved in calcium signalling, cell death and metabolite synthesis. Mitochondrial 
dysfunction is linked to a range of diseases, including neurodegenerative diseases, 
cardiomyopathies, cancer, diabetes, muscular diseases and premature ageing (Vafai 
and Mootha, 2012, Nunnari and Suomalainen, 2012).  
The mitochondria are highly dynamic organelles forming a network which depends on 
the interplay of fusion and fission. Structurally, mitochondria consist of an inner and 
outer mitochondrial membrane. Energy production via the ETC (Electron Transport 
Chain) takes place in the IMM. The space between the IMM and OMM is called the 
intermembrane space. The IMM forms cristae, thereby providing a large surface area 
to perform electron transport. The matrix contains the mitochondrial enzymes that are 
responsible for the TCA, (TriCarboxylic Acid cycle, also known as the citric acid cycle 
or Krebs cycle), which produced NADH (reduced Nicotinamide Adenine Dinucleotide) 
and FADH2 (reduced Flavin Adenine Dinucleotide), which function as electron carriers. 
The TCA cycle generates ATP through the oxidation of acetate derived from 
carbohydrates, fats and proteins into CO2 (Carbon diOxide) (Watt et al., 2010). During 
this cycle, NAD+ and FAD are reduced to NADH and FADH2, which are donated to the 
ETC. NADH and FADH do not only originate from the TCA cycle, but can also be 
produced during glycolysis and fatty acid oxidation (Houten and Wanders, 2010). 
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1.9.1 The electron transport chain 
The ETC consists of four complexes (I-IV), which are responsible for the oxidation of 
NADH and FADH2 (Figure 11). Most enzymes of the ETC are large multi-subunit 
protein assemblies containing many redox cofactors. This complexity has made it hard 
to understand how the ETC functions. However, over the last decades the basic 
functional principles have been elucidated. 
NADH enters the ETC through complex I (NADH:ubiquinone oxidoreductase) and 
FADH2 enters the ETC through complex II (succinate dehydrogenase). The electrons 
are then transferred to ubiquinone (CoQ, Q, coenzymeQ), followed by complex III 
(cytochrome C oxidoreductase), cytochrome C and complex IV (Cytochrome c 
oxidase), which transfers the electrons to oxygen as the final electron acceptor. 
Membrane-embedded ubiquinone and soluble cytochrome C mediate electron 
transport between complexes. The oxidation is coupled to the pumping of protons by 
CI, III and IV from the matrix into the IMS (Inter Membrane Space), creating the ΔΨm 
for the synthesis of ATP by the ATPase (ATP synthase/ complex V) (Figure 11) (Okuno 
et al., 2011, Watt et al., 2010, Sazanov, 2015). This respiratory process is called 
OXPHOS (OXidative PHOSphorylation). OXPHOS complexes function most efficiently 
in supercomplexes of which the respirasome (Acin-Perez et al., 2008), consisting of 
complex I, 2x complex III and complex IV is the most common supercomplex, but 
complex IV copies can vary. Recently, two independent groups determined the 
structure of the respirasome, which revealed that subunits within the different 
complexes interact (Gu et al., 2016, Letts et al., 2016). Multiple interactions were 
especially observed between complex I and III, explaining the increased stability of 
complex I in the supercomplex (Letts et al., 2016). Furthermore, the tight arrangements 
are thought to optimize the use of available substrates and the efficiency of electron 
transfer, but also prevent ROS production (Letts et al., 2016, Maranzana et al., 2013, 




Figure 11 Schematic diagram of the mitochondrial electron transport chain (ETC) and ATP synthase. 
The red line shows the path of the electrons and the blue line the path of the protons that are pumped from 
the matrix into the inter membrane space (IMS). Electrons are transferred from NADH into complex I, and 
FADH2 into complex II, via complex III, cytochrome c and complex IV, which transfers the electrons to 
oxygen. During this process, protons are pumped into the IMS, creating a proton gradient. This gradient is 
used by complex V, the ATP synthase, to phosphorylate ADP, thereby producing ATP.  
1.10 Mitochondrial quality control 
A decline in mitochondrial quality control has been associated with ageing and 
correlates with the development of several age-related diseases. For example, ageing 
is accompanied by a decline in mitochondrial enzyme activity, decreased respiratory 
capacity per mitochondrion and increased ROS (Sun et al., 2016).  
Mitochondrial maintenance is a balance between biogenesis and the different 
mechanisms that provide quality control, resulting in a healthy functional pool of 
mitochondria. Because mitochondria produce ROS, resulting in protein damage, the 
antioxidant system can be seen as the first mechanism to provide mitochondrial quality 
control (Section 1.8.4), followed by chaperones and proteases that promote protein 
folding and degradation, respectively. When unfolded, misfolded or unassembled 
proteins accumulate beyond folding capacity, the UPRmt (Mitochondrial Unfolded 
Protein Response) can be initiated. This pathway results in transcriptional up-
regulation of chaperones and antioxidants, and thereby tries to recover mitochondrial 
protein homeostasis. When this pathway is not sufficient, proteasomal degradation and 
autophagy can grant further mitochondrial quality control.  
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1.10.1 Mitochondrial proteases 
Several mitochondrial proteases and antioxidants have been identified. In the 
mitochondrial matrix, three major ATP-dependent AAA proteases, Lon, ClpXP and the 
membrane bound m-AAA play a critical role in mitochondrial protein homeostasis 
(Figure 12) (Voos et al., 2013). The Lon (also known as LON and LON) protease forms 
a barrel-shaped homo-hexamer and has been shown to play an important role in 
degrading oxidised proteins, such as aconitase, COX4I1 (Cytochrome C Oxidase 
Subunit 4I1), Trx2 and TFAM (Bota et al., 2002, Bota and Davies, 2016). Additionally, 
Lon functions as a chaperone for ETC complex assembly (Bota et al., 2002). The 
ClpXP complex consists of two hexamer ClpX lids, that is important to unfold target 
proteins, and two heptamer ClpP barrels that function as proteolytic chambers (Gersch 
et al., 2016, Voos, 2009). To date only one ClpXP substrate has been identified, being 
Noa1 (Al-Furoukh 2014). m-AAA is a protease that is anchored in the IMM and faces 
the matrix. m-AAA consists of either homo-oligomers of AFG3L2 (ATPase Family 
Gene 3-Like 2) or hetero-oligomers of AFG3L2 and paraplegin (also known as SPG7) 
(Atorino et al., 2003, Levytskyy et al., 2016) and is primarily involved in the degradation 
of ETC subunits. m-AAA assembles with prohibitins (Phb 1 and 2) in large 
supercomplexes in the IMM and modulate the degradation of non-assembled proteins 
(Steglich et al., 1999). i-AAA is an IMM anchored protease that faces the IMS and 
functions as a homo-hexamer (Scharfenberg et al., 2015). Substrates of i-AAA include 
ETC subunits, proteins involved in lipid transport and synthesis and IMM dynamics 
(Song et al., 2007, Stiburek et al., 2012, Potting et al., 2010). In addition to the ATP-
dependent proteases, mitochondria are also equipped with ATP-independent 
proteases, such as Oma1, PARL (Presenilins-Associated Rhobiod Like) and HTRA2 
(HTrA serine peptidase 2, also known as Omi), which reside in the IMM (Levytskyy et 




Figure 12 Schematic diagram of the main mitochondrial proteases. 
ClpXP, Lon and m-AAA are the proteases that reside in or face the mitochondrial matrix and degrade 
damaged, misfolded and oxidised proteins, whilst i-AAA faces the IMS. m-AAA and i-AAA are important for 
the degradation of non-assembled proteins and ETC subunits, respectively. Red stars depict oxidative 
damage.  
1.10.2 Mitochondria As Guardian In Cytosol (MAGIC) 
An interesting theory was reported recently involving the degradation of cytosolic 
aggregate prone proteins by mitochondrial proteases. In yeast, upon a heat shock, 
aggregates containing cytosolic as well as mitochondrial proteins form. The cytosolic 
proteins can be co-imported by mitochondrial proteins via the mitochondrial import 
machinery (Ruan et al., 2017). Hsp104 (Heat Shock Protein 104) , but not Hsp70, is 
required for this process, potentially to unfold and disaggregate the proteins before 
mitochondrial import (Ruan et al., 2017). It has to be determined if such a pathway 
exists in mammalian cells as well. In several neurodegenerative diseases, aggregate 
prone proteins have been reported to accumulate in mitochondria, resulting in 
mitochondrial dysfunction (Schapira, 2012, Li et al., 2007, Devi et al., 2008). Thus, this 
accumulation of disease proteins could be a result of more general cytosolic 
proteotoxic stress.  
1.10.3 Mitochondrial unfolded protein response (UPRmt) 
The UPRmt is a recently identified retrograde signalling pathway that is important for 
the maintenance of mitochondrial quality. This pathway, that is very similar to the 
extensively studied UPRer (ER Unfolded Protein Response), promotes the recovery of 
dysfunctional mitochondria. UPRmt has been studied mostly in C.elegans, where 
mitochondrial dysfunction, resulting in increased UPRmt was shown to extend life span 
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(Dillin et al., 2002, Durieux et al., 2011). It is thought that modest mitochondrial 
dysfunction leads to life span extension, even though this seems counterintuitive (Yee 
et al., 2014). Several triggers have been shown to induce the UPRmt pathway in 
C.elegans. For example, inhibition of mitochondrial transcription, which results in an 
imbalance of mitochondrial and nuclear encoded proteins, and the accumulation of 
unassembled proteins initiate UPRmt (Yoneda et al., 2004). These accumulated 
unfolded proteins are digested by ClpP (Clp protease proteolytic subunit) into small 
peptides, which are actively exported across the IMM and then diffuse through the 
OMM to the cytosol (Haynes et al., 2007, Haynes and Ron, 2010). The peptides in the 
cytosol trigger the nuclear translocation of a transcription factor ATFS-1 (Activating 
Transcription Factor associated with Stress 1), which results in a transcriptional 
response. This response involves genes that encode for mitochondrial chaperones, 
antioxidants, but also promotes a rewiring of metabolism by increasing glycolysis and 
amino acid catabolism genes, whilst repressing TCA cycle and OXPHOS genes 
(Nargund et al., 2015, Nargund et al., 2012). ATFS-1 is a transcription factor that 
contains a nuclear and mitochondrial localisation signal. In normal conditions, ATFS-1 
it is continuously imported into mitochondria, where it is degraded. However, during 
mitochondrial stress, a reduced ΔψM prevents the efficient import of ATFS-1 into the 
mitochondria. Instead, it accumulates in the cytosol, and due to its nuclear localisation 
signal, it translocates to the nucleus (Nargund et al., 2012). A portion of ATFS-1 also 
accumulates within mitochondria, where it binds mtDNA and potentially inhibits 
transcription (Nargund et al., 2015). It is not clear how this is mechanistically regulated 
and how the accumulation of cytosolic peptides regulates ATFS-1 translocation to the 
nucleus. Two more transcription factors (Dve1 and Ubl5) were identified to be involved 
in UPRmt in C.elegans. ClpP triggers the activation of Ubl5 (UBiquitin-Like protein 5), 
which acts as a coactivator of the transcription factor Dve1 (Defective proVEntriculus 
in Drosophila), which bind to the promoters of chaperones, such as Hsp60 (Haynes et 
al., 2007, Benedetti et al., 2006). Less is known about the UPRmt in mammals; 
however, some progress has been made in the last years. Evidence suggests that the 
UPRmt is conserved in mammals, where mitochondrial proteotoxic stress also induces 
transcription of mitochondrial chaperones and proteases (Zhao et al., 2002, Martinus 
et al., 1996). Similar triggers were found to induce the UPRmt, such as mitonuclear 
protein imbalance, which results in the up-regulation of ClpP and heat shock proteins, 
which are often used as an indicator for the UPRmt induction (Houtkooper et al., 2013). 
It was shown that ClpXP plays an important role in the UPRmt, indeed overexpression 
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of ClpX is sufficient to initiates the UPRmt (Al-Furoukh et al., 2015). Peptides produces 
by ClpP activate two kinases (JNK (c-Jun N-terminal Kinase) and PKR (Protein Kinase 
R)), which up-regulate the transcription factor CHOP (C/EBP-HOmologous 
Protein)(Figure 13). CHOP was shown to primarily mediate this ClpX-induced UPRmt 
and also transcription factors Ubl5, SatB2 (Special AT-rich sequence-Binding protein 
2, mammalian homolog of Dve1) and ATF5 (Activating Transcription Factor 5) levels 
depend on ClpX (Al-Furoukh et al., 2015). Recently, ATF5, which has a lot of homology 
with ATFS-1, was found to localise to mitochondria, and upon mitochondrial stress 
ATF5 plays a protective role by inducing the UPRmt (Figure 13) (Fiorese et al., 2016). 
If misfolded proteins accumulate in the IMS, an alternative UPRmt is induced, involving 
the protease HTRA2 (also known as Omi) and the transcription factor Nrf1 (Radke et 
al., 2008, Papa and Germain, 2011). 
In addition, it was found that the mammalian UPRmt not only regulates gene 
expression, but in response to acute folding stress also represses transcription and 
translation (Munch and Harper, 2016). In yeast another interesting pathway, called 
UPRam (UPR Activated by protein Mistargeting) was discovered, which acts in 
response to mistargeted proteins due to mitochondrial import defects. This pathway 
was shown to up-regulate proteasome activity in response to the amount of 
mislocalised mitochondrial precursor proteins in the cytosol (Wrobel et al., 2015). This 
multifaceted response helps to recover the mitochondrial protein homeostasis. 
 
Figure 13 Schematic model of the UPRmt in mammals. 
Unfolded proteins in mitochondria are degraded by ClpXP into small peptides, which activate PKR and JNK. 
JNK phosphorylates c-JUN, resulting in CHOP expression, which induces the UPRmt. ATF5 is an 
transcription factor, which upon mitochondrial stress was suggested to translocate to the nucleus to 
induce the UPRmt.  
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1.10.4 Mitochondrial-associated degradation (MAD) 
The ubiquitin-proteasome system (UPS) is responsible for the degradation of 
misfolded proteins from several cellular compartments to maintain protein 
homeostasis. Soluble proteins are easily targeted to the proteasome for degradation; 
however, the degradation of OMM proteins requires an additional step, because they 
need to be extracted from the membrane.  
In yeast, MAD is a UPS (Ubiquitin-Proteasome System) driven pathway responsible 
for the degradation of OMM proteins via the AAA-ATPase VCP (also known as 
Cdc48/p97). VCP removes ubiquitinated proteins from the mitochondrial membrane 
and escort the substrates to the proteasome, where they are degraded to small 
peptides and this pathway is conserved in mammals.  
As discussed previously, mitophagy can be triggered by the loss of ΔψM, which, via 
the kinase PINK1 and the Ub ligase Parkin, results in the ubiquitination of OMM 
proteins. These ubiquitinated proteins are recognised by autophagy receptors, 
followed by the recruitment of the autophagosomal machinery and the formation of the 
autophagosome around the mitochondrion and subsequent lysosomal degradation. 
Interestingly, VCP and UPS components, including the E3 ligating-enzyme HUWE1 
(HECT, UBA and WWE domain containing 1, E3 ubiquitin ligase) are also recruited to 
these ubiquitinated mitochondria and target a subset OMM proteins, such as Mfn1 and 
2 (MitoFusiN 1 and 2) for degradation by the 26S proteasome (Karbowski and Youle, 
2011, Heo et al., 2010, Tanaka et al., 2010, Cohen et al., 2008, Taylor and Rutter, 
2011). The recruitment of the highly conserved ubiquitin-directed segregase VCP, 
which forms a hexameric ring-like structure, depends on Vms1 (Heo et al., 2010, Braun 
et al., 2015). VCP then extracts proteins from the membrane and recently Doa1 was 
identified as an adapter that recognises the OMM substrates in yeast (Figure 14) (Wu 
et al., 2016b). It is not clear if the highly conserved mammalian orthologue PLAA 
(PhosphoLipase A2 Activating protein) has the same function. 
Finally, the proteins are targeted to the 26S proteasome. The 26S proteasome is a 
barrel-shaped proteolytic organelle that consists of a 20S core particle that can be 
capped with one or two 19S regulatory particles. Ubiquitinated proteins are recognised 
by the 19S subunit, followed by deubiquitination, unfolding and translocation to the 
proteolytic chamber of the 20S core particle (Livneh et al., 2016, Beck et al., 2012). To 
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date not many MAD substrates have been identified, thus more investigation is needed 
to identify these.  
Interestingly, mitochondrial metabolism has been linked to UPS activity. When 
mitochondrial respiration was genetically impaired, the cytosolic UPS was less active. 
This phenotype could be prevented by antioxidants, suggesting that it is ROS 
dependent (Segref et al., 2014). This correlation seems counterintuitive, as upon 
mitochondrial stress OMM proteins are degraded via the UPS. However, decreasing 
the cytosolic UPS activity could tip the balance towards degradation of OMM proteins 
and strengthen the capacity of the UPS at the OMM.  
 
 
Figure 14 Schematic diagram of mammalian mitochondrial-associated degradation (MAD). 
Damaged mitochondrial membrane proteins are presented at the OMM, where they are ubiquitinated by 
HUWE1 and Parkin. Doa1 in yeast, and potentially PLAA in mammals, binds to the ubiquitinated protein. 
Vms1 and VCP (p97) are recruited and extract the protein from the OMM, followed by the proteasomal 
degradation of the OMM protein.  
1.10.5 Mitophagy 
When the selective removal of damaged oxidised mitochondrial proteins is not 
sufficient to restore mitochondrial function, cells can use a more robust mechanism to 
eliminate mitochondria, called mitophagy (Section 1.5). This is a last resort before the 
cell decides to go into apoptosis.  
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Many studies revealed crosstalk between these described quality control pathways in 
maintaining mitochondrial health. For example, it has been suggested that the 
degradation of OMM proteins via MAD is required for downstream mitophagy (Yoshii 
et al., 2011, Chan et al., 2011), because the degradation of mitofusins via the MAD 
pathway facilitates mitochondrial fragmentation and promotes mitophagy (Tanaka et 
al., 2010). Furthermore, it was shown that among the many Parkin targets, several 
proteasome subunits and VCP were found (Sarraf et al., 2013). Future research could 
elucidate the triggers, interdependence and timing of these different mitochondrial 
quality control events in order to keep a healthy mitochondrial pool that matches the 
cellular energy demand. 
1.11 Mitochondrial complex I 
The mitochondrial complex I catalyses the transfer of two electrons from NADH to 
ubiquinone (Q) to form ubiquinol (QH2), and simultaneously translocates four protons 
across the mitochondrial membrane. Complex I is a reversible machine that can also 
use ΔΨm and ubiquinol to reduce NAD+. 
NADH + H+ + Q +4H+ in  NAD+ + QH2 + 4H+ out 
1.11.1 Complex I structure 
A 5 Å high-resolution X-ray structure of complex I from Bos Taurus (a close relative to 
the human enzyme) was determined (Vinothkumar et al., 2014), followed up by a 6.8 
Å X-ray crystallographic analysis of the membrane bound domain (Zhu et al., 2015). 
The L-shaped mammalian complex I is a very complex structure containing 44 different 
subunits, of which 7 of the membrane bound core subunits (ND1-6 and 4L) are 
mitochondria-encoded, while the others are nuclear-encoded. The complex consists of 
a membrane bound domain, which comprises the proton-translocating P-module and 
a mitochondrial matrix-facing arm, containing the NADH-oxidizing dehydrogenase 
module (N-module) and the Q-module (Figure 15). The N-module provides electrons 
from the FMN (Flavin MonoNucleotide) into the chain of Fe-S clusters. The Q-module 
transfers the electrons from the Fe-S clusters to ubiquinone. The P-module is divided 
into two modules called PP and PD (proximal and distal proton pomp) and the PD 
contains the proposed proton-translocating subunits ND4 and ND5 (Figure 15) (Hunte 
et al., 2010). At the moment it is thought that ubiquinone reduction, but not discrete 
electron transfer steps within the Fe-S clusters, triggers proton pumping (Sazanov, 




Figure 15 Architecture of mitochondrial complex I. 
The matrix arm of complex I consists of the N- and Q-modules. Electrons are transferred from NADH to 
FMN. Fe-S clusters (yellow circles) transfer electrons from FMN to ubiquinone. The membrane bound 
core consists of PP (proximal) and PD-(distal) modules. PD contains the proposed proton-translocating 
subunits (blue arrow). Modified after (Kmita and Zickermann, 2013). 
1.11.2 ROS production via complex I 
Mitochondrial complex I is a major source of ROS (Murphy, 2009) and these have been 
implicated in many human diseases, including several neurodegenerative diseases 
(Viscomi et al., 2015). In the last decade a lot of research has been done to elucidate 
the exact site of ROS production and how this can modulated. To prevent this 
excessive ROS leakage, complex I exhibits a regulatory switch between an active and 
deactive form (A and D-form). When there is a lack of substrate, the complex can 
convert into the D-form via an S-nitrosation of a cysteine in the ND3 subunit. The A/D 
transition is a protective mechanism to prevent ROS formation by reverse electron flow 
of the enzyme during myocardial ischemia/reperfusion in mice (Methner et al., 2014). 
Furthermore, the assembly of complex I into respirasomes has been shown to prevent 
ROS production, due to more efficient transfer of electrons through the complexes. In 
different cell types with different bioenergetics preferences, the ETC is organized 
differently. For example, when comparing neurons and astrocytes it became apparent 
that in neurons, which rely on mitochondrial respiration, complex I was embedded into 
the respirasome more than in astrocytes, resulting in more efficient respiration and less 
ROS production (Lopez-Fabuel et al., 2016). On the contrary, astrocytes rely more on 
glycolysis and these cells have more free complex I, which correlates with more ROS 
production. NDUFS1 was shown to be essential for the assembly of complex I into the 
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supercomplex and was more highly expressed in neurons compared to astrocytes 
(Lopez-Fabuel et al., 2016).  
At least 11 ROS producing sites linked to substrate oxidation and respiration have 
been identified, of which two main sites locate at complex I, being site IF, which is the 
Flavin-binding site and IQ, the Q-binding site (Brand, 2016). Rotenone is a well-known 
complex I inhibitor and binds to the IQ site and thereby prevents electrons flowing back 
from ubiquinone into complex I (Reverse Electron Transport, RET) (Brand, 2016), but 
more recently also more specific drugs were developed which specifically bind site IF 
and IQ without effecting respiration (Brand et al., 2016). Preventing ROS production at 
site IQ by using one of these inhibitors protected against ischemia-reperfusion injury in 
perfused mouse heart (Brand et al., 2016). This suggests that preventing aberrant 
ROS production at this site of complex I can be protective, however, it must be noted 
that ROS also function as an important signalling molecule. Scialò et al. elegantly 
demonstrated that RET, resulting in ROS production specifically through complex I 
extends fly lifespan (Scialo et al., 2016). Thus, low levels of ROS produced by IQ can 
be beneficial for animal lifespan due to its signalling function, whilst ROS produced by 
IQ in stress conditions can be highly damaging and result in cell death.  
1.11.3 Turnover of complex I 
Because complex I is important in redox signalling, but also potentially dangerous for 
the cells, its quality control is of high importance. Therefore, it is surprising that to date 
not much is known about how complex I is turned-over. Complex I outside of the 
respirasome or other supercomplexes is less stable and produces more ROS 
(Schagger et al., 2004, Guaras et al., 2016). Guaras et al. beautifully demonstrate a 
link between complex I degradation and the ubiquinone redox status. Preventing the 
binding of ubiquinone and the transfer of electrons from ubiquinone to complex I, 
restores complex I stability in a complex IV or Cytochrome C knock-out background 
(Guaras et al., 2016). They found that superoxide produced via RET destabilises 
complex I by causing oxidative damage to the complex. When cells were switched to 
hypoxic conditions, complex I was destabilised. The least stable group were the 
subunits located in the peripheral arm, whilst the membrane arm was more stable, this 
correlated to the number of cysteines of the different subunits being oxidised. 
Interestingly, other mitochondrial respiratory complexes were not destabilised, 
showing that reoxygenation results in an isolated complex I loss (Guaras et al., 2016). 
Oxidation of cysteines of the different complex I subunits (especially the ones that 
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stabilise iron-sulfur clusters) could result in the destabilisation of iron-sulfur clusters 
and trigger the disassembly of complex I, followed by the degradation of the individual 
subunits (Guaras et al., 2016).  
Recently, the first evidence was presented for the selective degradation of the ROS 
producing N and Q modules of complex I by the mitochondrial matrix localised 
proteases Lon and ClpP (Pryde et al., 2016). Interestingly, preventing ROS production 
by IQ prevented degradation of the N and Q modules (Pryde et al., 2016), suggesting 
that RET results in oxidative damage in complex I, which could be the trigger for 
degradation. How Lon and ClpP recognise damaged complex I is not entirely clear, but 
it was proposed that Lon can specifically recognise oxidised peptides and Fe-S 
clusters, which could act as ROS sensors (Pryde et al., 2016).  
1.11.4 Metabolism and autophagy in neurons 
Neurons heavily rely on mitochondrial respiration to meet their extremely high-energy 
demands, demonstrated by the fact that the brain is responsible for 20% of all oxygen 
consumption (de Castro et al., 2010). During differentiation from neuronal progenitor 
cells into neurons, a few rearrangements result in a switch from aerobic glycolysis to 
mitochondrial respiration (Zheng et al., 2016, Agathocleous et al., 2012). Firstly, LDHA 
(Lactate DeHydrogenase A) is down-regulated, which is a key switch to turn off aerobic 
glycolysis. Secondly, there is a shift from PKM2 (Pyruvate Kinase isozyme M2) to 
PKM1 expression and thirdly, HK2 (HexoKinase2), GLUT1 (GLUcose Transporter 1) 
and GLUT3 glucose transporters reduce cellular glucose import, thereby reducing 
glycolysis. Surprisingly, even though mitochondrial mass increases during 
differentiation, the expression of TCA and mitochondrial respiratory genes do not 
increase (Zheng et al., 2016). Even though neurons rely heavily on mitochondrial 
respiration, its ability to withstand oxidative stress is limited. Amongst other things, this 
is due to relatively low levels of antioxidants and more endogenous ROS generation 
via specific reactions and high iron levels in certain areas of the brain.  
Neurons have highly polarised axons and dendrites in which many macromolecules 
are synthesised, delivered and degraded for their dynamic functions in synaptic growth 
and synaptic activity. Since neurons are post-mitotic cells that cannot dilute their toxic 
waste by cell division, autophagy-dependent cellular quality control is of essential 
importance. Indeed, autophagy dysfunction is known to cause neurodegeneration in 
neurons, suggesting that it may regulate neuronal homeostasis (Hara et al., 2006).  
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1.12 Mitochondrial dysfunction and autophagy deficiency in 
neurodegeneration 
1.12.1 Alzheimer’s disease (AD) 
AD is the most common form of dementia and affects nearly 44 million people 
worldwide and is characterised by the progressive loss of cholinergic neurons in the 
cerebral cortex and accumulation of extracellular amyloid plaques and intracellular 
neurofibrillary tangles, leading to severe behavioural, motor and cognitive impairment 
(Salawu et al., 2011). The most common variant of AD usually starts after age 65. Most 
late onset cases occur sporadically, however some genes have been identified that 
enhance the risk (Cuyvers and Sleegers, 2016). The most common gene associated 
with late-onset AD is APOE (Apolipoprotein E), which has three forms, being E2, E3 
and E4. The APOE4 form appears to increase the risk to develop AD (Cuyvers and 
Sleegers, 2016).  
Changes in mitochondrial appearance precedes the appearance of neurofibrillary 
tangles and for that reason mitochondrial dysfunction has been implicated in disease 
pathogenesis (Hirai et al., 2001, Garcia-Escudero et al., 2013). Overexpression of 
APP, leading to the accumulation of amyloid plaques, induced a decrease in ATP 
production, decreased ΔΨm, decrease complex IV activity and increased ROS 
production (Grimm et al., 2016). It is not clear what is the actual causative factor, but 
recently, it was suggested that ROS can trigger the formation of amyloid plaques 
(Leuner et al., 2012). 
Another AD hallmark are the previously mentioned neurofibrillary tangles that consist 
of abnormally hyperphosphorylated tau. Mice with a mutation in FTDP-17 
(FrontoTemporal Dementia with Parkinsonism-17) leading to the production of 
abnormally phosphorylated tau, show decreased mitochondrial respiration and ATP 
levels, decreased complex I activity and increased ROS production (David et al., 
2005). In another mouse study, it was confirmed that neurofibrillary tangles are linked 
to complex I dysfunction, whereas amyloid plaques affect complex IV activity (Rhein et 
al., 2009).  
Impaired autophagy has been linked to AD in AD animal models as well as in AD 
patients. The consensus now is that in early stages of AD autophagy is induced; the 
expression of lysosomal proteins is increased which promotes the autophagy flux. This 
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happens prior to the formation of amyloid plaques and neurofibrillary tangles. However, 
in later stages of AD autophagy may be blocked (Rubinsztein et al., 2005).  
In patients’ AD brain neocortical biopsies accumulation of autophagosomes and other 
prelysosomal autophagic vacuoles was observed, especially in dystrophic neurites, 
suggesting impaired autophagosome maturation (Nixon et al., 2005). A similar 
phenotype was observed in PS-1/APP double transgenic mice, an AD mouse model 
where the accumulation of autophagosomal structures preceded the formation of 
amyloid plaques (Yu et al., 2005). There are several known causes of the impaired 
autophagy in AD, including the toxic effects of amyloid plaques on lysosomal function 
(Lai and McLaurin, 2012). Also the most-common genetic risk factor for late-onset AD 
links AD to autophagy dysfunction, as the E4 variant of APOE, a neuronal cholesterol 
transport protein, results in lysosomal membrane disruption and leakage (Ji et al., 
2002, Ji et al., 2006). In addition, expression levels of Beclin 1, a protein important for 
autophagy induction, were found to be decreased in AD-affected brains (Pickford et 
al., 2008). It is clear that a complex interplay between autophagy deficiency, 
mitochondrial dysfunction and ROS play an important role in the development of AD. 
1.12.2 Dementia with Lewy Bodies (DLB) 
DLB is the second most frequent form of dementia and is very similar to Parkinson’s 
disease and AD. Classical DLB is characterised by the presence of Lewy Bodies in the 
brainstem, limbic region and cortical areas, and the majority of patients have 
neurofibrillary tangles and amyloid plaques as well (McKeith et al., 2004, Walker et al., 
2016). Patients have cognitive and motor symptoms, such as progressive dementia, 
fluctuations in mental state, visual hallucinations and Parkinsonism (McKeith et al., 
2005). Due to the overlap in clinical presentation, neuropathological characteristics and 
genetic risk factors with AD and Parkinson’s disease, DLB is often misdiagnosed, 
therefore studies of the underlying molecular cause of the pathology have been rare 
(Guerreiro et al., 2016, McKeith et al., 2005). Mutations in the SNCA (α-SyNuClein) 
were found in DLB patients and α-synuclein is the main component of Lewy bodies 
(Spillantini et al., 1997). Furthermore, mutations in Parkinson’s disease genes GBA 
(Glucosylceramidase β), LRRK2 and SCARB2 (Scavenger Receptor Class B member 
2) and Alzheimer’s disease gene APOE4 was linked to DLB (Geiger et al., 2016, Bras 
et al., 2014, Nalls et al., 2013, Berge et al., 2014). Autophagy dysfunction has been 
implicated in DLB; α-synuclein is a substrate for chaperone mediated autophagy and 
mutant forms of α-synuclein block autophagy (Cuervo et al., 2004). Overexpression of 
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α-synuclein impairs autophagy by inhibiting Rab1a, resulting in Atg9 mislocalisation 
and impaired autophagosome formation (Winslow et al., 2010). LRRK2, GBA and 
SCARB2 are also involved in the autophagy-lysosome pathway (Schapansky et al., 
2014, Schapansky et al., 2015, Maor et al., 2016). Furthermore, as discussed before 
in the case of AD, DLB patients carrying the APOE risk variant exhibit lysosomal 
dysfunction (Ji et al., 2002, Ji et al., 2006). 
1.12.3 Frontotemporal dementia (FTD) and Amyotrophic Lateral Sclerosis 
(ALS) 
FTD and ALS are considered to be part of a disease spectrum. FTD is a common form 
of dementia and characterised by problems with behaviour, language and motor and 
cognitive function. Approximately 50% of the FTD cases are familial, with mutations in 
GRN (proGRaNulin), MAPT (Microtubule-Associated Protein Tau) and C9ORF72 
(Chromosome 9 Open Reading Frame 72) genes accounting for the majority of cases 
(Cruts et al., 2006, Baker et al., 2006, DeJesus-Hernandez et al., 2011, Renton et al., 
2011, Hutton et al., 1998). ALS is a more progressive motor neuron disorder 
characterised by muscle wasting. Around 10% of the ALS cases are familial, and 
mutations in SOD1 account for 20% of the fALS (Familial ALS) cases (Rosen et al., 
1993).  
FTD and ALS are two overlapping diseases; 15% of FTD patients develop ALS-like 
symptoms and 15% of ALS patients develop cognitive abnormalities that are 
associated with FTD (Lomen-Hoerth et al., 2002). The clinical, genetic and pathological 
overlap of FTD and ALS is summarised by Ling et al. (Ling et al., 2013). Proteins 
involved in common dysregulated pathways have been identified, including TDP-43, 
FUS, ubiquilin-2, VCP and C9ORF72 (DeJesus-Hernandez et al., 2011, Renton et al., 
2011, Gijselinck et al., 2012, Deng et al., 2011, Watts et al., 2007, Johnson et al., 2010, 
Wang et al., 2016a). More recently mutations in the autophagy adapter protein p62, 
OPTN and the kinase TBK1 were identified that underlie FTD and ALS (Borghero et 
al., 2016, Cirulli et al., 2015, Freischmidt et al., 2015, Gijselinck et al., 2015, Le Ber et 
al., 2015, Rubino et al., 2012). TBK1 mutations were only associated with FTD patients 
who were also diagnosed with ALS. The same was observed for p62 mutations, 
however also a few cases have been identified with pure FTD, without ALS (Miller et 
al., 2015, Le Ber et al., 2013). ALS-associated p62 mutations have been discusses in 
more detail in section 1.4.1. 
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The kinase TBK1 is a key molecule in the NF-Κβ signalling pathway which is also 
important for autophagosome maturation and has been implicated in different selective 
autophagy pathways, and has mainly been studied in the context of mitophagy and 
xenophagy (Section 1.5 & 1.6) (Richter et al., 2016, Heo et al., 2015, Moore and 
Holzbaur, 2016, Radtke et al., 2007, Thurston et al., 2016, Thurston et al., 2009, Wild 
et al., 2011, Freischmidt et al., 2015). TBK1 phosphorylates p62 and OPTN, thereby 
linking these proteins in a common pathway (Richter et al., 2016, Lazarou et al., 2015, 
Matsumoto et al., 2011).  
More genes that have been associated with ALS or ALS-FTD, such as VCP, 
C9ORF72, CHMP2B (CHarged Multivesicular body Protein 2B) and ubiquilin-2 are 
indirectly or directly involved in the autophagy process, making a strong case for 
autophagy being a potential causative factor in the FTD and ALS pathogenesis 
(Maruyama et al., 2010, Pottier et al., 2015, DeJesus-Hernandez et al., 2011, Renton 
et al., 2011, Johnson et al., 2010, Skibinski et al., 2005, Parkinson et al., 2006, 
Weishaupt et al., 2016). 
FTD and ALS have been linked to mitochondrial dysfunction, firstly because the 
identification of the genes involved in mitophagy. Secondly, based on pathogenic 
mutations found in the mitochondrial protein CHCHD10 (Coiled-coil-Helix-Coiled-coil-
Helix Domain containing 10) (Bannwarth et al., 2014). HeLa cells overexpressing the 
pathogenic mutant have fragmented mitochondria, disorganised mitochondrial cristae 
and increased mtDNA deletions (Bannwarth et al., 2014, Genin et al., 2016). In addition 
to mitochondrial dysfunction, oxidative stress is considered to be a potential causative 
factor for the disease too. The involvement of oxidative stress is supported by the 
observed accumulation of oxidative damage to proteins, lipids and DNA in sporadic 
and familial ALS cases (D'Amico et al., 2013). The involvement of ROS was confirmed 
by the discovery that mutations in the cytosolic antioxidant SOD1 cause ALS (Rosen 
et al., 1993). Interestingly, mutant SOD1 localises to the OMM, IMS and matrix, where 
it forms macromolecular aggregates (Vijayvergiya et al., 2005) (Tafuri et al., 2015), 
causing mitochondrial toxicity (Vehvilainen et al., 2014). In a SOD1 mouse model, 
mitochondrial abnormalities appear before the onset on motorneuron degeneration 
(Kong and Xu, 1998), suggesting that mitochondria are involved in disease initiation. 
Furthermore, mutant SOD1 interacts with Beclin 1, thereby disrupting autophagy 
initiation (Nassif et al., 2014). Thus, mutant SOD1 causes oxidative stress, 
mitochondrial dysfunction, but also autophagy deficiency.  
Chapter 1 
50 
To conclude, according to all these findings, the current dogma is that ALS an FTD are 
complex multi-factorial syndromes, involving oxidative stress, mitochondrial 
dysfunction and autophagy deficiency, but also RNA dysregulation (specifically in ALS) 
(Peters et al., 2015), which is not discussed in this thesis. Furthermore, mutations in 
certain genes can lead to different disease phenotypes. It is not clear why different 
mutations in the same gene can result in different disease outcomes and phenotypes. 
Furthermore, not all carriers of pathogenic TBK1 loss of function mutations develop 
ALS or FTD, suggesting that additional genetic variants or external factors play a role 
and the body has protective mechanisms in place to prevent disease onset. Identifying 





Despite identification of several genetic hereditary cases, most neurodegenerative 
cases have an unknown cause and a sporadic onset. Age is one of the risk factors of 
neurodegeneration and autophagy and mitochondrial function both decrease with age 
and in age-related neurodegenerative diseases (Wyss-Coray, 2016, Lopez-Otin et al., 
2013).To investigate how diminished autophagy can lead to disease the following aims 
were designed: 
Main aim 1: To investigate the interdependence between autophagy and mitochondrial 
function, especially how autophagy deficiency affects mitochondrial health.  
Specific aim 1.1: To investigate mitochondrial function, specifically the respiratory 
chain, in autophagy deficient cells.  
Specific aim 1.2: To prevent or bypass the identified mitochondrial defect in autophagy 
deficient cells in order to prevent cell death.  
Specific aim 1.3: To investigate a potential correlation between autophagy and 
mitochondrial dysfunction in neurodegeneration.  
With age and in neurodegenerative diseases (such as ALS) cells have to cope with 
increased oxidative and proteotoxic stress conditions. Autophagy is a prosurvival 
pathways that protects cells against these stress conditions by degrading damaged 
proteins and organelles, however molecular mechanisms how autophagy is activated 
in oxidative stress conditions and has a prosurvival role has not been investigated in 
detail. Data from our laboratory have shown that the autophagy receptor p62 gets 
oxidised in oxidative stress conditions and cysteine 105 and 113 are essential for its 
redox-regulation. To investigate what functional significance the oxidation of p62 has 
the following aims were designed: 
Main aim 2: To investigate the importance of oxidation of p62 for cellular homeostasis 
in oxidative stress conditions with a focus on ageing and ALS. 
Specific aim 2.1: To investigate the role of oxidation of p62 on autophagy efficiency. 
Specific aim 2.2: To investigate the role of oxidation of p62 on oxidative stress 
resistance in cells and flies.  
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Specific aim 2.3: To investigate the effect of the ALS-related K102E mutation on 
oxidation of p62. 
Specific aim 2.4: To investigated if other autophagy receptors (OPTN, NDP52, 
TAX1BP1 and NBR1) have the same ability as p62 to get oxidised. 
Specific aim 2.5: Generate tools to study the role of oxidation of these other autophagy 
receptors in autophagy and mitophagy. 
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2 CHAPTER 2: MATERIALS AND METHODS  
2.1 Materials 
2.1.1 Tissue culture consumables 
Table 1: Tissue culture consumables 
Consumable Manufacturer Catalogue 
number 
0.6 ml 'Crystal Clear' microcentrifuge tube Starlab E1405-0600 
1.5 ml microcentrifuge tubes Starlab S1615-5500 
12-well plate Fisher TKB-100-110R 
15 ml Centrifuge Tube, Conical (Sterile), 
Loose 
Star labs E1415-0200 
175 cm² TC treated flask with filter cap Greiner-Bio one 661175 
2 ml 'Crystal Clear' Microcentrifuge Tube Starlab E1420-2000 
24-well plates Fisher TKB-100-115H 
50 ml Centrifuge Tube, Conical (Sterile), 
Loose 
Starlab E1450-0200 
6-well plates Fisher 11825275 
75 cm2 TC treated flask with filter cap Greiner-Bio one 658175 
Acrodisc® Mini Spike syringe filters Sigma-Aldrich Z260444-1PAK 




Bijou sample container, plain label Sigma-Aldrich Z645346-700EA 
Cell culture dish treated with vents sterile 
polystyrene non-pyrogenic 
Thermo Fisher Scientific 10075371 
Coverglass 13 mm/0.16 mm VWR 631-0150 
CryoTube vials Thermo Fisher Scientific 377267 
Glass Pasteur pipettes 230 mm VWR 612-1702 
Mr. FrostyTM freezing container Thermo Fisher Scientific 5100-0001 
Serological pipettes 10 ml Sarstedt 86.1254.001 
Serological pipettes 25 ml Sarstedt 86.1685.001 




2.1.2 Tissue culture reagents 
 
Table 2: Tissue culture reagents 
Reagent Manufacturer Catalogue 
number 
20x PBS New England BioLabs  9808 
Blasticidin Thermo Fisher Scientific  R21001 
D-Galactose  Sigma-Aldrich G0750 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich D2650 
DMEM glucose-free medium  Thermo Fisher Scientific A14430-01 
Dulbecco’s Modified Eagle’s Medium 
(DMEM), high glucose 
Sigma-Aldrich D5796 
Fetal Bovine Serum (FBS), heat 
inactivated 
BioSera FB1001H 
Gelatine Sigma-Aldrich G7041 
Hepes  Sigma-Aldrich H0887 
Isopropanol Sigma-Aldrich 278475 
Leukaemia inhibitory factor (LIF) Merck Millipore ESG1106 
L-Glutamine solution Sigma-Aldrich G7513 
Lipofectamine® 2000 Thermo Fisher Scientific 11668019 
MEM Non-essential amino acid solution  Sigma-Aldrich M7145 
Mycoalert Detection Kit Lonza LT07-218 
Non-essential amino acids Sigma-Aldrich M7145 
Opti-MEM® I Reduced-Serum Medium, no 
phenol red 
Thermo Fisher Scientific 11058021 
Penicillin-Streptomycin Sigma-Aldrich P4333 
Ready Probes Cell Viability Imaging kit  Thermo Fisher Scientific R37609 
Sodium pyruvate  Sigma-Aldrich P2256 




2.1.3 Cloning and mutagenesis consumables and reagents 
 
Table 3: Cloning and mutagenesis reagents 
Consumable / reagent Manufacturer Catalogue 
number 
10-beta Competent E. coli (High 
Efficiency) 
New England BioLabs C3019 
Agarose Thermo Fisher Scientific BP1356-500 
Ampicillin Sigma-Aldrich A5354 
Burner Bunsen Natural Gas 13mm SLS BUR3000 
Calf Intestinal Alkaline Phosphatase Thermo Fisher Scientific 18009019 
Cell culture dish treated with vents sterile 
polystyrene non-pyrogenic 
Thermo Fisher Scientific 10075371 
Glass spreaders Sigma-Aldrich S4522-6EA 
Kanamycin Sigma-Aldrich K0254 
LB Agar Miller Thermo Fisher Scientific 10734724 
LB Broth Miller Powder Thermo Fisher Scientific 10638013 
Molecular Grade RNase-free water Thermo Fisher Scientific B-003000-WB-
100 
NEB 5-alpha competent E. coli New England BioLabs C2987I 
NEBuilder HiFi DNA Assembly Cloning Kit New England BioLabs E5520S 
peqGREEN Peqlab 37-5000 
PfuUltra High-Fidelity DNA Polymerase Agilent Technologies 600380 
PfuUltra II Fusion HS DNA Polymerase Agilent Technologies 600672 
Phusion High Fidelity PCR kit Thermo Fisher Scientific F553S 
PureYield™ Plasmid Midiprep System Promega A2492 
Q5 Site-Directed Mutagenesis Kit (Without 
Competent Cells) 
New England BioLabs E0552S 
QIAprep Spin Miniprep Kit Qiagen 27104 
QIAquick Gel Extraction Kit Qiagen 28704 
QuikChange II XL Site-Directed 
Mutagenesis Kit 
Agilent Technologies 200521 
S.O.C. Medium Thermo Fisher Scientific 15544-034 
Stable Competent E. coli (High Efficiency) New England BioLabs C3040 
T4 DNA Ligase New England BioLabs  M0202S 
XL10-Gold® Ultracompetent Cells Agilent Technologies 200314 
α-Select Bronze Competent Cells Bioline BIO-85025 




2.1.4 Western blot reagents 
Table 4: Western blot reagents 
Reagent Manufacturer Catalogue 
number 
20x PBS New England Bio 9808 
2x Laemmli buffer Bio-Rad 1610737 
Acrylamide/Bis-acrylamide Severn Biotech 20-2100-10 
Ammonium persulphate (APS) Sigma-Aldrich A3678 
Bovine Serum Albumin (BSA) Sigma-Aldrich A2153 
Clarity western ECL substrate Bio-Rad 170-5061 
DC Protein Assay Kit Bio-Rad 500-0112 
Gel loading tips Starlab 1022 0600 
GelCodeTM Blue stain reagent Thermo Fisher 
Scientific 
10608494 
Glycine Sigma-Aldrich G8898 
Goat-α-mouse HRP Sigma-Aldrich A2554 
Goat-α-rabbit HRP Sigma-Aldrich A0545 
IGEPAL® CA-630 (NP-40) Sigma-Aldrich I3021 
Immobilon-P polyvinylidene difluoride 
(PVDF) membrane 
Millipore IPVH00010 
Marvel non-fat dry milk powder Asda N/A 




N-ethylmaleimide (NEM) Sigma-Aldrich E3876 
Phosphatase inhibitor cocktail 100X Thermo Fisher 
Scientific 
1861280 
Polyoxyethylene sorbitan (Tween-20) Sigma-Aldrich 93774 
Precision Plus Protein™ Dual Color 
Standards 
Bio-Rad 610374 
Rabbit-α-guinea pig HRP Dako P0141 





Sodium chloride (NaCl) Sigma-Aldrich S7653 
Sodium deoxycholate (NaDoC) Sigma-Aldrich D6750 
Thick blotting paper VWR 732-0594 
Trizma® base (Tris) Sigma-Aldrich T1503 
β-mercaptoethanol (β-mE) Sigma-Aldrich M3148 




2.1.5 Blue native page reagents 
Table 5: Blue native page reagents and consumables 
Reagent/Consumable Manufacturer Catalogue 
number 
30% Acrylamide/Bis-acrylamide Severn Biotech 20-2100-10  
Ammonium persulphate (APS) Sigma-Aldrich A3678 
Ammonium persulphate (APS) Sigma-Aldrich A3678 
Bis-tris  Amresco 715 
Bovine Serum Albumin (BSA) Sigma-Aldrich A2153 
Coomassie blue G  Sigma-Aldrich B0770 
Coomassie Brilliant Blue – R Sigma-Aldrich T0377 
Digitonin Santa cruz biotechnology sc-280675 
D-Mannitol Sigma-Aldrich M4125 
DTT Thermo Fisher Scientific R0861 
EDTA  Sigma-Aldrich EDS  
Glass homogeniser Sigma-Aldrich  D8938  
Glycerol Sigma-Aldrich   G5516 
Gradient mixer Thermo Fisher Scientific 11544424 




NaCl Sigma-Aldrich   S7653 
PMSF Sigma-Aldrich  93482  
Sucrose Sigma-Aldrich S0389 
Tricine Sigma-Aldrich T0377 
Triton X-100  Sigma-Aldrich X100 
ε-amino n-caproic acid  Calbiochem  1381 
2.1.6 Immunofluorescence reagents 
Table 6: Immunofluorescence reagents 
Reagent Manufacturer Catalogue 
number 
20x PBS New England Bio 9808 
37% Formaldehyde Sigma-Aldrich 252549 
Bovine Serum Albumin (BSA) Sigma-Aldrich 5482 
Microscope slide ground edges, twin frosted Thermo Fisher 
Scientific 
FB58628 
Normal Goat Serum Plasmid Laboratories S-1000 
Normal Rabbit Serum Plasmid Laboratories S-5000 
Polyoxyethylene sorbitan (Tween-20) Sigma-Aldrich 93774 
ProLong® Gold Antifade Mountant with DAPI Thermo Fisher 
Scientific 
P36935 
TO-PRO-3 iodide Thermo Fisher 
Scientific 
T3605 




2.1.7 Immunohistochemistry reagents 
Table 7: Immunohistochemistry reagents 
Reagent Manufacturer Catalogue 
number 
Microscope slide ground edges, twin frosted Thermo Fisher Scientific FB58628 
Histoclear National Diagnostics HS-200 
Ethanol Thermo Fisher Scientific E/0650DF/17 
Normal Goat Serum Vector Laboratories S-1000 
VECTASTAIN ABC kit Vector Laboratories PK-4000 
NovaRED Vector Laboratories SK-4800 
Haematoxylin Vector Laboratories H-3401 
DPX mounting medium Thermo Fisher Scientific 12658646 
2.2 Methods 
2.2.1 Tissue culture 
HeLa, HEK293FT, Atg5 knock-out (Atg5-/-) and wild-type (Atg5+/+) mouse embryonic 
fibroblasts (MEFs), M5-7 MEFs, p62-/- and p62+/+ MEFs (Table 8) were grown in DMEM 
supplemented with 10% heat-inactivated FCS (Foetal Calf Serum, Biosera), 5% 
penicillin/streptomycin (Sigma) and 2mM L-glutamine (Sigma) in a humidified 
atmosphere containing 5% CO2 at 37°C. Galactose-based medium consisted of 
DMEM glucose-free medium supplemented with 4mM glutamine (Thermo Fisher 
Scientific), 10mM galactose (Sigma), 1mM sodium pyruvate (Sigma), MEM 
nonessential amino acids (Sigma), 10% FCS and 5% penicillin/streptomycin. Control 
mouse embryonic stem-cell (mES) line ES-I and complex I deficient mES (Cy3-1) 
(Table 8) were grown in DMEM supplemented with 10% FCS, 2mM L-glutamine, 1mM 
sodium pyruvate, 100uM 2-mercaptoethanol (Sigma), non-essential amino acids, 
(Sigma) 1ng/ml LIF (leukaemia inhibitory factor, Merck Millipore) in 0.1% gelatine 
(Sigma) coated flasks. 
Cells were treated different reagent as shown in table 2 at different concentration and 
time-points in glucose- or galactose-based medium as indicated, all consumables used 




Table 8: Mouse and human cell lines 
Cell line Source reference 
mouse cell lines 
Atg5+/+ MEFs Dr. Noboru Mizushima (Tokyo Medical and 
Dental University) 
(Kuma et al., 2004) 
Atg5-/- MEFs Dr. Noboru Mizushima (Tokyo Medical and 
Dental University) 
(Kuma et al., 2002) 
M5-7 MEFs Dr. Noboru Mizushima (Tokyo Medical and 
Dental University) 
(Hosokawa et al., 
2007) 
p62+/+ MEFs Dr. Eiji Warabi (University of Tsukuba) (Komatsu et al., 
2007) 
p62-/- MEFs Dr. Eiji Warabi (University of Tsukuba) (Komatsu et al., 
2007) 
human cell lines 
HEK293FT Thermo Fisher Scientific #R700-07 
 
HeLa cells ECACC (European Collection of Cell 
Cultures), Salisbury, UK 
 
mES ctr Dr. Amy Reeve (Newcastle University) (Kirby et al., 2009) 
mES CI Dr. Amy Reeve (Newcastle University) (Kirby et al., 2009) 
HeLa ctr CRISPR Dr. Michael Lazarou (Monash University, 
Melbourne) 
(Lazarou et al., 
2015) 
HeLa PentaKO Dr. Michael Lazarou (Monash University, 
Melbourne) 
(Lazarou et al., 
2015) 
HeLa PentaKO + 
YFP-Parkin+ mtKeima 
generated by Dr. Michael Lazarou 
(Monash University, Melbourne) 
unpublished 
 
Table 9: Tissue culture treatments 






Antimycin A Sigma-Aldrich A8674 40mM 4µM 
Auranofin Sigma-Aldrich A6733 1mM 5µM 




100µM 50 or 400nM 
Chloroquine Sigma-Aldrich C6628 50mM 50µM 
Curcumin Sigma-Aldrich C1386 200mM 50µM 
Cyclohexamide Sigma-Aldrich C7698 20mg/ml 50µg/ml 
H2O2 Sigma-Aldrich H1009 1M 1mM-5mM 
I-BET 525762A Insight 
Biotechnology 
HY-13032 1mM 1µM 
MG132 Sigma C2211 40mM 600nm-20µM 






Oligomycin Merck Millipore 495455 5mg/ml 10µM 
Polybrene Sigma-Aldrich 107689 5mg/ml 5µg/ml 
PR-619 LifeSensors S19619 10mM 5µM-20µM 
S1QEL2.2 Life Chemicals 
Europe 
F2068-0013 500µM 500nM 
Tetracycline Sigma-Aldrich 87128 1mg/ml 1µg/ml 







2.2.2 Alignments and in silico calculations 
p62 protein sequences in 14 organisms were identified by searching UniProt for the 
gene names SQSTM or Ref(2)P, then removing sequence fragments and choosing the 
longest isoform from each organism. Multiple Sequence alignment was carried out 
using the Muscle server at EBI (http://www.ebi.ac.uk/Tools/msa/muscle/) with default 
parameters. The resulting alignment was visualised using ALINE (Bond and 
Schuttelkopf, 2009). Conservation is indicated by depth of 10 colour from light to dark 
red, with conservation below 30% indicated in white. Secondary structure in the PB1 
domain was indicated by using the X-ray crystal structure (PDB entry 4MJS chain B), 
and in the ZZ domain using homology to CBP (PDB entry 1TOT). Alignments were 
carried out by Dr. Graham Smith.  
Table 10: organisms used for multiple protein alignments of p62 
Organism Gene name Protein ID 
Homo sapiens (Human) SQSTM1 Q13501|SQSTM_HUMAN 
Pongo abelii (Sumatran orang-utan) SQSTM1 Q5RBA5|SQSTM_PONAB 
Macaca mulatta (Macaque) SQSTM1 H9G1C8|H9G1C8_MACMU 
Bos taurus (Cow) SQSTM1 Q32PJ9|Q32PJ9_BOVIN 
Mus musculus (Mouse) Sqstm1 Q64337|SQSTM_MOUSE 
Canis familiaris (Dog) SQSTM1 F1P6L5|F1P6L5_CANFA 
Cavia porcellus (Guinea pig) SQSTM1 H0W6B1|H0W6B1_CAVPO 
Gallus gallus (Chicken) SQSTM1 F1NA86|F1NA86_CHICK 
Sarcophilus harrisii (Tasmanian devil) SQSTM1 G3W939|G3W939_SARHA 
Anolis carolinensis (Carolina anole) SQSTM1 G1KYX2|G1KYX2_ANOCA 
Xenopus laevis (African clawed frog) sqstm1 Q6PGS1|Q6PGS1_XENLA 
Latimeria chalumnae (West indian Ocean 
coelacanth) 
SQSTM1 H3AW10|H3AW10_LATCH 
Drosophila melanogaster (Common fruit fly) ref(2)P P14199|REF2P_DROME 
Caenorhabditis elegans (roundworm) sqst-1 Q22436|Q22436_CAEEL 
 
2.2.3 Structural modelling 
To model the p62 linker region (the part between the PB1-domain and the ZZ-domain), 
which is most likely natively unstructured, the consensus annotation from MobiDB 
(http://mobidb.bio.unipd.it/entries/Q13501) was used (Potenza et al., 2015). This 
consensus (amino acids 105-117) was extended slightly to include the ALS-related 
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K102E mutant. PyMOL (The PyMOL Molecular Graphics System, Version 1.7.0.0 
Schrödinger, LLC) was used to build structures of the linker using the wild type 
sequence and the K102EALS mutant. Electrostatics calculation were carried out with 
the APBS plug-in for PyMOL (Baker et al., 2001), with PyMOL-generated hydrogens 
and termini and a concentration of monovalent cations and anions of 0.15 M and the 
resulting electrostatic potential was mapped to the solvent-accessible surface. 
Structural modelling was carried out by Dr. Graham Smith. 
2.2.4 Modelling of the p62 construct comprising of PB1 and zinc finger 
domains (residues 3-183)  
Prediction of an initial 3D structure of zinc finger domain of p62 (residues 121-183) 
was performed using MODELLER (Webb and Sali, 2016) using the crystal structure of 
human MZM-REP domain of Mib E3 ubiquitin ligase (PDB code: 4XI6) as a template. 
The sequence identity between the template and the target was 38%. The model has 
been refined by molecular-mechanical energy minimization (50 000 cycles) and 10 ns 
of unrestrained all-atom MD simulation using Gromacs 5.1.2 (Van Der Spoel et al., 
2005) with Amber99SB-ILDN* force field (Lindorff-Larsen et al., 2010) and explicit 
TIP3P water model. The obtained structure has been fitted on the PB1 domain using 
protein-protein docking with PatchDock (Schneidman-Duhovny et al., 2005), and the 
top 5 predicted models were refined by 50 000 cycles of MM minimization and 5 ns of 
MD simulation. The obtained models were fitted on cryoEM assemblies of p62 PB1 
domains (PDB codes 4UF8 and 4UF9), and the final model has been selected using 
the geometric constraints (relative positions of cysteines, steric clashes overall the 
model) and energy-minimised with the disulphide bonds introduced. Structural 
modelling of residues 3-183 was carried out by Dr. Agnieszka Bronowska. 
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2.2.5 Modelling of the impact of K102E mutation 
The mutation has been introduced to the PB1 domain models (residues 3-125) by 
manual replacement, followed by the conformational using UCSF Chimera (Couch et 
al., 2006). Then, the whole structure of the mutant (in the monomeric form) has been 
subjected to 50 000 cycles of MM energy minimization, followed by 10 ns of all-atom 
MD in Gromacs 5.1.2 with TIP3P explicit water and the Amber99SB-ILDN* force field 
(Lindorff-Larsen et al., 2010, Van Der Spoel et al., 2005). The wild-type PB1 domains 
were subjected to the same protocol, as the control group. In the analysis, we focused 
on the differences between the interactions in the wild-type and the K102E mutant and 
on the local sampling of the region surrounding the mutated residue. The modelling of 
the oligomers was done in UCSF Chimera. The positions of the 102-125 loops were 
refined using FlexPepDock Monte Carlo approach (Alam and Schueler-Furman, 2017). 
The figure has been generated using UCSF Chimera (Couch et al., 2006). Structural 
modelling of the K102E mutant was carried out by Dr. Agnieszka Bronowska. 
2.2.6 Cloning of His-FLAG-p62 in lentiviral construct (pLENTI6/V5-DEST) 
His-FLAG-p62 and His-FLAG-C105,113Ap62 for lentiviral expression were subcloned 
into the pLENTI6/V5-DEST (Invitrogen, V496-10) using EcoRI and XhoI 
(ThermoFisher Scientific). His-FLAG-p62 and His-FLAG-C105,113Ap62 inserts were 
produced using the primers in table 11 which introduce an EcoRI and XhoI restriction 
site, using His-FLAG-p62 wild-type (pcDNA 3.1, kind gift from Dr. Robert Layfield, 
University of Nottingham) or C105,113A mutant as templates. PCRs were performed 
using the Phusion High-Fidelity PCR kit (Thermo Fisher Scientific) and every PCR 
mixture was prepared according to the provided protocol: 1x Phusion High-Fidelity 
buffer, 10 ng DNA template, 125 ng oligonucleotide primers (both forward and 
reverse), 200μM dNTP, Phusion High-Fidelity DNA polymerase (2 U/μl) and H2O up to 
final volume of 50 μl. PCR reactions were placed on a Veriti 96-Well Thermal Cycler 
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(Applied Biosystems) using the provided program: 1 cycle at 98°C for 30 sec, 25 cycles 
(Denaturation 98°C for 10 sec, Annealing 57°C for 30 sec, Extension 72°C for 1 kb/min) 
and 1 cycle at 72°C for 5 min. The p62 fragments were then digested with EcoRI and 
XhoI for 5 min at 37°C and run on 0.8% agarose gel (Thermo Fisher Scientific), which 
was then gel purified using the QIAquick Gel Extraction Kit (Qiagen). The pLENTI6/V5-
DEST plasmid was digested with EcoRI and XhoI and gel purified as well. After the 
double digestion, the pLENTI6/V5-DEST backbone was dephosphorylated by calf 
intestinal alkaline phosphatase (Thermo Fisher Scientific) for 50 min at 37°C. The 
digested p62 fragments were ligated into the double digested pLENTI6/V5-DEST 
backbone using the T4 DNA Ligase (New England BioLabs) at 16°C overnight. 
Bacterial transformation was performed using NEB3040 NEB Stable Competent E. coli 
(New England Biolabs) and adding 2μl of ligation mixture to 45μl of cells. Cells were 
plated on LB agar plates containing 50ng/ml of Ampicillin (Sigma-Aldrich). Colonies 
were grown for 24 hours at 31 °C the plasmid was extracted using QIAprep Spin 
Miniprep Kit (Qiagen). To test if the obtained plasmid was correct EcoRV was used as 
a control digestion, which results in 855 and 8172 bp fragments. The plasmid was 
sequenced to confirm correct insertion of FLAG-p62 using the UB forward and V5 
reverse primers (Table 12) (Eurofins Genomics). 
Table 11: Primers used to clone His-FLAGp62 into pLENTI6/V5-DEST 
p62startEcoRI  GGGGGAATTCATGGCGTCGCTCACCG 
p62stopXhoI GGGCTCGAGTCACAACGGCGGGGG 
 
Table 12: Sequencing primers 
LNCX FWD  AGCTCGTTTAGTGAACCGTCAGATC 
UB FWS TCAGTGTTAGACTAGTAAATTG 
V5 REV ACCGAGGAGAGGGTTAGGGAT 




2.2.7 Cloning His-FLAG-NDP52 and His-FLAG-OPTN in lentiviral construct 
(pLENTI6/V5-DEST) 
For cloning of NDP52 and OPTN into pLENTI6/V5-DEST (His-FLAG), Gibson 
assembly was used. NDP52, OPTN and pLENTI6/V5-DEST (His-FLAG) were PCR 
amplified using PfuUltra II Fusion HS DNA Polymerase (Agilent) and Gibson assembly 
primers with 20 bp overhangs (Table 13). As a template FLAG-NDP52 M5P (kindly 
provided by Dr. Felix Randow), OPTN pDESt26 (Addgene #23050) and the previous 
generated His-FLAGp62 (pLENTI6/V5-DEST) were used (See appendix for plasmid 
maps). PCR products were separated by agarose gel electrophoreses, and fragments 
excised and purified before use in DNA assembly reaction with the NEBuilder HiFi DNA 
Assembly kit (New England Biolabs) according to the manufacturer’s instructions. After 
the assembly, the reaction mix was transformed into NEB3040 NEB Stable Competent 
E. coli (New England Biolabs) and 2μl of ligation mixture was added to 45μl of cells. 
Cells were plated on LB agar plates containing 50ng/ml of Ampicillin (Sigma-Aldrich). 
Colonies were grown for 24 hours at 31 °C and the plasmid was extracted using 
QIAprep Spin Miniprep Kit (Qiagen). To test if the obtained plasmid was correct, EcoRV 
and NotI were used for a control digest of the His-FLAG-OPTN and His-FLAG-NDP52 
plasmids, resulting in 9403 bp fragment for the OPTN plasmid and 2228 and 6816 bp 
fragments for the NDP52 plasmid. The plasmids were sequenced to confirm correct 
insertion of His-FLAG-OPTN and His-FLAG-NDP52 using the UB forward and V5 




Table 13: Primers used to clone NDP52 and OPTN into pLENTI6/V5-DEST 
(His-FLAG) 
His-FLAG-pLENTI6 FWD TCGAGTCTAGAGGGCCCGCGGTT 









2.2.8 Cloning NDP52 in pDEST26 backbone 
To clone FLAG-NDP52 in the mammalian pDEST26 backbone (His) Gibson assembly 
was used. FLAG-NDP52 and pDEST26 were PCR amplified using PfuUltra II Fusion 
HS DNA Polymerase (Agilent) and Gibson assembly primers with 20 bp overhangs 
(Table 14). As a template FLAG-NDP52 M5P (kindly provided by Dr. Felix Randow) 
and OPTN pDESt26 (Addgene #23050) were used. PCR products were separated by 
agarose gel electrophoreses, and fragments excised and purified before use in DNA 
assembly reaction with the NEBuilder HiFi DNA Assembly kit (New England Biolabs) 
according to the manufacturer’s instructions. After the assembly, the reaction mix was 
transformed into α-select GOLD Efficiency chemically competent cells (Bioline), 2μl of 
ligation mixture was added to 45μl of cells. Cells were plated on LB agar plates 
containing 50ng/ml of Ampicillin (Sigma-Aldrich). Colonies were grown overnight at 
37 °C and the plasmid was extracted using QIAprep Spin Miniprep Kit (Qiagen). To 
test if the obtained plasmid was correct, SacI was used for a control digest of the His-
FLAG-NDP52 pDEST26 plasmid, resulting in 754 and 6640 bp fragments. The plasmid 
was sequenced to confirm correct insertion of FLAG-NDP52 using the LNCX forward 






















Point mutagenesis of the p62, NDP52 and OPTN genes were carried out using the 
QuikChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies) or Q5 Site-
Directed Mutagenesis Kit (NEB) according to manufacturer’s instructions. Mutagenesis 
primers were designed using the online QuikChange Primer Design program 
(http://www.genomics.agilent.com/) or the NEB primer design program 
http://nebasechanger.neb.com (Tables 15, 16 & 17). The GFP-p62 (pEGFP C2, 
Clontech, 632481), His-FLAG-p62 (pcDNA3.1, Kind gift from Dr. Robert Layfield, 
University of Nottingham), His-FLAG-NDP52 (pDEST26) and His-FLAG-OPTN 
(pDEST26, Addgene, 23050) wild-type plasmids were used as templates. PCR 
reactions were placed on a Veriti 96-Well Thermal Cycler (Applied Biosystems) using 
the provided program: 1 cycle at 95°C for 1 min, 18 cycles (Denaturation 95°C for 50 
sec, Annealing 60°C for 50 sec, Extension 68°C for 7 min) and 1 cycle at 68°C for 6 
min. Bacterial transformation was then carried out using 45μl of XL10-Gold® 
Ultracompetent Cells (Agilent Technologies) and 2μl of β-mE mix provided with the kit, 
together with 2μl of the DpnI-treated DNA per reaction. Transformation mixtures were 
incubated on ice for 30 min, heat-pulsed in a 42°C water bath for 30 sec, incubated on 
ice for 2 min, followed by the addition of 950 μl of S.O.C. medium (Thermo Fisher 
Scientific). After 1 hour incubation at 37°C with shaking at 220 rpm, 250μl of each 
transformation reaction were plated on LB agar (Thermo Fisher Scientific) plates 
containing 100ng/μl of ampicillin (Sigma-Aldrich) and incubated overnight at 37°C. 
Chapter 2 
67 
Then, colonies were picked and grown in 5ml of LB broth (Thermo Fisher Scientific) 
overnight at 37°C with shaking at 220 rpm. Bacterial DNA was extracted using the 
QIAprep Spin Miniprep Kit (Qiagen) to a final volume of 50μl and sent for sequencing 
(Eurofins Genomics). 
Table 15: Primers used for p62 mutagenesis 
p62 C105A FWD ACATTAAAGAGAAAAAAGAGGCCCGGCGGGACCACCG 
p62 C105A REV CGGTGGTCCCGCCGGGCCTCTTTTTTCTCTTTAATGT 
p62 C113A FWD CCACCGCCCACCGGCTGCTCAGGAGGCG 
p62 C113A REV CGCCTCCTGAGCAGCCGGTGGGCGGTGG 
p62 K102E FWD CCCGCCGGCACTCTTTCTCCTCTTTAATGTAGATTCGGAA 
p62 K102E REV TTCCGAATCTACATTAAAGAGGAGAAAGAGTGCCGGCGGG 
p62 K7A FWD CGTCGCTCACCGTGGCGGCCTACCTTCTGG 
p62 K7A REV CCAGAAGGTAGGCCGCCACGGTGAGCGACG 
p62 D69A FWD CGCACTACCGCGCTGAGGACGGGGA 
p62 D69A REV TCCCCGTCCTCAGCGCGGTAGTGCG 
p62 R106E NEB FWD AAAAGAGTGCGAGCGGGACCACC 
p62 R106E NEB REV TTCTCTTTAATGTAGATTCGGAAG 
p62 R107E NEB FWD AGAGTGCCGGGAGGACCACCGCC 
p62 R107E NEB REV TTTTTCTCTTTAATGTAGATTCGGAAGATGTC 
p62 H109A NEB FWD CCGGCGGGACGCCCGCCCACCGT 
p62 H109A NEB REV CACTCTTTTTTCTCTTTAATGTAGATTCGGAAGATGTCATC 
p62 D108A NEB FWD GTGCCGGCGGGCCCACCGCCCAC 
p62 D108A NEB REV TCTTTTTTCTCTTTAATGTAGATTCGGAAGATGTCATCCTTCA
CGTAGGACATGGCC 
p62 E104K NEB FWD AGAGAAAAAAAAGTGCCGGCGGG 






Table 16: Primers used for OPTN mutagenesis 
OPTN C8A FWD CCCATCAACCTCTCAGCGCCCTCACTGAAAAGGAGG 
OPTN C8A REV CCTCCTTTTCAGTGAGGGCGCTGAGAGGTTGATGGG 
OPTN C239A NEB 
FWD 
GCTCCTGCTGGCCCTAAGGGAAG 
OPTN C239A NEB 
REV 
TGGCTCACAGTTAACTCC 
OPTN C334A FWD TAATGAAGAAGAGACTTCAAGAAAAGGCTCAGGCCCTTGAAAGG 
OPTN C334A REV CCTTTCAAGGGCCTGAGCCTTTTCTTGAAGTCTCTTCTTCATTA 
OPTN C472A FWD CTTTCAGCATGAAAATCAGAAGCGTAAACTTCCATCTGAGCCCT 
OPTN C472A REV AGGGCTCAGATGGAAGTTTACGCTTCTGATTTTCATGCTGAAAG 
 



































































2.2.10 DNA transfections 
HeLa cells and MEFs were seeded in either 6- or 12-well plates, cultured for 24 (HeLa) 
or 48 (MEFs) hours and transfected with Lipofectamine 2000 (Thermo Fisher 
Scientific) according to the manufacturer’s instructions for 24 hours prior to lysis. For 
each transfection in 6-well plates, 1μg DNA, 3μl of transfection reagent and 100μl Opti-
MEM I Reduced-Serum Medium (Thermo Fisher Scientific) was used per well.  
2.2.11 SiRNA transfection 
ON-TARGETplus SMARTpool siRNA against mouse VCP (L-057592-00), ClpP (L-
044020-01), Lon (L-054897-01), Afg3L2 (L-056354-01) and non-targeting SMARTpool 
siRNA (D-001810-04) were purchased from Dharmacon. p62+/+ and p62-/- MEFs were 
seeded in 6-plates, 90% confluent cells were transfected with 100ng siRNA using 
Lipofectamine 2000 according to the manufacturer’s instructions for 24 hours. The 
following day, cells were split and seeded in 6 well plate and the next day 70% 
confluent cells were transfected again with 30ng siRNA using the same procedure 24 
hours prior to lysis.  
2.2.12 Generating stable cell lines by lentiviral transductions 
Stable expression of FLAG-p62 and FLAG-C105A-C113Ap62 in p62-/- MEFs was 
generated via lentiviral transductions. HEK293FT cells were seeded in antibiotic-free 
medium supplemented with 0.1mM MEM non-essential amino acids (Gibco) and then 
cotransfected with either empty or p62 lentiviral expression vectors and 3rd generation 
packaging system plasmids (Thermo Fisher Scientific). After 24 hours, media was 
replaced with fresh media without antibiotics. 48 hours after transfection, viral 
transduction was performed by transferring media from HEK293FT cells to 70% 
confluent p62-/- MEFs in the presence of 5μg/ml Polybrene (Sigma-Aldrich). Media 
containing virus was replaced after 24 hours with fresh media containing 8μg/ml of 
blasticidin (Thermo Fisher Scientific) for selection of transduced cells. Media was 
replaced every 2-3 days for 10-12 days by keeping the antibiotic selection. Stable cell 
lines were maintained in lower levels of blasticidin (4μg/ml) until seeding for 
experimental purposes. 
2.2.13 Generating stable cell lines via DNA transfections 
To generate HeLa PentaKO or HeLa PentaKO + YFP-Parkin + mtKeima cells stably 
expressing His-FLAG-NDP52, His-FLAG-OPTN or the respective oxidation mutants, 
HeLa PentaKO were seeded into 6-well plates and 70% confluent cells were 
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transfected with 1µg of DNA (receptors in pLENTI6/V5-DEST constructs) using 
Lipofectamine 2000 (Thermo Fisher Scientific) according to the manufacturer’s 
instructions for 24 hours. Cells that incorporated the plasmid into their genome were 
selected with Blasticidin (8μg/ml), media was replaced every 2-3 days for 3 weeks, 
after which the expression levels were tested by western blot. Stable cell lines were 
maintained in lower levels of blasticidin (4μg/ml) until seeding for experimental 
purposes. 
2.2.14 Generation of ‘humanised’ D. melanogaster Ref(2)P 
CRISPR/Cas9-Mediated Genome Editing (homology-dependent repair (HDR) using 
one guide RNA and a dsDNA plasmid donor) was utilised to generate a humanised 
Ref(2)P (CG10360) (WellGenetics, Taiwan). Amino acids 91-116 of Drosophila (knock-
in strain w1118) Ref(2)P were replaced with amino acids 100-118 of human 
p62/SQSTM1 peptide. Guide RNA primers: sense 5’-
CTTCGACAGAAGGAGCTTCAGCGT-3’; antisense 5’-
AAACACGCTGAAGCTCCTTCTGTC-3’. 
2.2.15 Fly husbandry  
Flies were crossed and maintained on standard media (Table 18) at 25°C in a 
controlled 12 hr light: dark cycle. Male flies were used in all experiments. Survival 
graphs were created using Graphpad Prism software and log rank statistics applied. 
60 flies were used for each experimental group and 3 replicate experiments were 





Table 18: Fly food recipe 
%(w/v) Ingredient Catalogue number 
1 Drosophila agar Type II Dutscher Scientific #789150 
1.5 Saccharose (sucrose) VWR #27480.294 
3 D-(+)-Glucose VWR #101176K 
3.5 Active Dried Yeast Dutscher Scientific #789093 
1.5 Maize meal Supermarket 
1 Wheat germ MP biomedicals #0290328805 - 5 lb 
1 Soybean flour Santa Cruz Biotechnology #sc-215897A 
3 Treacle Bidvest #90028S 
2.2.16 Paraquat Survival 
Two days old males (20 flies/vial) were starved overnight on 5ml 1% agar at 25°C. 
Flies were transferred to vials containing filter paper soaked in 150μl of a 5% Sucrose 
solution with 20mM paraquat (Sigma) and maintained at 25°C. Dead flies were counted 
at 12 hr intervals and media changed daily. 
2.2.17 32°C Survival  
2 day old males (20 flies/vial) were transferred to 32°C. Media was changed every 1-2 
days and dead flies were counted. 
2.2.18 Chloroquine feeding  
Two days old males (20 flies/vial) were transferred to standard media containing 
2.5mg/ml chloroquine (Sigma). Flies were maintained at 25°C for 2 days and then 
transferred to 32°C for 2 days. Media was changed every 1-2 days and dead flies were 
counted. 
2.2.19 Preparing fly western blot samples  
10-20 flies were crushed (using homogeniser) in 200-300µl 1x homogenising buffer, 
containing 0.2% Triton X-100 (w/v, Promega, H5141), complete mini EDTA-free 
Protease Inhibitor (Sigma, 000000004693159001) and 1x PBS and left on ice for 10 
min, followed by a 15 min spin at 13,000 rpm at 4ᵒC, the supernatant was analysed by 
western blot analysis described in section 2.2.21.  
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2.2.20 Cell survival assay 
MEFs were seeded 24 hours prior to treatments in 12-well plate. After treatments, cells 
viability was assessed using Ready Probes Cell Viability Imaging kit (Thermo Fisher 
Scientific) according to the manufacturer’s instructions. Briefly, NucBlue Live reagent 
(Hoechst 33342) and NucGreen Dead reagent (FITC/GFP) were added to the media 
for 10 min after treatments to determine cell viability. Cells were imaged on inverted 
DM IL LED Leica microscope equipped with an Invenio 3SII digital camera (3.1 Mpix 
Colour CMOS; DeltaPix). Images were analysed using ImageJ and the percentage of 
cell death was quantified. The cell death analysis using the Ready Probes Cell Viability 
was done in collaboration with Dr. Bernadette Carroll. Alternatively, bright field images 
were taken in combination with western blot analysis for apoptotic cell death markers 
cleaved caspase 3 and Parp-1.  
2.2.21  Western blot analysis 
MEFs, mES or HeLa cells were seeded in 6-plates 24 hours prior to treatments. After 
treatments, cells were washed in ice-cold 1x PBS then lysed in RIPA buffer (150 mM 
NaCl, 1% NP-40, 0.5% NaDoC, 0.1% SDS, 50 mM Tris pH 7.4, supplemented with 1X 
Halt Protease & Phosphatase inhibitor cocktail in ddH2O). Cell lysates were then 
centrifuged at 4°C at 13,000 rpm for 10 min. Protein concentration was measured by 
Bradford assay using the DC Protein Assay (Bio-Rad) and a FLUOstar Omega plate 
reader (BMG Labtech). Samples were prepared by boiling in SDS-Loading buffer (Bio-
Rad) containing 2.5% β-mE at 100°C for 5 min. 20-40 μg protein was run on 10, 12 or 
15% Tris-Glycine SDS-PAGE gels and transferred to Immobilon-P PVDF membranes 
using a Trans-Blot SD Semi-Dry Transfer Cell (Bio-Rad). Blots were incubated with a 
blocking solution (PBS containing 5% fat-free dry milk and 0.1% Tween-20) for 1 hour, 
followed by a wash with PBS. Blots were incubated with primary antibodies (Table 19) 
diluted in blocking solution at 4˚C overnight, followed by three washes, 10 min each: 
one time with PBS, once in PBS with 0.1% Tween-20 and one more time in PBS. Then, 
blots were incubated with secondary HRP-conjugated antibodies α-mouse, α-rabbit or 
α-guinea pig (1:5000) in blocking solution for 1 hour at room temperature, followed by 
three washes as described above. Blots were incubated for 5 min with the Clarity 
Western ECL Substrate (Bio-Rad) and signals were detected by chemiluminescence 




Table 19: Antibodies used for western blot analysis 






p-AMPK rb 62 
 
New England Bio 2535 
AMPK rb 62 
 
New England Bio 2603 
PKM1/2 rb 60 
 
New England Bio 3190 
ATG5 rb 56 
 
Sigma-Aldrich A0856 
NDUFA9 ms 40 36 Abcam ab14713 
NDUFB8 rb 22 
 
Abcam ab110242 
NDUFB9 rb 22 
 
Abcam ab106699 
NDUFS3 ms 30 
 
Abcam ab110246 
NDUFV2 rb 27 24 proteintech, 15301-1-AP 
SDHA rb 70 
 
New England Bio 11998 
UQCRC2 ms 49.5 
 
Abcam ab14745 
MT-CO1 rb 57 40 Abcam ab14705 
TOMM20 ms 16 
 
Abcam ab56783 
Mfn2 ms 86 75 Sigma-Aldrich WH0009927M3 
GAPDH rb 37 
 
New England Bio 3868 
p62 gp 62 
 
Progen GP62-C 
LC3B rb 14-16 
 
New England bio ALX-803-081-
C100 
ATP5A ms 53 
 
Abcam ab14748 





New England Bio 9661S 
Parp rb 89, 116 
 
New England Bio 9542P 
ClpP rb 27 
 
Abcam ab124822 
Tubulin ms 50 
 




Prx-SO3 rb 22 
 
Abcam ab16830 
Prx 3 rb 20 
 
(Olahova et al., 2008) 








Atg8 rb 14-16 
 









NDP52 rb 52 
 
New England Bio 9036S 
OPTN rb 66 74 Abcam ab23666 
NBR1 ms 120 
 
Abnova H00004077-MOI 
TAX1BP1 rb 92 
 
New England Bio 5105 
2.2.22 Mitochondrial isolation and Blue native page  
Atg5+/+ and ATG5-/- MEFs were seeded in 10cm dishes and collected in 5ml cold PBS 
and transferred to a 15ml falcon. Cells were centrifuged for 5 min at 800g at 4ᵒC and 
washed in cold PBS, followed by another round of centrifugation to pellet the cells. 
Cells were resuspended in solution A (20mM Hepes-KOH pH 7.6 (Sigma), 220mM 
mannitol (Sigma), 70mM sucrose (Sigma), 1mM EDTA (Sigma), 2mg/ml BSA (Sigma), 
2mM DTT (Thermo Fisher Scientific) and 0.5mM PMSF (Sigma)) and homogenised 
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with 30 stroking using a glass homogeniser and a drill. Cells were centrifuged for 5 min 
at 800g at 4ᵒC and the supernatant (containing the mitochondria) was collected and 
aliquoted into 1.5ml tubes, centrifuged for 10 min at 10,000g at 4ᵒC. The supernatant 
(cytosolic fraction) was removed and the pellet (crude mitochondria) was resuspended 
in solution B (20mM Hepes-KOH pH 7.6, 220mM mannitol, 70mM sucrose, 1mM 
EDTA) and centrifuged again for 10 min at 10,000g at 4ᵒC. The pellet was resuspended 
in 100µl solution B and protein concentration was determined using a BCA kit. 
30µg pellet of isolated mitochondria were centrifuged for 10 min at 10,000g at 4ᵒC and 
resuspenden in 30µl 1% digitonin or 30µl 1% triton X-100 buffer (1% digitonin or 1% 
Triton X-100, 20mM Bis-Tris pH 7, 50mM NaCl, 10% glycerol and 1mM DTT) and 
titrated 20x without making bubbles and incubated on ice for 20 min. Detergent-
solubilised samples were centrifuged for 10 min at 16,000g at 4ᵒC to remove insoluble 
material. 10x blue native page loading dye (5% Coomassie blue G (Sigma), 500mM ε-
amino n-caproic acid (Calbiochem), 100mM Bis-Tris pH 7.0 (Amresco)) was added 
and ran on a 4 to 13% acrylamide–bisacrylamide BN–PAGE gel (in 70mM ε-amino n-
caproic acid and 50mM bis-Tris pH 7) using an SE600 Electrophoresis Unit (Hoefer). 
For separation, cathode buffer (15mM bis-Tris pH 7 and 50mM tricine (Amresco)) 
containing 0.02% (w/v) Coomassie Blue G was used until the dye front had reached 
approximately one-third of the way through the gel before exchange with cathode 
buffer lacking Coomassie Blue G. Anode buffer contained 50 mM bis-Tris (pH 7.0). 
Native complexes were separated at 100V/10mA for 30 min at 4 °C, then 400V/15mA 
for 45-60 min and 400V/20mA for approximately 1 hour (till the blue front runs out of 
the gel into the anode buffer). Thyroglobulin (669 kDa), ferritin (440 kDa), and bovine 
serum albumin (BSA, 140 and 67 kDa) were used as markers. The gel was transferred 
to PVDF membranes (400 mA for 1.5 hour) and Coomassie stained (40% Ethanol, 7% 
Acetic acid 0.2% Coomassie Brilliant Blue – R (Sigma)) and destained with 20% 
Ethanol, 7% Acetic acid, further destained with 90% methanol, 10% acetic acid. 
Membranes were blocked in blocking solution as described in section 2.2.21. Primary 
antibodies used were Ndufa9 (Kindly provided by Dr. Michael Ryan (Johnston et al., 




2.2.23  Nuclear fractionation 
Nuclear fractionation was carried out as in (Suzuki et al., 2010). Briefly, 1.8x105 MEFs 
were seeded 6-well plates 48 hours prior to collection. Cells were washed in ice-cold 
PBS, scrapped in 1 ml ice-cold PBS and centrifuged for 10 sec at 13,000 rpm at 4˚C. 
The pellet was carefully resuspended in 1 ml ice-cold 0.1% NP40 in PBS. 50μL was 
collected in a fresh tube (whole cell sample). Samples were centrifuged again for 10 
sec at 13,000 rpm at 4˚C and supernatant, which represents the cytoplasmic fraction, 
was discarded. The pellet was resuspended in 1 ml ice-cold 0.1% NP40 in PBS. 
Samples were centrifuged for 10 sec at 13,000 rpm at 4˚C, supernatant was discarded 
and the nuclear pellet and the earlier collected whole cell lysates were prepared for 
western blot analysis. The whole cell lysate was mixed 3:1 with 4x Laemmli sample 
buffer with 10% β-mE (2.5% final concentration) and boiled at 100°C for 10 min on a 
thermomixer, shaking at 200 rpm. Nuclear pellets were resuspended in 200μL 1x 
Laemmli sample buffer with 2.5% β-mE and boiled at 100°C for 10 min on a 
thermomixer, shaking at 200 rpm. Samples were ran on a 12% agarose gel as 
described in section 2.2.21. 
2.2.24  ROS Measurements 
MEFs were seeded in a 12-well plate and grown in glucose- or galactose-based 
medium. Cells were then washed with PBS and trypsinised. Cells were then transferred 
to a 15 ml falcon tube and centrifuged for 3 min at 1600 rpm. The pellet was 
resuspended in 200μl SFM containing MitoSOX (5μM, Thermo Fisher Scientific) and 
incubated at 37˚C for 10 min. Cells were centrifuged again for 5 min at 900 rpm and 
the pellet was resuspended in 5ml SFM. Cells were analysed by fluorescence-
activated flow cytometry (FACS, Partec) and mean fluorescence values were obtained. 
2.2.25  qPCR 
RNA from Atg5+/+ and Atg5-/- MEFs or p62-/- MEFs stably expressing FLAG-tagged wild 
type, C105A,C113A or K7A,D69A PB1 domain mutant p62 was isolated using the 
RNeasy minikit (Qiagen) and cDNA was made using the Omniscript RT Kit (Qiagen, 
#205111) according to the manufacturer’s instructions. qPCR was performed using the 
Power Syber Green PCR Master Mix (Thermo Fisher Scientific, #4368706) in a 
C1000TM Thermal Cycler, using CFX96TM Real‐Time System (Bio‐Rad) and Bio‐Rad 




Table 20: Primers against mouse genes 
Atp5ase FWD CTGCCACTCAACAGCTCTTG 
Atp5ase REV GGCTGATAACGTGAGACAAG 
Mt-co1 FWD CTGAGCGGGAATAGTGGGTA 
Mt-co1 REV TGGGGCTCCGATTATTAGTG 
Ndufa9 FWD GTCCGCTTTCGGGTTGTTAGA 
Ndufa9 REV CCTCCTTTCCCGTGAGGTA 
Ndufb8 FWD CAAGAAGTATAACATGCGAGTGGAA 
Ndufb8 REV CCATACCCCATGCCATCATC 
Ndufb9 FWD GCATCCCTCTGAGAAAGCAA 
Ndufb9 REV CATCAGGTGATGTTTCCTCCTG 
Ndufs3 FWD TGGCAGCACGTAAGAAGGG 
Ndufs3 REV CTTGGGTAAGATTTCAGCCACAT 
Ndufv2 FWD CGTTCCCTGTCAGCCTAGAG 
Ndufv2 REV TGCACTGCTGTCTTATGCAA 
Sdha FWD GGAACACTCCAAAAACAGACCT 
Sdha REV CCACCACTGGGTATTGAGTAGAA 
Uqcrc2 FWD CCCATCTTGCTTTGCTGTCTG 
Uqcrc2 REV AATAAAATCTCGAGAAGGACCCG 
Pdk1 FWD ACAAGGAGAGCTTCGGGGTGGATC 
Pdk1 REV CCACGTCGCAGTTTGGATTTATGC 
Pkm2 FWD TCGCATGCAGCACCTGATT 
Pkm2 REV CCTCGAATAGCTGCAAGTGGTA 
Atf5 FWD TTGTTGGTGCAGCCTCCATT 
Atf5 REV ATCAGAGAAGCCGTCACCTGC 
Chop-10 FWD CCTGAGGAGAGAGTGTTCCAG 
Chop-10 REV CCTCTTCGTTTCCTGGGGAT 
ClpP FWD TGGGCCCGATTGACGACAGTG 
ClpP REV TAGATGGCCAGGCCCGCAGT 
ClpX FWD TGTTGTTGGCCAGTCGTTTG 
ClpX REV AGCGATCTGAAGGAACTCTCT 
Hsp70 FWD TGCCTCCAATGGTGATGCTT 
Hsp70 REV CAGCATCCTTAGTGGCCTGT 
Hspd1 FWD CCCGCAGAAATGCTTCGACT 
Hspd1 REV ACTTTGCAACAGTGACCCCA 
SatB2 FWD GTCTCCAAATCGGAGCAGCA 
SatB2 REV GAATCATCAAACCTCCCACGG 
Ubl5 FWD TGCGCAACAGAATCGCAAAT 
Ubl5 REV GTGTCATCGGTGTTGCACTT 
Actin FWD TAAGGCCAACCGTGAAAAG 
Actin REV ACCAGAGGCATACAGGGACA 
Ho-1 FWD GGTCAGGTGTCCAGAGAAGG 
Ho-1 REV CTTCCAGGGCCGTGTAGATA 
2.2.26 Human brain samples and spinal cord tissue from the Newcastle Brain 
Tissue Resource Bank 
Frozen brain and spinal cord tissue were obtained from the Newcastle Brain Tissue 
Resource bank. Frozen tissue from Alzheimer’s disease (AD, temporal cortex), 
frontotemporal dementia (FTD, temporal cortex), dementia with Lewy bodies (DLB, 
cingulate cortex), Parkinson’s disease (PD, substantia nigra), sporadic amyotrophic 
lateral sclerosis (SALS, spinal cord), and matched controls (Table 21 & 22) were 
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homogenised using a Ultra-Turrax T10 (IKA) in homogenisation buffer (0.1M Tris pH 
7.4, 0.5% Triton X-100, 50mM NEM supplemented with 1X Halt protease & 
phosphatase inhibitor cocktail (Thermo Fisher Scientific) in ddH2O) in a 1:10 ratio (e.g. 
50mg of tissue in 500 μl of buffer). Homogenised samples were centrifuged (13,000 
rpm for 10 min at 4°C), protein concentration in supernatants was measured as 
described previously and samples were made by adding 2x Laemmli sample buffer to 
supernatants in the presence or absence of 2.5% β-mE. Samples were then analysed 
by immunoblot analysis. 
Table 21: Frozen brain tissues 
Case 
ID 
Diagnosis Area (Cortex) Hemisphere Age Sex PM delay 
(h) 
205 AD Temporal Left 86 F 5 
26 AD Temporal Left 83 M 12 
83 AD Temporal Left 63 F 11 
378 FTD Temporal Left 88 M 42 
51 FTD Temporal Left 73 F 47 
85 FTD Temporal Left 83 F 39 
932 DLB Cingulate Left 78 M 8 
310 DLB Cingulate Left 91 F 10 
17 DLB Cingulate Left 77 M 8 
115 Control Cingulate/Temporal Left 82 F 12 
1035 Control Cingulate/Temporal Right 66 M 9 
102 Control Cingulate/Temporal Left 72 M 17 
 
Table 22: Frozen spinal cord tissues 
Case 
ID 
Diagnosis Area of 
Onset 
Age Sex PM delay 
(h) 
768 ALS Limbs 75 F 26 
219 ALS Limbs 72 F 52 
1913 ALS Limbs 80 F 26 
496 Control N/A 80 F 31 
1016 Control N/A 74 F 49 
891 Control N/A 73 M 25 
2.2.27  ALS spinal cord tissue from the tissue bank of the Pitié-Salpêtrière 
hospital Neuropathology Department 
Transversal sections (2µm of thickness) of lumbar spinal cords (Table 23) were 
homogenized in 50mM Tris-HCl pH 8, 150mM NaCl, protease inhibitors (Complete 
mini tablets, Roche) and 0.5U/µl benzonase endonuclease (Merck Millipore). The 
samples were incubated at 37°C during 30 min SDS was then added at a final 
concentration of 2%. Tissue extracts were centrifuged at 13,000 rpm for 10 min and 
protein concentration of supernatants was estimated by the bicinchoninic acid assay 
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(Sigma Aldrich). Samples were made by adding 2x Laemmli sample buffer to 
supernatants in the presence or absence of 2.5% β-mE. Samples were then analysed 
by immunoblot analysis. 
Table 23: Lumbar spinal cord tissues 
case 
ID 
site of ALS 
onset 




768 Limbs SALS F 75 72 
219 Limbs SALS F 72 60 
1913 Limbs SALS1 F 80 36 
A42 Bulbar SALS2 F 74 9 
A40 Bulbar SALS3 M 71 22 
A43 Bulbar K102E F 82 10 
496 Control n/a F 80 n/a 
1016 Control n/a F 74 n/a 
891 Control n/a M 73 n/a 
2.2.28  Histochemistry of mouse tissues 
Mice were housed in same-sex cages in groups of 4 to 6 (56×38×18 cm, North Kent 
Plastics, Kent, UK) and individually identified by an ear notch. Mice were housed at 20 
± 2°C under a 12 hours light/12 hours dark photoperiod with lights on at 7.00 am. The 
diet used was standard rodent pelleted chow (CRM (P); Special Diets Services, 
Witham, UK). Paraffin sections were deparaffinised with Histo-Clear (National 
Diagnostics) and ethanol, antigen was retrieved by incubation in 0.01M pH 6.0 citrate 
buffer at 95°C for 20 min. Slides were incubated in 0.9% H2O2 for 30 min and 
afterwards placed in blocking buffer (normal goat serum, Vector Lab) for 30 min at 
room temperature. Primary antibody (guinea pig α-p62) was applied overnight at 4°C. 
Slides were washed three times with PBS and incubated for 30 min with secondary 
antibody (Vector Lab). Antibodies were detected using peroxidase VECTASTAIN ABC 
kit (Vector Lab) according to the manufacturer’s instructions. Substrate was developed 
using NovaRED (Vector Lab). Sections were counterstained with haematoxylin and 
mounted with DPX (Thermo Fisher Scientific). This experiment was carried out in 
collaboration with Dr. Diana Jurk. 
2.2.29  Immunofluorescence microscopy 
HeLa cells and MEFs were seeded on coverslips in 12-well plates. After treatments, 
cells were fixed in 3.7% formaldehyde in PBS for 5 min at room temperature. Cells 
were permeabilised with 0.5% Triton X-100 for 5 min at room temperature (or in 
methanol at -20°C for LC3 staining). Coverslips were blocked for one hour in 5% 
normal goat or rabbit serum in PBS 0.05% Tween-20 (for LC3 staining, the Tween-20 
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was omitted from all steps). Cells were incubated with primary antibodies (Table 24) 
overnight at 4°C. Cells were washed three times and incubated with the appropriate 
secondary antibodies for one hour at room temperature (Thermo Fisher Scientific, 
1:5000). Cells were washed and nuclear DNA was stained by incubation with TO-PRO-
3 iodide (Thermo Fisher Scientific, 1:3000) for 10 min at room temperature. Coverslips 
were mounted on slides with Prolong Gold Antifade (Thermo Fisher Scientific) and 
imaged with an LSM 510 META Confocal Microscope (Zeiss) using a 63X Plan-
Apo/1.4 NA Oil objective. Images were analysed using ImageJ software (NIH). 
Table 24: Antibodies used for immunofluorescence microscopy 
Antibody species Dilution Manufacturer Catalogue 
number 
p62 ms 1/200 BD Bioscience  610832 
LC3 rb 1/200 New England BioLabs 3868 
2.2.30  Immunofluorescence labelling of mouse intestine 
To deparaffinise and rehydrate, paraffin-fixed mouse intestine were incubated at 65°C 
for 25 min, followed by sequential washing steps in Histoclear (5 min, 10min) (National 
Diagnostics), and a graded ethanol series (2x100%, 95%, 70%, 5 min each). Next, 
sections were washed in distilled water and antigen retrieval was performed in 1 mM 
EDTA, pH 8, in a pressure cooker for 40 min followed by a wash in distilled water and 
PBS (5 min each). Sections were blocked in 1% NGS (normal goat serum) in PBS for 
30 min at room temperature. Ndufb8 (IgG subtype 1, Abcam, ab110242) and the 
mitochondrial mass marker Vdac (IgG subtype 2b, Abcam, ab14734) were used at a 
concentration of 1/100 and 1/400 respectively overnight at 4°C. This was followed by 
three wash steps for 5 min in PBS followed by incubation with secondary anti-mouse 
conjugated with Alexa Fluor 488 antibodies IgG subtype 1 (Thermo Fisher Scientific, 
A-21121) and Alexa Fluor 546 IgG subtype 2b (Thermo Fisher Scientific, A-21143) for 
30 min at room temperature followed by a three times wash of 5 min in PBS. Nuclei 
were stained with Hoechst (1/200, Thermo Fisher Scientific) for 30 min at room 
temperature. Finally sections were washed three times for 5 min in PBS and incubated 
in Sudan black solution for 10 min, washed again three times with PBS and counted in 
Prolong Gold (Thermo Fisher Scientific). This experiment was carried out in 
collaboration with Dr. Amy Reeve. 
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2.2.31  Live cell imaging to monitor mitophagy 
HeLa wild type or PentaKO cells expressing His-FLAG-NDP52 wild type or His-FLAG 
C153,163,321A-NDP52 were seeded 2 days prior the imaging in glass bottom dishes, 
70% confluent cells were treated with 4µM antimycin A (Merck Millipore) and 10µM 
oligomycin (Merck Millipore) for 3 hours. Imaging was performed using a spinning disk 
confocal head (CSU-X1, Yokogawa, Japan) mounted on an Axiovert 200M equipped 
with a 20x NA 0.8 objective driven by Axiovision software (v4.8.1, Zeiss, Cambridge, 
UK). Mt-Keima was excited with a 458 nm Argon laser (to excite at pH 7.2) and a 561 
nm solid-state laser (to excite mtKeima at pH 4.8). Emission was collected using a 
630/30 nm filter. YFP-Parkin was excited with a 488 nm Argon laser and 535/30 nm 
emission filter was used.  
2.2.32 OCR and ECAR measurements using Seahorse analysis 
Cellular oxygen consumption rates (OCR) and extracellular acidification rate (ECAR) 
in Atg5+/+ and Atg5-/- MEFs were measured in parallel using a Seahorse XF24 analyser 
according to the manufacturer’s instructions in unbuffered basic medium 
supplemented with 5mM glucose, 1mM sodium pyruvate, 2mM L-glutamine and 3% 
FCS or for galactose-based medium with 10mM galactose, 1mM sodium pyruvate, 
4mM L-glutamate and 3% FCS. During analysis the following compounds were added 
to test mitochondrial activity and cellular bioenergetics flux: 0.5µM oligomycin to inhibit 
complex V, 2.5µM FCCP to stimulate mitochondrial oxygen consumption to maximum 
capacity, 80mM 2-deoxyglucose (2-DG) to inhibit glycolytic flux and 0.5µM rotenone 
and 2.5µM antimycin A to inhibit complex I and III respectively. Calculation of ATP 
production was carried out as described in (Mookerjee et al., 2015). 
2.2.33 Complex I- and II-linked respiration measurements using Seahorse 
analysis 
To measure complex I and II-linked respiration cells were permeabilised using 
Seahorse XF Plasma Membrane Permeabilizer (Agilent Technologies) and OCR was 
measured in the assay buffer (115 mM KCl, 10 mM KH2PO4, 2 mM MgCl2, 3 mM 
HEPES, 1 mM EGTA and 0.2% fatty acid-free BSA, pH 7.2, at 37 °C) with complex I 
substrates (10 mM pyruvate and 1 mM malate) or complex II substrate (4mM 
succinate) in the presence of 0.5µM rotenone to prevent respiration via complex I. 




Table 25: Reagents used for Seahorse analysis 






Oligomycin Sigma-Aldrich O4876 5mM 0.5µM 
FCCP Sigma-Aldrich C2920 20mM 2.5µM 
Antimycin A Sigma-Aldrich A8674 25mM 2.5µM 
ADP Sigma-Aldrich A5285 100mM 4mM 
2-deoxyglucose Sigma-Aldrich D8375 - 80mM 
Rotenone Sigma-Aldrich R8875 5mM 0.5µM 
Pyruvate Sigma-Aldrich P5280 1M 5mM 
Malate Sigma-Aldrich M6413 1M 5mM 
2.2.34 Quantifications and Statistical Analysis 
Quantification of cells was performed by blind scoring of slides as described previously 
(Korolchuk et al., 2011). More than 200 cells were counted per slide and quantification 
was based on at least three independent experiments. Quantification of immunoblots 
was carried out using ImageJ software (National Institutes of Health) by measuring the 
integrated density from each band after background subtraction. Two-tailed, unpaired 
Student’s t-tests were carried out on experimental data from at least three individual 
experiments. Unpaired Student’s t-tests were used on Seahorse data from at least 
three individual experiments. 
For the quantification of mitophagy events, the ratio (550/438) images of mtKeima were 
created and analyzed using ImageJ software. High ratio (550/438) regions were 
automatically segmented, and their areas were calculated. The whole cell region was 
delineated manually on a fluorescent image to facilitate area calculation. The ratio 
(high ratio [550/438] area/total cell area) was used as an index of mitophagy. 




3 CHAPTER 3: AUTOPHAGY DEFICIENCY AND 
MITOCHONDRIAL DYSFUNCTION 
3.1 Introduction 
Many neurodegenerative diseases, such as Alzheimer’s disease (AD), frontotemporal 
dementia (FTD) and dementia with Lewy bodies (DLB), have been associated with 
autophagy dysfunction (Section 1.12). Different genes associated with these diseases, 
directly or indirectly point to autophagy as the common pathway affected (Frake et al., 
2015).  
Mutations in core autophagy genes, such as ATG4D, cause neurodegeneration 
(Kyostila et al., 2015) and in mice loss of core autophagy genes specifically in neurons 
result in neurodegenerative phenotypes as well (Komatsu et al., 2006). Thus, impaired 
autophagy function has been shown to be an important contributor to 
neurodegenerative diseases (Menzies et al., 2017). Neurons seemed to be particularly 
susceptible for autophagy dysfunction, which is thought to be due to their post-mitotic 
nature and highly polarised cell shape. The long axons and dendrites are especially 
very susceptible to the accumulation of protein aggregates and damaged organelles, 
when not cleared efficiently by autophagy. More work needs to be done to investigate 
the involvement of autophagy in neuropathic mechanisms. How does autophagy 
dysfunction result in neurodegeneration? The accumulation of toxic protein aggregates 
in neurons is a common hallmark of neurodegenerative diseases and has been 
suggested to be pathogenic (Williams et al., 2006), even though this is under debate. 
These protein aggregates have also been suggested to be protective, whilst the 
damaged misfolded proteins are pathogenic (Ross and Poirier, 2005). As extensively 
discussed in section 1.12 mitochondrial dysfunction has been associated with AD, FTD 
and DLB. Despite identification of several genetic hereditary cases, most 
neurodegenerative cases have an unknown cause and a sporadic onset. As age is one 
of the risk factors of neurodegeneration and autophagy and mitochondrial function both 
decrease with age and in age-related neurodegenerative diseases (Wyss-Coray, 2016, 




Whilst the molecular mechanisms of autophagy are currently an area of intense 
research, very little is known how autophagy (or its deficiency) affects mitochondrial 
function. Furthermore, the interdependence has not been studied in great detail, 
especially the effect of defective autophagy on mitochondrial function. In this results 
chapter, we aimed to understand if autophagy dysfunction affects mitochondrial 
function and if mitochondrial dysfunction is the cause of cell death in 
neurodegeneration. We found that autophagy deficient cells have an isolated complex 
I dysfunction and preventing ROS production via complex I or bypassing complex I 
respiration rescues galactose-induced cell death. These results imply that associated 
with autophagy dysfunction aberrant ROS production via complex I is pathogenic for 
neurodegenerative diseases and this could be an interesting target for treatment. 
3.1.1 A switch to galactose-based medium induces cell death in autophagy 
deficient MEFs  
Culturing cells in galactose- instead of the standard glucose-based medium initially 
causes energy stress, because of the lack of glucose no energy can be produced via 
glycolysis, however after longer time periods, the cells adapt and up-regulate 
mitochondrial respiration (Rossignol et al., 2004). In glucose-free medium containing 
galactose, cells are forced to rely predominantly on mitochondrial respiration for ATP 
production because galactose as a carbon source feeds the glycolytic pathway with a 
low efficiency. It has been shown previously that cells with mitochondrial deficiency do 
not survive in galactose-based medium (Robinson et al., 1992). To test if autophagy 
deficient cells have a mitochondrial deficiency, Atg5-/- and wild type MEFs were 
switched to galactose-based medium. Atg5 is an E3 ubiquitin-like ligase, which is 
required for autophagy, thus loss of this protein results in a complete block of 
autophagy (Mizushima et al., 2001). Western blot analysis was performed and blots 
were probed for cleaved caspase 3 and cleaved Parp-1, which are both markers for 
cell death via apoptosis. After culturing Atg5-/- MEFs in galactose-based medium for 24 
hours, cleaved caspase 3 was increased, which was significant after 48 hours 
compared to Atg5+/+ MEFs (Figure 16A). Parp-1 showed the same trend, however this 
was not significant. This increased cell death was confirmed by bright field microscopy 
(Figure 16B). Importantly, re-expressing Atg5 rescued cell death as was shown by 
bright field microscopy and western blot of cleaved caspase (Figure 16C&D). 
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Furthermore, to confirm that the cell death was via apoptosis, cells were treated with 
Z-VAD-FMK. This pan-caspase inhibitor binds to caspase proteases and thereby 
inhibits apoptosis. Treating cells with Z-VAD-FMK prevented galactose-induced cell 
death in Atg5-/- MEFs, showing that cell death is induced via apoptosis (Figure 16E). 
Thus, Atg5-/- MEFs do not survive in galactose-based medium, suggesting that these 
cells might have a mitochondrial defect.  
This experiment was repeated in M5-7 MEFs, which is an inducible Atg5 knock-out cell 
line, which showed a similar phenotype. Removing Tetracycline and thus allowing the 
cells to re-express Atg5 rescued cell death (Figure 16F). Interestingly, M5-7 cells have 
to grow in tetracycline for at least 5 weeks in order to observe the phenotype. This 
suggests that autophagy deficiency could results in a build-up of dysfunctional 
mitochondria in time (potentially due to a lack of mitophagy), but also suggests that the 





Figure 16 Apoptotic cell death in Atg5-/- MEFs upon a switch to galactose-based medium. 
(A) Western blot analysis of markers for apoptosis; cleaved caspase and cleaved Parp-1 in Atg5+/+ and Atg5-
/- MEFs upon a 24, 48 or 72 hours switch to galactose-based medium. The ratio to actin was normalised to 
Atg5+/+ MEFs. Error bars represent s.e.m., *P<0.05 (n=3). (B) Bright field microscopy images of Atg5+/+ and 
Atg5-/- MEFs grown in glucose- or in galactose-based medium for 72 hours. (C) Bright field microscopy 
images of Atg5+/+, Atg5-/- or Atg5-/- stably expressing ATG5 or (E) Atg5-/- MEFs treated with Z-VAD-FMK 
grown in galactose-based medium for 48 hours, after 24 hours Z-VAD-FMK (20µM) was added to the cells. 
(D) Western blot analysis of Atg5+/+, Atg5-/-, Atg5-/- MEFs re-expressing ATG5 grown in galactose-based 
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medium for 48 hours. Blots were probed for cleaved caspase 3, Atg5 and LC3. (F) Bright field microscopy 
images of M5-7 (inducible ATG5 KO MEFs) grown in galactose-based medium for 5 days. Before switching 
to galactose, cells were grown in the presence of tetracycline for 5 weeks and release was for 5 weeks. (G) 
Western blot analysis of inducible ATG5 KO MEFs grown in glucose- or galactose-based medium for 5 
days. Blots were probed for cleaved caspase 3. 
3.1.2 Atg5-/- MEFs are characterised by the reduced oxygen consumption 
rate and increased glycolysis 
To assess if loss of autophagy influences cellular bioenergetics characteristics through 
mitochondrial function, cellular oxygen consumption rates (OCR) and extracellular 
acidification rates (ECAR) were measured in intact Atg5+/+ and Atg5-/- MEFs using a 
Seahorse XF24 analyzer (Agilent technologies). First the basal oxygen consumption 
is measured, then the ATP synthase inhibitor oligomycin A is added, which gives 
information about the proton leak as well as the OCR that is being used for ATP 
synthesis by calculating the difference. Addition of the mitochondrial uncoupler FCCP 
(Carbonyl Cyanide-4-(triFluoromethoxy)Phenylhydrazone) results in stimulation of 
electron transport chain, resulting in maximal OCR. Finally, Antimycin A inhibits the 
electron flux through complex III, resulting in a block in oxygen consumption (Figure 
17). The remaining OCR determined after Antimycin A treatment is non-mitochondrial 
respiration (www.seahorsebio.com). 
 
Figure 17 Inhibitors used for Seahorse analysis. 
To measure the OCR, first oligomycin A is used to inhibit complex V, giving information about the proton 
leak from the IMS. FFCP is added to dissipate the ΔψM, resulting in maximum respiration and finally, 
Antimycin A and rotenone, which inhibits complex III and complex I, resulting in a block in electron flow 
and thus oxygen consumption. To measure ECAR oligomycin A is added to prevent ATP production via 
respiration and thus shifts the energy production to glycolysis, the resulting slope gives information about 
the glycolytic capacity and 2-DG (2-Deoxy-Glucose), a glucose analogue, is added to inhibit glycolysis. 
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As shown in Figure 18A, Atg5-/- MEFs have a reduced basal and maximum OCR. This 
suggests that when the cells have an increased ATP demand, the reduced maximal 
respiratory capacity may lead to an energetic crisis for the cells. Therefore, the ECAR 
(Extracellular ACidification Rate) was determined as well, which is an indirect measure 
for glycolysis, after corrected for the contribution by CO2 produced by mitochondrial 
respiration through TCA cycle to the ECAR (Mookerjee et al., 2015). Because 
respiration was less efficient in Atg5-/- MEFs, we expected the cells to compensate by 
increasing glycolysis in order to prevent a shortage of energy. To measure ECAR, 
oligomycin A, FCCP, 2-DG and antimycin A and rotenone were sequentially used, as 
described in Figure 17. When we calculate the ATP production via OXPHOS and 
glycolysis, we observed that in Atg5-/- MEFs significantly less ATP is produced via 
mitochondrial respiration and more ATP is produced via glycolysis (Figure 18C). The 
total ATP production seems to be decreased as well, however this is not significant 
(Figure 18C). In Atg5+/+ MEFs approximately 95% of the ATP is produced via OXPHOS 
and only 5% via glycolysis (Figure 18C). Most likely, pyruvate produced via glycolysis 
enters the TCA cycle and produces ATP via OXPHOS, whilst in Atg5-/- MEFs pyruvate 
is diverted towards lactate production to produce ATP, potentially because of their 
mitochondria being dysfunctional. In cells grown on galactose-based medium no ATP 
production via glycolysis was observed as expected and a clear reduction in total ATP 
production in Atg5-/- MEFs was observed (Figure 18D). 
Furthermore, western blot analysis showed increased Ampk phosphorylation in Atg5-/- 
MEFs (Figure 18E). Phosphorylation of this energy sensor indicates that there is 
energy stress. Ampk gets activated by an increased AMP/ATP ratio and needs to be 
phosphorylated at Thr172 for its activity (Gowans et al., 2013).  
In addition, the glycolytic enzyme Pkm1/2 protein levels were increased in Atg5-/- 
MEFs. Pkm1 is expressed in most adult tissues, whereas Pkm2 is a splice variant that 
is shown to be essential for aerobic glycolysis in cancers. qPCR revealed that mRNA 
levels of Pdk1 (Pyruvate Dehydrogenase Kinase 1), another glycolytic enzyme, that 
has been implicated in the Warburg effect, was significantly increased and Pkm2 
mRNA levels showed a trend to be increased too (Figure 18F). From these results, we 
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conclude that Atg5-/- MEFs respire less efficiently and to compensate for the loss of 
mitochondrial respiratory function, up-regulate glycolysis. 
 
Figure 18 Bioenergetic analysis of Atg5+/+ and Atg5-/- MEFs. 
(A) Seahorse analysis of oxygen consumption rate (OCR) in Atg5+/+ and Atg5-/- MEFs in glucose-based 
medium under basal conditions or following the addition of oligomycin A, FCCP or Antimycin A (n = 3). (B) 
Seahorse analysis of the extracellular acidification rate (ECAR) in Atg5+/+ and Atg5-/- MEFs under basal 
conditions or following the addition of oligomycin A, FCCP, 2-DG, antimycin A and rotenone (n = 3). (C) ATP 
production by glycolysis (black) and OXPHOS (grey) calculated based on the Seahorse results in A and B 
in Atg5+/+ and Atg5-/- MEFs (n=3). (D) ATP production in in Atg5+/+ and Atg5-/- MEFs in galactose-based 
medium by glycolysis (black) and OXPHOS (grey) calculated based on the Seahorse results (n=3). (E) 
Western blot analysis of phospho-Ampk, Ampk, Pkm1/2 and Gapdh in Atg5+/+ and Atg5-/- MEFs. The ratio of 
phospho-Ampk to total Ampk and Pkm1/2 to GAPDH was quantified and normalised to the Atg5+/+ MEFs. 
(n=3) (F) mRNA expression of the glycolytic enzymes Pkm2 and Pdk1 in Atg5+/+ and Atg5-/- MEFs, mRNA 
levels were normalised to the Atg5+/+ MEFs. (n=6) Error bars represent s.e.m., *P<0.05. Seahorse 
experiments were carried out by Dr. Satomi Miwa.  
3.1.3 Atg5-/- MEFs have an isolated complex I defect 
Intact cellular bioenergetics assessment using Seahorse analyzer does not give any 
information about what the site of mitochondrial dysfunction is, causing the lower 
maximal respiratory capacity. Therefore, Seahorse analysis was performed in 
permeabilised cells, using complex I and complex II substrates (pyruvate and malate 
or succinate, respectively) to assess mitochondrial functional property in more depth 
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(Figure 19). Firstly ADP, a complex V substrate, was added to stimulate state 3 
respiration. Secondly, oligomycin A was added to inhibit complex V to bring the state 
4 respiration rate. Thirdly, FCCP was added to stimulate the electron transport chain 
without coupling and finally the complex III inhibitor antimycin A was added to inhibit 
the respiratory chain.  
Mitochondrial function could be assessed by the RCR (Respiratory Control Ratio), 
which is state 3 divided by state 4. This ratio indicates the coupling between the ETC 
and ATP production and the greater the RCR, the better the mitochondrial coupling is. 
State 3 was initiated with ADP, state 4 induced with oligomycin A. In Atg5-/- MEFs the 
RCR for complex I-linked respiration was lower, meaning that complex I linked 
respiration is less coupled to ATP production (Figure 19A&B). This indicates that 
mitochondria are less functional in Atg5-/- MEFs and that complex I is the main site of 
dysfunction. Complex II-linked respiration was not impaired in these cells, showing that 
complex II, III, IV and V function are not affected (Figure 19C&D). The complex-II linked 
RCR was even higher in Atg5-/- MEFs, suggesting that there is a compensatory 
mechanism to bypass complex I-linked respiration. This data show that Atg5-/- MEFs 




Figure 19 ATG5-/- MEFs have reduced complex I-linked respiration. 
(A) Seahorse analysis of complex I-linked respiration in permeabilised Atg5+/+ and Atg5-/- MEFs. Media 
contained pyruvate and malate as a complex I substrate. Sequential measurement of basal, state3, state 4 
and uncoupled state were performed through the sequential injections of ADP, oligomyin, FCCP and 
antimycin. (B) Quantification of the respiratory control ratio (RCR; state 3/state 4 respiration) in Atg5+/+ and 
Atg5-/- MEFs. (C) Seahorse analysis of complex II-linked respiration, using succinate as a substrate. (D) 
Quantification of the RCR calculated based on the data in C. Error bars represent s.e.m., *P<0.05, (n=3). 
Seahorse experiments were carried out by Dr. Satomi Miwa. 
To characterise the mitochondrial complex I phenotype we observed via Seahorse in 
more detail, we performed western blot analysis of mitochondrial ETC complexes. We 
used set of antibodies recognising subunits in different modules of complex I. Ndufb8 
and Ndufb9 are accessory subunits residing in the membrane bound core. Ndufb8 and 
Ndufb9 were shown to be important for the interaction between complex I to complex 
III within the respirasome (Wu et al., 2016a, Letts et al., 2016). Ndufs3 is a core subunit 
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of the matrix arm, which contains three FeS clusters and Ndufa9 has not been 
allocated to one module, but probably resides in a module interface, between module 
Q and PP (Wu et al., 2016a, Stroud et al., 2016) and finally Ndufv2 is a core subunit of 
the distal matrix arm (module N) (Wu et al., 2016a) (Figure 20C). 
To our surprise, we observed a substantial loss of all the nuclear encoded 
mitochondrial complex I subunits, Ndufb8, Ndufs3, Ndufa9 and Ndufv2, but not Ndufb9 
in Atg5-/- MEFs, whilst complex II (Sdha), III (Uqcrc2), complex IV (Mt-co1) subunits 
were unaltered (Figure 20A&B). As a control, complex I deficient mES (mouse 
Embryonic Stem cells) were used. These cells have mutations in ND5/ND6, which are 
mitochondrial encoded complex I core subunits, resulting in a severe complex I defect 
(7% complex I activity) (Kirby et al., 2009). In these cells all complex I subunits tested 
were decreased (Figure 20A&B). Complex II (Sdha), III (Uqcrc2), complex IV (Mt-co1) 
and Mfn2 protein levels were unaffected in Atg5-/- MEFs and mES cells (Figure 20A). 
To exclude genetic drift, the M5-7 MEFs (inducible Atg5 knock-out) were used again 
and these cells displayed the same loss of complex I subunits Ndufb8, Ndufs3, Ndufa9 
and Ndufv2 (Figure 20A).  
An even more striking phenotype was observed in Npc1-/- MEFs, this cell line has a 
defect in amphisome maturation, resulting in accumulation of immature 
autophagosomes (Sarkar et al., 2013). In these cells Ndufb8, Ndufs3, Ndufa9 and 
Ndufv2 protein levels were reduced even more than in Atg5-/- MEFs, whilst Ndufb9 and 
other ETC complexes were unaffected (Lucy Sedlackova, data not shown), suggesting 
that this isolated loss of complex I is a common feature of autophagy deficient cells 
and this rules out that complex I is degraded via an Atg5-independent autophagy (Ma 
et al., 2015).  
In literature it has been established that in Atg5-/- MEFs mitochondria accumulate 
(Komatsu et al., 2005, Nakai et al., 2007), however we observed that certain complex 
I subunits are selectively down-regulated, which suggests that that their protein levels 
are regulated via a different mechanism in autophagy deficiency. These subunits 
locate to the different modules of complex I, Ndufs3 (Q module) and Ndufv2 (N module) 
being in the matrix arm, Ndufa9 has not been allocated to any module, but reside in 
either the Q or PP module. Ndufb8 is part of the PD module in the membrane bound 
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core (Figure 20C) (Stroud et al., 2016), suggesting that most of the complex is down-
regulated.  
 
Figure 20 ATG5-/- MEFs have reduced complex I protein levels. 
(A) Western blot analysis of complex I subunits: Ndufb8, Ndufs3, Ndufa9, Ndufv2, Ndufb9, complex II: Sdha, 
complex III: Uqcrc2, complex IV: Mt-co1, Tomm20 and Mfn2 in Atg5+/+, Atg5-/- MEFs and inducible Atg5-/- 
MEFs (M5-7). As a positive control for complex I deficient cells, complex I deficient mouse embryonic stem 
cells (mES) were subjected to the same procedure. (B) Quantification of A. The ratio of the different proteins 
to Gapdh was normalised to Atg5+/+ MEFs. Error bars represent s.e.m., *P<0.05, **P<0.01 (n=3). (C) 
Schematic diagram of mitochondrial complex I and the location of the different subunits used in this results 
chapter. The matrix arm consists of the N- and Q-model. The membrane bound core consists of PP 
(proximal) and PD-(distal) modules. PD contains the proposed proton-translocating subunits. The affected 
complex I subunits are depicted in red. Modified after (Kmita and Zickermann, 2013). 
3.1.4 Complex I subunits are not down-regulated in autophagy deficient 
mouse tissues  
Next, we were investigated if the observed loss of complex I subunits in Atg5-/- MEFs 
could also be observed in vivo. Atg5+/+ and Atg5-/- mouse intestine sections were 
subjected to an Ndufb8 and Vdac immunofluorescence staining. Ndufb8 was used as 
the marker for complex I and Vdac was used as a marker for total mitochondrial mass. 
No difference in the Ndufb8/Vdac ratio was observed between Atg5+/+ and Atg5-/- 
mouse intestine (Figure 21A&B). In addition, mitochondrial ETC composition was 
assessed in autophagy deficient (Atg7-/-) and wild type (Atg7+/+) mouse brains by 
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western blot analysis. All mitochondrial proteins showed a trend to be increased and 
no loss of complex I subunits was observed (Figure 21C&D). Thus, in vivo we did not 
observe a down-regulation of complex I in response to an autophagy defect. 
 
Figure 21 No difference in ETC composition in autophagy deficient mouse intestine and brain. 
(A) Immunohistochemistry labelling of intestine from Atg5+/+ and Atg5-/- mice. S0-10 and S20-30 are different 
sections from a 10 cm length small intestine. Paraffin embedded sections were stained for NDUFB8 
(complex I) and VDAC (total mitochondria). This experiment was performed in collaboration with Dr. Amy 
Reeve. (B) Quantification of A. The Ndufb8/Vdac ratio was normalised to Atg5+/+ intestine. Error bars 
represent standard deviation, (n=2). (C) Western blot analysis of complex I subunits: Ndufa9, Ndufv2, 
Ndufb9, Ndufb8, Ndufs3, complex II: Sdha, complex III: Uqcrc2, complex IV: Mt-co1 and Mfn2 in Atg7+/+ and 
Atg7-/- MEFs. (D) Quantification of C. Ratio to Gapdh was normalised to Atg7+/+. Error bars represent 
standard deviation, (n=2). 
3.1.5 Switching cells from glucose to galactose-based media results in the 
recovery of respiratory complex I subunits in Atg5-/- MEFs 
Thus far we only observed down-regulation of mitochondrial complex I subunits in 
autophagy deficient cell lines, but not in vivo. Cells in tissue culture are grown in 
glucose rich medium and therefore have the ability to use glycolysis, in addition to 
mitochondrial respiration. On the contrary, in vivo tissues such as mouse intestine and 
brain rely mainly on mitochondrial respiration (Bolanos and Almeida, 2010). 
Interestingly, in glucose-based medium Atg5-/- MEFs no cell death is observed, whilst 
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in mice loss of Atg5 in neurons, results in neurodegeneration and apoptotic granular 
cells were observed (Hara et al., 2006). In Atg5-/- MEFs in galactose-based medium 
we previously observed cell death, similar to the in vivo phenotype in mice (Figure 21). 
Therefore, we hypothesised that when mitochondrial respiration is enforced by 
galactose-based medium, complex I levels are maintained, similar to what we see in 
vivo.  
To test this Atg5+/+ and Atg5-/- MEFs were switched to galactose-based medium for 24, 
48 and 72 hours and protein levels of the different mitochondrial ETC complexes were 
determined (Figure 22). The subunits that were down-regulated in Atg5-/- MEFs 
(Ndufb8, Ndufs3, Ndufa9 and Ndufv2) in glycolytic media were up-regulated to the 
levels comparable to those in Atg5+/+ MEFs after being cultured for 24 hours in 
galactose-based medium, this increase in protein levels continued after 48 and 72 
hours. The other complex I subunits (Ndufb9) were also up-regulated, as well as 
complex III (Uqcrc2) and complex V (Atp5a). Complex II (Sdha) showed a slightly 
different behaviour, protein levels increased after 24 hours, followed by a decrease 
after being cultured in galactose-based medium for 48 and 72 hours (Figure 22). As 
an indication of total mitochondrial mass, Mfn2 and Tomm20 protein levels were 
assessed too. These showed a similar behaviour as mitochondrial complex II, being 
up-regulated after 24 hours, followed by a down-regulation after 48 and 72 hours of 
galactose-based medium (Figure 22). Thus, cells up-regulate mitochondrial respiratory 





Figure 22 Switching MEFs to galactose-based medium results in up-regulation of ETC complexes in 
Atg5+/+ and Atg5-/- MEFs. 
(A) Western blot analysis of complex I subunits: Ndufb8, Ndufs3, Ndufa9, Ndufv2, Ndufb9, complex II: Sdha, 
complex III: Uqcrc2, complex IV: Mt-co1, complex V: Atp5a, Tomm20 and Mfn2 in Atg5+/+ and Atg5-/- MEFs 
upon a 24, 48 or 72 hours switch to galactose-based medium. (B) Quantification the different mitochondrial 
proteins in A. The ratio to actin was normalised to Atg5+/+ MEFs. Error bars represent s.e.m., **P<0.01 (n=3).  
3.1.6 Atg5-/- MEFs incorporate less complex I into higher-order 
supercomplexes 
The individual complex I subunits assemble into the holo-complex I, which is a tightly 
regulated process. ETC complexes then assemble in supercomplexes (CI-III2-IV) to 
allow the efficient transfer of electrons through the different complexes (Section 1.11). 
It has been shown that high ROS levels results in the dissociation of complex I from 
complex III and this disruption results in less complex I dependent respiration and 
instability of the complex (Schagger et al., 2004). It could be speculated that these 
disassembled subunits are then targeted for degradation. We tested the assembly 
state of complex I and its assembly into supercomplexes in autophagy deficient cells 
using blue native page electrophoreses. Digitonin is a mild detergent that results in the 
solubilisation of mitochondrial membranes, whilst mitochondrial supercomplexes 
remain intact. On the contrary, Triton X-100 is a stronger detergent and disrupts the 
supercomplexes and is used to assess the assembly state of individual holo-
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complexes. In glucose-rich medium we observe less of the holo-complex I in Atg5-/- 
MEFs as we expected based on our western blot results and it is also assembled less 
into the respirasome (CI-III2-IV) (Figure 20 & 23). Upon a switch to galactose-based 
medium we previously observed the recovery of complex I subunits (Figure 22). We 
wanted to test if these newly produced subunits assembled efficiently into the holo-
complex and if this holo-complex is incorporated into supercomplexes. Interestingly, 
we did observe the recovery of the respirasome in Atg5-/- MEFs upon a switch to 
galactose-based media. However, a band on top of the respirasome did not recover. 
These higher bands are thought to be higher-order supercomplexes that have not been 
studied in great detail, but have been observed by others as well (Gu et al., 2016). 
 
Figure 23 Atg5-/- MEFs incorporate less complex I into higher-order supercomplexes. 
Blue native page analysis of digitonin or Triton X-100 solubilised mitochondria isolated from Atg5+/+ and 
Atg5-/- MEFs grown in glucose-based or galactose-based medium for 24 hours. Complex I was analysed by 
Ndufa9, complex II by Sdha and Vdac was used as a loading control. (n=2) 
3.1.7 Antioxidants and bypass of complex I-linked respiration rescue 
galactose-induced cell death in Atg5-/- MEFs 
Complex I is known as the main source for ROS production (Section 1.11.2) and we 
observed a clear complex I deficiency in Atg5-/- MEFs in glycolytic conditions (e.g. less 
respiration (Figure 19) and down-regulation of subunits (Figure 20)). However, in 
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galactose-based medium and in vivo complex I is not down-regulated (Figure 21 & 22), 
potentially because the cells rely too much on complex I-dependent mitochondrial 
respiration and cannot afford it. Furthermore, we observed less complex I incorporated 
into respiratory supercomplexes in Atg5-/- MEFs (Figure 23). Therefore, we 
hypothesised that the down-regulation of complex I in glycolytic conditions is a 
protective mechanism to prevent aberrant ROS production via complex I. To test this 
hypothesis, Atg5-/- MEFs were switched to galactose-based medium and mitochondrial 
ROS was measured using mitoSOX as a dye to detect superoxide. In glucose-based 
medium not much mitochondrial superoxide was produced in Atg5+/+ nor Atg5-/- MEFs, 
however upon a switch to galactose-based medium a striking increase in mitochondrial 
superoxide was observed (Figure 24A). Scavenging this mitochondrial ROS by using 
a mitochondrial targeted antioxidant (mitoQ) (Kelso et al., 2001), partially prevented 
galactose-induced cell death in Atg5-/- MEFs (Figure 24B). These antioxidants are not 
specifically targeting ROS produced by complex I, therefore S1QEL2.2 was used 
(Brand et al., 2016). This drug specifically prevents ROS production at site Q of 
complex I. This inhibitor prevents electrons flowing back from complex III, via Q, and 
thus limits RET (Reverse Electron Transport). Intriguingly, treating Atg5-/- MEFs with 
S1QEL2.2 fully prevents galactose-induced cell death (Figure 24C). This suggests that 
cell death in these cells is caused by ROS produced at complex I.  
Another way to determine if dysfunctional complex I is the cause of galactose-induced 
cell death in Atg5-/- MEFs is by bypassing respiration via complex I and rewiring 
respiration towards complex II, which can be accomplished with a drug (I-BET 762) 
recently published (Barrow et al., 2016). I-BET 762 is a chemical inhibitor of BRD4 
(Bromodomain-containing protein 4) and prevents binding of BRD4 to promotors of 
nuclear-encoded mitochondrial genes and its inhibition results in the rewiring of 
respiration via complex II and IV (Barrow et al., 2016). Barrow et al. convincingly show 
that cell death caused by chemically inhibition or mutations in complex I could be 
rescued by I-BET 762. Similar to treating Atg5-/- MEFs with S1QEL2.2, treating with I-
BET762 also fully prevented galactose-induced cell death (Figure 24C). This suggests 





Figure 24 ROS produced by complex I causes galactose-induced cell death in Atg5-/- MEFs. 
(A) Mitochondrial superoxide production was measured using mitoSOX in Atg5+/+ and Atg5-/- MEFs in 
glucose-based medium and upon a 24 switch to galactose-based medium. mitoSOX intensity was analysed 
by FACS (Fluorescence-Activated Cell Sorting). Data were normalised to Atg5+/+ MEFs, error bars represent 
standard deviation (n=2). (B) Western blot analysis of Atg5+/+ and Atg5-/- MEFs switched to galactose-based 
medium for 48 hours in the absence or presence of mitoQ (20nM), or (C) S1QEL 2.2 (500nM) and I-BET 762 
(1µM). All drugs were re-fed after 24 hours. Blots were probed for cleaved caspase 3. Error bars represent 
s.e.m., *P<0.05, **P<0.01, ***P<0.05, (n=3).  
3.1.8 Mitochondrial respiratory complexes are transcriptionally up-
regulated in galactose-based medium 
Based on the timeframe, it is not likely that the increase of respiratory complexes upon 
a switch to galactose-based medium is caused by stabilisation of the complexes or 
less degradation. The half-lives of mitochondrial proteins are longer than half-lives on 
non-mitochondrial proteins and has been estimated to be approximately 400 hours in 
D. melanogaster (Vincow et al., 2013). Hence, we assumed that mitochondrial 
respiratory complexes were transcriptionally up-regulated. mRNA levels of the 
complex I subunits Ndufa9, Ndufb8 and Ndufs3, complex II (Sdha), complex III 
(Uqcrc2) and complex V (Atp5a) were measured by qPCR in glycolytic and 24 
galactose-based medium in Atg5+/+ and Atg5-/- MEFs. mRNA levels of these subunits 
all tended to be increased upon a switch to galactose-based medium in Atg5+/+ as well 
as Atg5-/- MEFs (Figure 25). In galactose-based medium Ndufb8, Ndufs3 and Atp5a 
mRNA levels were even further increased in Atg5-/- MEFs compared to Atg5+/+ MEFs. 
Interestingly, there were no differences in mRNA levels of Ndufa9, Ndufb8 and Ndufs3 
between Atg5+/+ and Atg5-/- MEFs in glycolytic conditions (Figure 25). Therefore, the 
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decrease in protein levels of mitochondrial complex I subunits in Atg5-/- MEFs in 
glycolytic conditions cannot be explained by a reduced transcription, but the recovery 
of subunits can be explained by transcriptional up-regulation.  
 
Figure 25 Mitochondrial respiratory complexes are transcriptionally up-regulated in galactose-based 
medium. 
(A) mRNA expression of mitochondrial complex I subunits Ndufa9, Ndufb8 and Ndufs3 in Atg5+/+ and Atg5-
/- MEFs in glycolytic conditions or after being cultured in galactose-based medium for 24 hours. (B) mRNA 
expression of mitochondrial complex II, III and V subunits Sdha, Uqcrc2 and Atp5a in Atg5+/+ and Atg5-/- 
MEFs in glycolytic conditions or after being cultured in galactose-based medium for 24 hours. Error bars 
represent s.e.m., *P<0.05, ***P<0.005 (n=6). 
3.1.9 UPRmt related genes ClpX, ClpP and Ubl5 expression is increased in 
Atg5-/- MEFs 
It is not clear how complex I is down-regulated in Atg5-/- MEFs in glucose-based 
medium. We hypothesised that the increased mitochondrial stress in autophagy 
deficient cells activates the UPRmt pathway, and the up-regulating of mitochondrial 
proteases could result in the loss of complex I subunits and to a metabolic switch 
towards glycolysis. To assess the UPRmt, expression levels of several genes involved 
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in the UPRmt were determined. In Atg5-/- MEFs mRNA levels of ClpX, ClpP and Ubl5 
were increased (Figure 26A), expression levels of these three genes tightly correlate 
with the UPRmt, suggesting that the UPRmt is induced in these autophagy deficient 
cells. However, expression levels of Chop10, a transcription factor downstream of ClpX 
(Al-Furoukh et al., 2015), was not affected. Furthermore, Hsp60 and Hsp70 mRNA 
levels were not changed (Figure 26B). Therefore, we conclude that the canonical 
UPRmt is not activated, however an UPRmt-like pathway may be induced. In addition 
to the increased ClpP mRNA levels, also protein levels were increased in Atg5-/- MEFs 
(Figure 26C). ClpP is a protease that is part of the ClpXP complex, and has been 
suggested to be involved in the degradation of unfolded and disassembled respiratory 
subunits, therefore we hypothesised that increased ClpP expression could be 
responsible for the down-regulation of complex I subunits.  
 
Figure 26 ClpP mRNA and protein levels are increased Atg5-/- MEFs. 
(A) mRNA expression of UPRmt markers ClpX, ClpP and Ubl5 in Atg5+/+ and Atg5-/- MEFs. mRNA levels were 
normalised to the Atg5+/+ MEFs in glycolytic conditions. (B) mRNA expression of UPRmt markers Chop10, 
Hsp70 and Hsp60 in Atg5+/+ and Atg5-/- MEFs. mRNA levels were normalised to the Atg5+/+ MEFs in glycolytic 
conditions. Error bars represent s.e.m., *P<0.05 (n=6) (C) Western blot analysis of ClpP in Atg5+/+ and  
Atg5-/- MEFs. The ratio to actin was normalised to Atg5+/+ MEFs. Error bars represent s.e.m., *P<0.05, 
**P<0.01 (n=3).  
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3.1.10 Down-regulation of the mitochondrial proteases ClpP, Lon or Afg3L2 
with siRNA or inhibiting the MAD pathway does not prevent loss of 
complex I  
To test if ClpP or other mitochondrial proteases (Section 1.10.1) degrade complex I 
and are responsible for the down-regulation of complex I in glucose-based medium, 
ClpP, Lon and Afg3L2 were down-regulated using siRNA in Atg5-/- MEFs and western 
blot analysis of complex I subunits was performed. Down-regulation of these proteases 
did not recover the loss of complex I, which could suggest that loss of complex I is not 
due to degradation via these mitochondrial proteases. (Figure 27A&B)  
Azzu and Brand showed previously that IMM proteins can be degraded by the cytosolic 
proteasome and potentially this degradation happens via the MAD pathway (Section 
1.10.4) (Azzu and Brand, 2010). To study this pathway, we first used MG132 to inhibit 
the proteasome. This led to a mild recovery of complex I in Atg5+/+ and Atg5-/- MEFs 
(Figure 27C&D). In addition, siRNA against one off the main players of the MAD 
pathway, Vcp was used, but no significant recovery of complex I was observed (Figure 
27E&F). However, antibodies to test knock-down efficiency were not available, so the 
knock-down might not be efficient enough and the remaining protein levels might be 




Figure 27 Knocking-down components of the MAD pathway or mitochondrial proteases with siRNA does 
not recover complex I subunits in Atg5-/- MEFs in glucose-based medium in. 
(A) Western blot analysis of the complex I subunits: Ndufa9, Ndufb8 and Ndufs3 in Atg5+/+ and Atg5-/- MEFs 
transfected with siRNA against ClpP, Lon and Afg3L2. (B) Quantification of A, the ratio to actin was 
normalised to Atg5+/+ MEFs controls. (C) Same as A, but treated with the proteasomal inhibitor MG132 
(600nM, 24 hours). (D) Quantification of C, the ratio to actin was normalised to Atg5+/+ MEFs controls. (E) 
Western blot analysis of the complex I subunits: Ndufa9, Ndufb8 and Ndufs3 in Atg5+/+ and Atg5-/- MEFs 
transfected with siRNA against Vcp. (F) Quantification of E, the ratio to actin was normalised to Atg5+/+ 




3.1.11 Correlation between autophagy deficiency and complex I reduction in 
DLB, AD and FTD 
To investigate if autophagy deficiency and complex I deficiency are relevant in a wider 
context of neurodegeneration, western blot analysis was performed to compare brain 
tissue from AD (temporal cortex), FTD (temporal cortex) and DLB (cingulate cortex) 
patients as well as age-matched control brains. In affected brain regions of AD patients, 
no loss of mitochondrial ETC proteins was observed (Figure 28A&B). Furthermore, 
LC3-II levels were unaffected and p62 did not accumulate significantly (Figure 28A&C). 
Thus, no clear mitochondrial phenotype, nor an autophagy deficiency was detected in 
AD brains.  
In FTD only NDUFA9 protein levels were decreased, other complex I subunits also 
tended to be decreased, but this was not significant, whilst complex II (SDHA) and 
complex III (UQCRC2) protein levels were unaffected (Figure 28A&B). There was a 
tendency for less LC3 lipidation and more p62 in FTD patient brains, suggesting a 
potential autophagy block (Figure 28A&C).  
In the cingulate cortex of DLB patients, complex I subunit NDUFB8 and complex II 
protein SDHA levels were significantly reduced. Similar to FTD brains, other complex 
I subunits showed a tendency to be down-regulated, but not complex III (UQCRC2), 
TOMM20 (Figure 28A&B). This correlated with a significant increase in p62 levels and 
a tendency for less LC3-II (Figure 28A&C).  
To conclude, in FTD and DLB down-regulation of respiratory complex I and to a lesser 
extend complex II was observed and this correlates with a potentially impaired 
autophagy. Based on our data, this down-regulation can be part of a protective 
mechanism aiming to reduce damage from dysfunctional complex I. To draw stronger 
conclusions, more patient brains samples will have to be included in this study, as well 




Figure 28 Autophagy deficiency correlates with reduced complex I subunits in frontotemeral dementia 
(FTD) and dementia with Lewy bodies (DLB). 
(A) Western blot analysis of complex I subunits: NDUFA9, NDUFB8, NDUFS3, complex II: SDHA, complex 
III: UQCRC2, TOMM20 and autophagy markers p62 and LC3 in age-matched control brains, Alzheimer’s 
disease (AD), frontotemporal dementia (FTD) and dementia with Lewy bodies (DLB). (B) Quantification of 
the different mitochondrial proteins in A. (C) Quantification of the autophagy markers in A. The ratio to actin 
was normalised to control brains. Error bars represent s.e.m., *P<0.05 (n=3).  
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3.2  Discussion  
In this chapter, for the first time we have shown that autophagy dysfunction results in 
a striking mitochondrial phenotype, specifically an isolated down-regulation of 
respiratory complex I, reduced mitochondrial respiration via complex I and increased 
glycolysis, suggesting a metabolic rewiring. Furthermore, when cells are switched to 
galactose-based medium (promoting mitochondrial respiration) autophagy deficient 
cells die via apoptosis. Interestingly, this can be rescued by blocking ROS production 
via complex I and also by promoting respiration via complex II and thereby bypassing 
complex I. This suggests that ROS produced by complex I is causing galactose-
induced cell death in autophagy deficient cells. These results open up new possibilities 
for targeted intervention in a wide variety of neurodegenerative diseases.  
All the data shown was in Atg5 deficient MEFs, but was also confirmed in Npc1 
deficient MEFs, suggesting that our results are not specific for loss of Atg5, but more 
general for autophagy deficiency. However, to further establish that it is indeed 
autophagy deficiency that result in the complex I dysfunction and subsequent 
galactose-induced cell death, CRISPR KO MEFs will be generated for Fip200 and 
Atg7. Loss of these two genes are known to result in a block in autophagy (Hara et al., 
2008).  
3.2.1 How are complex I subunit protein levels down-regulated in Atg5-/- 
MEFs in glucose-based medium?  
First of all, it would be of interest to get a bigger picture of which mitochondrial ETC 
subunits are down-regulated in autophagy deficient MEFs using a proteomics 
approach like SILAC (Stable Isotope Labeling by Amino acids in Cell Culture). At the 
moment it is not entirely clear if it is specifically certain complex I subunits that are 
down-regulated, only certain complex I modules, or the entire holo-complex or even 
other ETC complexes. Our results suggest an isolated complex I dysfunction, as 
respiration via complex II was not affected, showing that complex II, III, IV and V 
function is not impaired.  
The complex I subunits that are down-regulated in autophagy deficient cells are 
nuclear encoded. Thus down-regulation can have several causes, of which the most 
obvious potential causes could be reduced nuclear transcription, reduced cytosolic 
translation, reduced mitochondrial import or less efficient incorporation of the subunits 
into the respiratory complex. Furthermore, it could be hypothesised that the subunits 
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are selectively degraded within the mitochondria or via the UPS, due to oxidative 
damage or due to misfolding or potentially signalling events that purposefully target 
certain mitochondrial subunits for degradation by a post-translation modification such 
as ubiquitination. mRNA levels of the different mitochondrial subunits were unaltered 
in Atg5-/- MEFs, therefore we conclude that complex I down-regulation is not at the 
transcriptional level.  
Interestingly, MG132, a potent proteasomal inhibitor, but also known to inhibit Lon 
(Granot et al., 2007), significantly recovered complex I subunits. At the moment it is 
not clear if this effect seen with MG132 treatment is due to inhibition of the proteasome 
or Lon. siRNA against Lon or Vcp did not result in the recovery of complex I subunits, 
however siRNA knock-down efficiency could not be tested as antibodies for the 
proteins were not available. Alternatively, mRNA levels could be assessed, but this 
has limitations, because it does not necessarily reflect the protein levels, therefore we 
cannot conclude if complex I is degraded by Lon or the proteasome.  
The proteasome/MAD pathway (Section 1.10.4) could be an interesting pathway to 
asses in more detail, however this pathway is more likely to be important for the 
degradation of mitochondrial proteins located to the outer membrane and it is not clear 
how damaged inner mitochondrial proteins can be transported to the outer membrane 
to be presented to the proteasome. One mechanism, could involve the proteasome-
dependent rupture of the OMM as was shown to occur during PINK1/Parkin mediated 
mitophagy (Yoshii et al., 2011, Wei et al., 2017), thereby leaving the IMM exposed to 
the cytosol. However, this would be expected to affect mitochondrial respiration quite 
drastically and is therefore not a very likely mechanism. Even though the mechanism 
how IMM can be presented to the cytosolic proteasome is unclear, evidence is 
accumulating that this pathway has the ability to degrade IMM as was nicely 
demonstrated for UCP2 in a cell free system (Azzu and Brand, 2010). In addition, it 
has been suggested that the proteasome has a higher capacity for proteolysis of 
mitochondrial proteins than mitochondrial proteases in basal conditions (Lau et al., 
2012).  
The other scenario would involve degradation via mitochondrial proteases, such as the 
mitochondrial matrix proteases Lon and ClpXP and the matrix-AAA and 
intermembrane-AAA metalloproteases, which are embedded in the IMM (Section 
1.10.1). Interestingly, ClpP mRNA and protein levels were up-regulated in Atg5-/- 
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MEFs. ClpP is a protease that degrades unfolded proteins in the mitochondrial matrix 
and has been implicated in the UPRmt (Haynes et al., 2007, Haynes and Ron, 2010).  
The mitochondrial proteasome Lon, has been implicated in the degradation of complex 
I, and specifically the peripheral arm, in response to antimycin A and oligomycin 
treatment (Pryde et al., 2016). To further test the involvement of mitochondrial 
proteases, especially ClpP and Lon, these could be knocked-out in Atg5-/- MEFs using 
CRISPR and complex I subunits assessed. Furthermore, to avoid potential redundancy 
of mitochondrial proteases, multiple KO’s could be created or dominant negative forms 
could be expressed. 
To our surprise, increased ClpP mRNA and protein levels were not accompanied by 
increased expression of heat shock proteins and the transcription factor Chop10, which 
are normally induced upon ClpP activation. Potentially other transcription factors are 
activated in our conditions, such as ATF5. The UPRmt has been studied mainly in 
C.elegans and only in the last year more mechanistic data has been revealed about 
the mammalian UPRmt (Section 1.10.3). The regulation of the mammalian UPRmt and 
consequent response to mitochondrial proteotoxic stress might be more complicated 
than what was described in C.elegans. This is demonstrated by the fact that for 
example Hsp70, but not Hsp60 was induced by accumulation of misfolded proteins in 
mitochondria in mammalians, suggesting that they can be regulated independently 
(Fiorese et al., 2016).  
3.2.2 Why is specifically complex I down-regulated? 
Loss of complex I has been observed with age and in neurodegenerative diseases, 
such as Alzheimer’s and Parkinson’s disease (Francis et al., 2014, Grunewald et al., 
2016, Schapira, 1998, Schapira, 2010). Now, we have shown that complex I, and to a 
lesser extend complex II, is down-regulated in FTD and DLB, whilst in autophagy 
deficient cells an isolated complex I loss (protein levels and function) was observed. It 
is not clear why a loss of specifically complex I and to lesser extend complex II is 
observed, whilst complex III and IV are unaffected. 
Recently the half-lives of ETC subunits in mice were determined, which showed that 
half-lives are very variable within the different complexes, which cannot be explained 
by a process like mitophagy, which is thought to degrade bigger portions of 
mitochondria (Karunadharma et al., 2015). It was also shown that the matrix facing 
subunits of complex I and II have shorter half-lives compared to the membrane-bound 
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subunits (Karunadharma et al., 2015), which could be caused by increased oxidative 
damage. Furthermore, on average complex IV subunits were shorter-lived than the 
others and, finally, the half-lives of the different ETC subunits correlated negatively with 
ubiquitin enrichment and a linear correlation between half-lives and 20S proteasome 
degradation susceptibility was observed (Karunadharma et al., 2015). This implies that 
the half-live of ETC subunits is determined by the susceptibility of being degraded via 
the proteasome, most likely via the MAD pathway. The half-lives of Ndufa9, Ndufb8 
and Ndufs3 and Ndufv2 (CI) were not shorter than Ndufb9 (complex I), Sdha (complex 
II) and Uqcrc2 (complex III). On the contrary, Ndufb8 is the longest lived among these 
ETC subunits in control mice, CR (calory restriction) mice and rapamycin fed mice 
(Karunadharma et al., 2015). The latter two are models in which autophagy is induced, 
unfortunately no model was used in which autophagy was blocked. The half-lives of 
the ETC subunits could drastically change upon mitochondrial damage, as more ROS 
production would mainly effect complex I.  
It has been suggested that the stoichiometric ratios of the respiratory chain complexes 
could explain an isolated loss of complex I. The ratios of the different complexes are 
as follows: complex I 0.8-1.3; complex II, 1.2-1.4; complex III, 3; and complex IV as 
6.0-7.5 in bovine heart mitochondria (Schagger and Pfeiffer, 2001). Thus complex I, 
and to a lesser degree complex II, might be limited, whilst there is an excess in complex 
IV (Grunewald et al., 2016). If this theory is correct, complex III and complex IV would 
only be affected in severe conditions.  
We obtained data suggesting that in autophagy deficient cells complex I is not 
incorporated in higher-order supercomplexes upon switching to galactose-based 
medium. This implies that there is an assembly defect of higher-order supercomplexes. 
Complex I outside of the respirasome or other supercomplexes is less stable and 
produces more ROS (Schagger et al., 2004, Guaras et al., 2016).  
The assembly status of complex I could be assessed in more details by blue native 
page in the Atg5 deficient MEFs, using antibodies against different complex I subunits, 
which are assembled into the complex at different stages (Stroud et al., 2016). Also 
proteomics approach like SILAC, as suggested before, could reveal more about which 





3.2.3 How does autophagy deficiency result in a dysfunctional 
mitochondrial complex I? 
Now the question remains how autophagy deficiency leads to this destabilisation of 
complex I in glucose-based medium. First of all, autophagy dysfunction does not lead 
to an acute defect in complex I, as in our inducible Atg5 knock-out model (M5-7s) cells 
need to be treated with tetracycline (thus suppressing autophagy) for 6 weeks to 
observe loss of complex I and increased galactose-induced cell death. This suggests 
that an accumulation of autophagy substrates, or genetic/epigenetic rewiring induced 
by prolonged starvation is required to induce a complex I defect. Potentially, this 
prolonged loss of mitochondrial quality control results in mitochondrial damage, which 
results in mitochondrial stress and increased ROS produced at complex I. Currently, 
we do not know if the bulk autophagy pathway or maybe more specifically mitophagy 
is required for maintenance of complex I function, therefore Pink1 KO MEFs will be 
generated as well, to distinguish between general autophagy and mitophagy. 
Recently, it was shown that mutant TDP43 accumulates in mitochondria in ALS and 
FTD patients, where it binds mitochondria-transcribed messenger RNAs encoding 
complex I subunits ND3 and ND6 (Wang et al., 2016b). This specific down-regulation 
of ND3 and ND6 also resulted in the loss of other CI subunits, such as NDUFB8, but 
not other mitochondrial complexes and this was pathogenic (Wang et al., 2016b). 
Therefore, it could be that the loss of complex I we observed in brains of FTD patients 
was also caused by TDP43 accumulation in the mitochondria. Autophagy is important 
for TDP43 turnover, therefore loss of autophagy results in TDP43 accumulation, which 
could accumulate in mitochondria, resulting in down-regulation of complex I. It would 
be interesting to test if in our autophagy deficient cells TDP43 accumulates in 
mitochondria and inhibits ND3 and ND6 protein synthesis.  
As a result of impaired autophagy, ubiquitinated proteins accumulate and could be 
imported into mitochondria via the MAGIC pathway (Section 1.10.2). The MAGIC 
pathway involves mitochondria functioning as “rubbish bins”, by clearing ubiquitinated 
protein aggregates (Ruan et al., 2017). It could be hypothesised that the co-import of 
protein aggregates by mitochondrial proteins containing a mitochondrial import signal, 
would interfere with the efficient import of mitochondrial proteins, such as nuclear 
encoded complex I subunits. Furthermore, the accumulation of cytosolic protein 




3.2.4 What causes cell death in Atg5-/- MEFs upon a switch to galactose-
based medium? 
Galactose-based medium lacks glucose and therefore cells grown in this medium 
completely rely on mitochondrial respiration for energy production. In glucose-based 
medium cells also mostly use mitochondria to produce ATP (Figure 18C), however 
they do have the option to switch to anaerobic ATP production by producing lactate. 
This is exactly what we observed in Atg5-/- MEFs in glucose-based medium, whilst they 
die in galactose-based medium, suggesting that their mitochondria are dysfunctional. 
We further characterised this and observed less mitochondrial respiration and less 
complex I-linked respiration, whereas complex II-linked respiration was unaffected. 
The complex I specific superoxide inhibitor S1QEL 2.2, which prevents superoxide 
being formed at site IQ and I-BET 762, which transcriptionally rewires the cell towards 
respiration via complex II, both rescued galactose-induced cell death in Atg5-/- MEFs, 
suggesting that mitochondrial ROS and, more specifically superoxide produced by 
complex I at site Q, is causing cell death. To further strengthen these conclusions, 
complex II substrates, such as succinate and fatty acids could be fed to the cells, to 
promote respiration of complex II and bypassing complex I-linked respiration. 
Furthermore, ROS measurements should be done in response to the S1QEL 2.2 and 
I-BET 762 treatment, to show that ROS production is reduced upon these treatments. 
Finally, overexpression of NDI1, a yeast NADH-quinone oxidoreductase, which 
mediates the electron transfer from NADH to ubiquinone and thus bypasses 
dysfunctional complex I (Marella et al., 2008, Seo et al., 1998). Expressing NDI1 will 
result in more RET, potentially leading to loss of complex I in these cells, which could 
rescue cell death if our hypothesis is correct. 
Another interesting observation was that changing the galactose-based medium every 
day prevented cell death (data not shown), suggesting that the cells were starved or 
alternatively changing the medium functioned as an antioxidant. Autophagy is 
important in starvation conditions, as it recycles cytosolic components for reuse. Thus, 
not only ROS produced by complex I, but also starvation is involved in galactose-
induced cell death, suggesting that the increased ROS production, combined with an 
energy and nutrient crises causes cell death. It needs to be determined how this 
interplay works and what the main cause is. Currently, it is not clear how increased 
complex I-linked ROS production, an energetic crisis and starvation can signal to 
induce apoptosis. Starvation is known to result in reduced mTORC1 signalling, whilst 
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the ADP/ATP ratio signals via the energy sensor Ampk. To disentangle how these 
signalling pathways might be involved in induction of apoptosis, activity of several 
cellular signalling pathways proceeding cell death can be investigated. Furthermore, 
assessing galactose-induced cell death whilst inhibiting Ampk and mTORC1 signalling, 
could give more information about the involvement of these signalling pathways. 
Interestingly, cells with hyperactive Akt signalling are more sensitive to oxidative stress 
by inhibiting Foxo signalling, which regulate the expression of antioxidants (Nogueira 
et al., 2008). 
3.2.5 Could reducing the damage from complex I be a protective mechanism 
in neurodegenerative diseases? 
Loss of complex I activity as well as altered autophagy activity is a hallmark of ageing 
and several neurodegenerative disorders (Section 1.12). This loss of complex I is 
thought to be damaging and pathogenic, however it could be speculated that loss of 
complex I in certain conditions (such as autophagy deficiency) is protective. 
Even though our results in AD, FTD and DLB are very preliminary and more work 
needs to be done, we found that FTD and DLB results in loss of respiratory complex I 
and to a lesser extend complex II and this correlates with impaired autophagy. 
In previous studies loss of complex I has been implicated in neurodegenerative 
diseases. For instance, in an amyloid-β protein precursor transgenic mouse model for 
Alzheimer’s disease reduced complex I activity coincided with reduced NDUFB8 
expression (Francis et al., 2014), however we did not observe this loss of NDUFB8 in 
the affected brain regions of Alzheimer patients. Complex I dysfunction has been 
heavily associated with Parkinson’s disease (Schapira et al., 1989). The pesticides 
paraquat and rotenone that inhibit complex I activity, resulting in increased ROS 
production and causing Parkinson’s disease (Abou-Sleiman et al., 2006), as well as 
mutant α-synuclein, inhibit complex I activity and result in neurodegeneration (Reeve 
et al., 2015). DLB also displays an isolated complex I deficiency (Navarro et al., 2009). 
Interestingly, autophagy deficiency also has been implicated in these diseases and our 
preliminary data suggested that autophagy is impaired in FTD and DLB as well. 
The consensus at the moment is that isolated loss of complex I, observed in several 
neurodegenerative diseases, is damaging to the cell. This is mainly based on the fact 
that Parkinson’s disease related toxins such as paraquat and rotenone inhibit complex 
I and result in more ROS production (Lenaz et al., 2006). In contrast, in C.elegans and 
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D.melanogaster RNAi knockdown of complex I subunits extends life span by 
increasing ROS levels and thereby activating stress response pathways (Hur et al., 
2014, Yang and Hekimi, 2010, Yee et al., 2014, Lee et al., 2010b, Owusu-Ansah et al., 
2013). Therefore, reduced complex I levels could potentially be both, beneficial and 
detrimental. In the case of damaged complex I, it might be beneficial to prevent 
damage, and down-regulate the complex. 
We found that switching cells to galactose-based medium is detrimental for Atg5-/- 
MEFs, these conditions result in the restoration of complex I protein levels at the 
transcriptional and protein level. Upon a switch to galactose-based medium,  
Atg5-/- MEFs are forced to switch to mitochondrial respiration, resulting in cell death. 
We propose this cell death occurs because they are forced to up-regulate complex I, 
which, because quality control is lacking, produces too much ROS. Therefore, it could 
be hypothesised that the loss of complex I in DLB, PD and FTD is a protective 
mechanism to prevent aberrant ROS production at complex I and forcing respiration 
via complex II or produce energy via glycolysis. 
3.2.6 Preventing ROS production at complex I, or bypassing respiration via 
complex I can be used a therapeutic target for autophagy-related 
neurodegenerative diseases. 
It would be exciting to take our initial S1QEL 2.2 and I-BET 762 data in mammalian 
cells to in vivo autophagy mouse models. Atg5flox/flox; nestin-Cre mice (a neuronal 
specific Atg5 knock-out mouse model) develop progressive motor and behavioural 
defects, which are often observed in neurodegenerative mouse models as well (Hara 
et al., 2006). Moreover, neuronal cell death and accumulation of Ub-positive 
cytoplasmic inclusion in neurons were observed with age in these mice (Hara et al., 
2006). It was shown previously that autophagy is important for the clearance of 
aggregate-prone proteins (Ravikumar et al., 2002). Hara et al. suggest that autophagy 
is essential for the clearance of intracellular proteins and this is required for neuronal 
survival. However, mitochondrial function has not been assessed in these mice. It 
would be of importance to translate our cell data to this model and test if I-BET762 and 
S1QEL 2.2 would rescue the neurodegenerative phenotypes of the Atg5flox/flox; nestin-
Cre mice. If positive results are obtained, it would open an interesting therapeutic target 




4 CHAPTER 4: OXIDATION OF p62 MEDIATES THE LINK 
BETWEEN REDOX STATE AND PROTEIN 
HOMEOSTASIS 
4.1 Introduction  
Ageing and age-related diseases are commonly associated with proteotoxic and 
oxidative stress, which can be highly damaging for cellular functioning and survival. 
Cells employ multiple defensive mechanisms to promote survival in these conditions. 
Autophagy is one of the key mechanisms to degrade toxic waste such as damaged 
and oxidised proteins and organelles.  
Autophagy is a prosurvival pathway that has a prominent role in determining longevity 
in many model organisms. A number of longevity-increasing manipulations are 
autophagy-dependent (Madeo et al., 2015). Loss of autophagy has been associated 
with accelerated ageing and reduced stress resistance, whilst autophagy induction 
prolongs life span ((Madeo et al., 2015). In yeast for instance, different autophagy 
mutants have a shorter chronological life span (Matecic et al., 2010). In C. elegans 
similar observations were made, where Atg1, Atg7, Atg18 and Beclin 1 loss of function 
mutants have decreased life span (Toth et al., 2008) and in D. melanogaster, Atg1, 
Atg8 and Ref(2)p mutants shorten lifespan (Simonsen et al., 2008, de Castro et al., 
2013). In mice, deletion of essential autophagy genes is lethal during the early 
postnatal period, but tissue specific loss of autophagy genes shows less dramatic 
phenotypes. Instead, age-related pathology is observed, such as p62 and ubiquitin 
positive aggregates and abnormal mitochondria accumulation (Rubinsztein et al., 
2011). Furthermore, autophagy induction can extend lifespan; for example 
overexpression of Atg5 in mice has anti-ageing properties and extends lifespan (Pyo 
et al., 2013). In addition, overexpression of Atg8a or Atg1 in fly neurons prolongs 
lifespan (Simonsen et al., 2008, Ulgherait et al., 2014). A question we have tried to 
address in this chapter is if autophagy has evolved and has become more efficient in 
longer lived species in order to cope with the increased stress resistance. 
Degradation of autophagy substrates requires autophagy receptors that can bind to 
the substrate and the nascent autophagosome, resulting in the delivery to the 
lysosome, where degradation takes place. p62 is the most studied autophagy receptor 
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(Section 1.3) and has been shown to be important for longevity too. Loss of p62 in 
mice results in late onset obesity, neurodegeneration and a decreased lifespan with 
increased ROS and impaired mitochondrial respiration (Ramesh Babu et al., 2008, 
Kwon et al., 2012).  
Notably, genetic and age-related loss of efficient autophagy has been linked to age-
related diseases, such as ALS (Section 1.12.3). More specifically, p62 mutations have 
been identified in ALS patients, which has been described in detail in section 1.4.1. 
In this chapter we discovered that p62 can become oxidised, resulting in its 
oligomerisation and promoting autophagy. This prosurvival mechanism is evolved in 
vertebrates promoting oxidative stress resistance and survival. In contrast, impairment 





4.2.1 p62 becomes increasingly oxidised with age and forms aggregates in 
mouse brain 
Firstly, we tested the proteostatic and autophagic status of young and old mice. In the 
old mouse brains, ubiquitinated proteins accumulate indicating that there is increased 
proteotoxic stress. This is accompanied by increased Prd-SO3, an accepted marker for 
oxidative stress (figure 29A)(Wagner et al., 2002). This is in agreement with the 
previously described proteostatic and redox imbalance in the brain of old mice (Wagner 
et al., 2002, Ohtsuka et al., 1995). However, no major changes in LC3-I and LC3-II 
levels were observed comparing young and old mouse brains, suggesting that 
autophagy function is not markedly affected (Figure 29A). In addition, total levels of the 
autophagy substrate p62 did not increase, implying that autophagy is unperturbed. 
Interestingly, with age p62 DLC (Disulphide-Linked Conjugates) accumulate, these 
were only observed in non-reduced conditions, but were broken down in reducing 
conditions (Figure 29B). This suggests that they are mediated by sulfhydryl groups, 
such as disulphide or thioester bonds. In reduced conditions (in the presence of a 
reducing agent, such as β-mE, disulphide bridges within a protein or between multiple 
proteins are reduced, resulting in the loss of a secondary structure of a protein, or 
resulting in the disassembly of a multimeric protein complex (Section 1.8.3). The main 
p62 oligomeric species we observed is around 250 kDa, which could correspond to 
p62 tetramers (Figure 29B). Interestingly, when we looked in neurons (Purkinje cells) 
of young and old mice, we observed more accumulation of p62 aggregates in neurons 
of old mice, despite total p62 protein levels being unaltered (Figure 29B and C).  
Next, we used mammalian cells in tissue culture to model the behaviour of p62 in 
response to oxidation and autophagy inhibition. After blocking autophagy with 
Bafilomycin A1 (Baf) or chloroquine (CQ) we observed an expected p62 accumulation, 
but primarily in monomeric form in non-reduced blots (Figure 29D). To induce oxidative 
stress we treated cells with H2O2 and PR-619. PR-619 is a redox cycler known to 
produce H2O2 in aqueous solutions, but it also non-specifically inhibits activity of DUBs 
(Redhead et al., 2015). Treating HeLa cells with H2O2 or PR-619 results in the 
formation of p62 DLC as we observed in old mouse brains (Figure 29B-D). PR-619 
treatment resulted in more p62 DLC compared to H2O2, with the majority of protein 
being in DLC, whilst in response to H2O2 a lot of the protein is still in its monomeric 
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form (Figure 29D). Furthermore, both ROS treatments results in the formation of p62 
aggregates similar to a block in autophagy (Figure 29E). From these results, we 
hypothesise that a block in autophagy results in the formation of aggregates based on 
non-covalent interactions, such as PB1 domain-dependent oligomerisation (Section 
1.3.2), whilst there is a different, disulphide dependent oligomerisation mechanism in 
response to oxidation.  
Thus, in vivo p62 is oxidised with age in mouse brains and this can be modelled in 
mammalian cells and this might contribute to the formation of p62 aggregates.  
 
Figure 29 p62 disulphide-linked conjugates (DLC) accumulate with age in old mouse brains. 
(A) Young (3 months) and old (24 months) mouse brain tissues were analysed by western blot analysis for 
ubiquitin, Prx-SO3 and LC3. (B) Young and old mouse brain tissue were analysed by western blot analysis 
for p62 in either reducing (2.5% β-mE) or non-reducing conditions. (C) Representative images and 
quantification of p62 aggregates in young and old mouse Purkinje cells in the cerebellum. % of cells 
containing p62 positive aggregates were quantified. This experiment was performed in collaboration with 
Dr. Diana Jurk. (D) Effect of autophagy inhibition (bafilomycin A1 (Baf, 400nM, 4 hours) and chloroquine 
(CQ, 50μM, 4 hours)) and oxidative stress (H2O2 (3mM, 10 min) and PR-619 (5μM, 30 min)) on p62 DLC 
analysed by western blot analysis (E) and p62 aggregation in HeLa cells analysed by immunofluorescence 
staining against p62 analysed by confocal microscopy. Error bars represent s.e.m., n=3, *P<0.05, **P<0.01, 
***P<0.005. Asterisk indicates a non-specific band. A, B and D were in collaboration with Dr. Diego Manni. 
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4.2.2 Oxidation of p62 promotes autophagy  
Cysteine residues are the predominant targets to be oxidised in redox-regulated 
proteins. After doing multiple rounds of cysteine to alanine mutagenesis, cysteine 
residues 105 and 113 were identified to be required for oxidation of p62 (data not 
shown).  
To study the significance of p62 oxidation in autophagy, p62-/- MEFs stably expressing 
FLAG-p62 and FLAG-C105,113Ap62 were generated (Figure 30A). FLAG-p62 and 
FLAG-C105,113Ap62 transgenes were expressed at slightly lower levels than the 
endogenous protein (Hewitt et al., 2016). The stable p62 cell lines were treated with 
ROS inducing agents H2O2 and PR-619, which both induce the formation of p62 DLC 
in cells expressing wild type FLAG-p62, but not in the cells expressing the FLAG-
C105,113Ap62 mutant as expected (Figure 30A). These cell lines were used to 
investigate the role of p62 oxidation in autophagy. In addition, a cell line was generated 
expressing a PB1 domain oligomerisation mutant (K7A,D69A) to study the role of p62 
oligomerisation in autophagy. The K7A and D69A mutations abolish the interaction 
surface of the PB1 domain, resulting in a loss of self-oligomerisation ability, whilst its 
ability to form DLC is unaffected (Lamark et al., 2003) and data not shown. 
In order to understand if the formation of p62 DLC is important for autophagy and 
protein homeostasis, p62 cell lines were switched to serum free media (SFM) as a 
control, or SFM with 1mM H2O2 for 5 hours to induce oxidative stress and the formation 
of p62 DLC. In this thesis H2O2 treatments are always performed in SFM, because 
H2O2 becomes quenched in media containing serum. Switching cell to SFM is a 
starvation treatment, and thus induces autophagy. In these conditions we observed 
that p62-/- MEFs and p62-/- MEFs re-expressing the p62 oxidation mutant (C105,113A) 
or the p62 PB1-domain mutant (K7A,D69A) have decreased LC3-II levels and an 
accumulation of ubiquitinated proteins compared to cells expressing wild type FLAG-
p62 (Figure 30B&C). This suggests that oxidation and oligomerisation of p62 is 
required for autophagy induction and clearance of ubiquitinated proteins. H2O2 
treatment results in autophagy induction in cells expressing FLAG-p62, as LC3-II levels 
increase and wild type p62 is cleared (Figure 30B&C). In cells expressing FLAG-
C105,113Ap62 or FLAG-K7AD69Ap62, autophagy is not induced to the same extend, 
as LC3-II levels increase less and p62 levels do not decrease significantly (Figure 
30B&C). The same phenotype was observed in response to PR-619 treatment, where 
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increased LC3 lipidation was observed in cells expressing wild type FLAG-p62, but not 
in the mutants (Figure 30D&E).  
 
Figure 30 Oxidation of p62 promotes autophagy induction in basal and oxidative stress conditions. 
(A) p62-/- MEFs stably expressing FLAG-p62 or the oxidation mutant FLAG-C105,113Ap62 were analysed by 
western blot analysis for p62 in non-reducing conditions in response to H2O2 (1mM, 1 min) or PR-619 (5µM, 
10 min). (B, D) p62-/- MEFs stably expressing empty vector, FLAG-p62, FLAG-C105,113Ap62 or FLAG-
K7AD69Ap62 were treated with (B) H2O2 (1mM, 5 hours) or (D) PR-619 (5µM, 3 hours) and subjected to 
western blot analysis for LC3, ubiquitin and p62. (C) Quantification of B for ubiquitin and LC3-II and p62. 
(E) Quantification of D for LC3-II. Quantifications were normalised to p62-/- MEFs stably expressing FLAG-
p62. Error bars represent s.e.m., (n=3), *P<0.05, **P<0.01, ***P<0.005, NS= not significant.  
The decrease in LC3 lipidation in the oxidation and oligomerisation mutants correlated 
with less autophagosomes observed by confocal microscopy (Figure 31A&B). Taken 
together these results suggest that autophagy induction, in particularly in oxidative 




Figure 31 Oxidation of p62 promotes the formation of autophagosomes. 
(A) Representative confocal microscopy images of p62-/- MEFs stably expressing empty vector, FLAG-p62, 
FLAG-C105,113Ap62 or FLAG-K7AD69Ap62 which were immunostained for p62 and LC3. (B) Quantification 
of A for percentage of cells with more than 20 autophagosomes. Error bars represent s.e.m., (n=3), 
***P<0.005.  
4.2.3 Oxidation of p62 is important for cell survival upon oxidative and 
proteotoxic stress 
Autophagy is a degradation pathway that is of great importance for cell survival in 
oxidative and proteotoxic stress conditions. We have shown that oxidation of p62 is 
required to induce autophagy in basal and oxidative stress conditions and promotes 
clearance of poly-ubiquitinated proteins. Next, we investigated if the oxidation of p62 
is important for cell survival under these circumstances. The p62 cell lines were treated 
with 1mM H2O2 for 5 hours and cell death was assessed. In p62-/- MEFs around 25% 
cell death was observed upon H2O2 treatment. In cells expressing wild type FLAG-p62 
the cell death was rescued, however no rescue was observed in cells expressing the 
oxidation mutant (C105,113A) or the PB1 domain mutant (K7A,D69A) (Figure 32A&B). 
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Hence, we conclude that p62 cysteines 105 and 113 are essential for cell survival in 
conditions of oxidative stress. Furthermore, in response to PR-619 treatment also 
significantly more cell death was observed in cells expressing FLAG- C105,113Ap62 
(Figure 32C). To determine if the rescue of cell death in cells expressing wild type 
FLAG-p62 is autophagy dependent, cells were treated with H2O2 in the absence or 
presence of autophagy inhibitors Bafilomycin A1 or chloroquine. Both autophagy 
inhibitors cancelled out the difference in cell survival between the two cell lines, 
suggesting that autophagy is the mechanism of oxidative stress resistance (Figure 
32C). 
 
Figure 32 Oxidation of p62 promotes survival in response to oxidative stress. 
(A) p62-/- MEFs stably expressing empty vector, FLAG-p62, FLAG-C105,113Ap62 or FLAG-K7AD69Ap62 
were treated with H2O2 (1mM, 5 hours) and stained with ReadyProbes fluorescent dyes to assess cell death 
and quantified (B). p62-/- MEFs stably expressing FLAG-p62 or FLAG-C105,113Ap62 were treated with PR-
619, H2O2 (1mM, 5 hours), H2O2 with Baf (50nM, 5 hours) or H2O2 with CQ (20µM, 5 hours) and stained with 
ReadyProbes fluorescent dyes to assess cell death and quantified. Error bars represent s.e.m., (n=3) 
**P<0.01, ***P<0.005, NS= not significant. These experiments were performed in collaboration with Dr. 
Bernadette Carroll.  
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4.2.4 Oxidation of p62 is not important for induction of the Nrf2 signalling 
pathway in response to H2O2 treatment 
p62 has also been implicated in Nrf2 signalling, which is another well-known 
prosurvival pathway, especially in oxidative stress conditions (Section 1.3.8). To test if 
Nrf2 signalling could be an alternative mechanism of increased stress resistance in 
cells expressing wild type FLAG-p62 we investigated the Nrf2 response in our cell lines 
in response to H2O2 treatment. Firstly, the translocation of Nrf2 to the nucleus was 
assessed. Nuclear fractionations were performed and we could observe a robust Nrf2 
translocation to the nucleus in response to H2O2, however no significant difference 
between p62-/- MEFs stably expressing FLAG-p62 or FLAG-C105,113Ap62 was 
observed (Figure 33A&B). Secondly, the induction of the Nrf2 target gene HO-1 (Heme 
Oxygenase 1) as measured by qPCR was not decreased in cells expressing the p62 
oxidation mutant (C105,113A) (Figure 33C). Finally, cell death was assessed in cells 
treated with H2O2 in the absence or presence of RA (Retinoic Acid, a potent Nrf2 
inhibitor (Wang et al., 2007)). Inhibition of Nrf2 signalling did not cancel out the 
difference in cell survival between the two cell lines. Altogether, the data suggest that 
Nrf2 signalling is not the mechanism of oxidative stress resistance in response to 




Figure 33 Oxidation of p62 is not important for induction of the Nrf2 signalling pathway in response to 
H2O2 treatment. 
(A) p62-/- MEFs stably expressing FLAG-tagged wild type, C105A,C113A or K7A,D69A PB1 domain mutant 
p62 were treated with H2O2 (1mM, 5 hours) in SFM and subjected to a nuclear fractionation followed by 
immunoblot analysis for Nrf2, Histone 3 and GAPDH and quantified (B). (C) Cells were treated as in (A) and 
Nrf2 target gene HO-1 mRNA levels were analysed by qPCR, actin was used as a loading control. This 
experiment was done in collaboration with Dr. Rhoda Stefanatos. (D) p62-/- MEFs stably expressing FLAG-
tagged wild type or C105A,C113A mutant p62 were pre-treated with retinoic acid (RA, 30µM, 1 hour) in serum 
free media followed by the same treatment as in (A) with or without retinoic acid (30µM) and % cell death 
was analysed by ReadyProbes fluorescent dyes (Life Technologies). Error bars represent s.e.m., (n=3) 
*P<0.05, **P<0.01, NS= not significant. 
4.2.5 Conservation of the p62 redox sensitive cysteines 105 and 113 
We established that the oxidisable p62 cysteine residues are essential for the 
formation of p62 DLC and the subsequent degradation (Figure 30 and unpublished). 
Next, we were interested to determine in what time during evolution these oxidisable 
p62 cysteines 105 and 113 were acquired. First, we performed a multiple sequence 
alignment of the N-terminal fragment of p62 containing cysteine 105 and 113 in several 
species and found that the two cysteines have a high degree of conservation, lie in an 
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unstructured region ranging between amino acids 102 and 122, and are surrounded 
by charged residues (Figure 34). Interestingly, the two key cysteines are only acquired 
in vertebrates, therefore we hypothesised that oxidation of p62 is a prosurvival 
mechanism only acquired late in evolution.  
 
Figure 34 p62 cysteines 105 and 113 are conserved from invertebrates to humans. 
Multiple alignment of p62 sequences (amino acid 1-200) in different species. Increasing conservation is 
shown by light-dark red; cysteine residues are indicated by stars, and a lysine residue that is mutated in a 
sporadic ALS-case is indicated by a diamond and a blue box. Lines above the sequence alignment indicate 
predicted ordered regions with β-sheets shown as blue arrows and α-helices shown as red cylinders. 
Cysteine 105 and 113 are marked by a green box. The alignment was performed by Dr. Graham Smith.  
4.2.6 The redox insensitive Drosophila melanogaster p62 homolog Ref(2)P 
accumulates with age 
Ref(2)P, which is the Drosophila orthologue of p62, similar to p62 has been found to 
be a component of protein aggregates formed during ageing in Drosophila 
melanogaster brains (Nezis et al., 2008). Ref(2)P does not contain oxidisable cysteines 
in between the PB1 domain and the ZZ domain and does not form p62 DLC with age 
(Figure 34 and 35A). Young and old flies were assessed for total Ref(2)P levels and 
Ref(2)P DLC. In old whole flies, Ref(2)P accumulated and no Ref(2)P DLC were 
observed (Figure 35A). This could suggest that indeed the missing oxidisable 
cysteines are required for efficient p62 degradation and that the prosurvival 
mechanism we identified is lacking in flies.  
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To test if the acquisition of redox-regulated cysteines in vertebrates is an evolutionary 
advantage we generated flies expressing humanised Ref(2)P using CRISPR/Cas9 
genome editing. Amino-acids 91-116 of D. melanogaster (knock-in strain w1118) 
Ref(2)P were replaced with amino acids 100-118 of human p62, including the 
oxidisable cysteine residues 105 and 113 (Figure 35B). Indeed, in response to H2O2, 
humanised Ref(2)Pox, but not wild type Ref(2)P, forms DLC (Figure 35C). Therefore, 
these flies were used for the experiments described in the rest of this results chapter.  
 
Figure 35 Ref(2)P is not oxidised and accumulates with age. 
(A) Young (10 days) and old (75 days) whole flies were analysed by western blot analysis for Ref(2)P in 
either reducing (2.5% β-mE) or non-reducing conditions. (B) Schematic diagram showing p62 and Ref(2)P 
domain structure and introduction of the p62 linker region, including the oxidable cysteines, into Ref(2)P. 
(C) Wild type and humanised oxidisable Ref(2)Pox flies treated with H2O2 in vitro (1mM, 5 min) were analysed 





4.2.7 Oxidisable humanised Ref(2)Pox promotes autophagy 
Previously we found that in mammalian cells p62 oxidation is a mechanism to promote 
autophagy (Figures 30). We were interested if a similar phenotype was observed in 
our flies expressing Ref(2)Pox. To test autophagy flux, flies were fed chloroquine for 2 
days and H2O was used as a control. Then flies were switched to 32ᵒC for 2 days to 
induce proteotoxic stress (Menger et al., 2015), also in the presence of H2O or the 
autophagy inhibitor chloroquine in the food. The flies expressing humanised Ref(2)Pox 
displayed increased lipidated Atg8 (the fly homolog of LC3) levels upon autophagy 
inhibition compared to flies expressing wild type Ref(2)P, indicating that these 
humanised flies have an increased autophagic flux (Figure 36).  
 
Figure 36 Oxidisable humanised Ref(2)Pox promotes autophagy. 
Wild type and humanised oxidisable Ref(2)Pox flies were switched to 32ᵒC for 2 days in the absence or 
presence of chloroquine and were analysed by western blot analysis for Atg8. Flies were pretreated with 
H2O as a control or chloroquine to block autophagy for 2 days. Error bars represent s.e.m., n=3 (at least 10 




4.2.8 Flies carrying oxidisable humanised Ref(2)Pox are more resistant to 
oxidative stress 
Next, we evaluated if this increased autophagy flux in flies carrying oxidisable 
humanised Ref(2)Pox also impacts on survival in stress conditions. In order to induce 
oxidative stress in the flies we used paraquat. This is an herbicide that is reduced within 
cells to increase ROS production. Flies were fed 20mM paraquat or H2O as a control 
and survival of wild type flies or flies carrying Ref(2)Pox was determined. We found that 
flies carrying Ref(2)Pox lived longer, showing that these flies are more resistant to 
oxidative stress (Figure 37A). This was associated with decreased levels of 
ubiquitinated proteins and Ref(2)P, indicating that autophagy substrates are degraded 
more efficiently in flies carrying oxidisable Ref(2)P (37B&C).  
 
Figure 37 Oxidisable humanised Ref(2)Pox protects agains oxidative stress. 
(A) Survival of wild type and humanised oxidisable Ref(2)Pox flies (three repeats, at least 60 flies per 
replicate) fed with paraquat (PQ, 20mM) and survival was assessed every 12 hours. Survival was plotted as 
adult life span in days. (B) Ctr (H2O) and paraquat (20mM, 12 hours) fed wild type and humanised oxidisable 
Ref(2)Pox flies were analysed by western blot analysis for ubiquitin and Ref(2)P. (C) Quantification of B. 
Error bars represent s.e.m., n=3 (at least 10 flies per replicate), *P<0.05. 
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We have shown that oxidisable humanised Ref(2)Pox protects against oxidative stress 
induced by paraquat. Next, we wanted to know if this is also applicable to another 
oxidative stressor. In order to test this, we switched flies to 32ᵒC after eclosing, this 
thermal stressor is also associated with oxidative stress (Jacobson et al., 2010) and 
results in a shorter life span (only around 20 days) and accumulation of ubiquitinated 
proteins and Ref(2)P (Figure 38A&B). Upon these conditions, flies carrying Ref(2)Pox 
had a striking life span extension compared to wild type flies (Figure 38A). This was 
accompanied by a significant reduction of Ref(2)P levels, and ubiquitinated protein 
levels showed a trend to be decreased at 32ᵒC as well (Figure 38B&C). Thus, 
oxidisable humanised Ref(2)Pox protects against oxidative stress and we propose that 
the same mechanism as for p62 oxidation in mammalian cells can be applied here. 
Thus, oxidative stress promotes the formation of Ref(2)P DLC, which promotes 
autophagy induction, and thus degradation of itself as well as associated substrates, 
such as ubiquitinated proteins and this promotes survival.  
We conclude that introducing the p62 linker region, including the oxidisable cysteines 
105 and 113, results in a gain of function of p62. Ref(2)Pox can be oxidised and form 




Figure 38 Oxidisable humanised Ref(2)Pox extends fly lifespan upon proteotoxic stress. 
(A) Combined survival data (three repeats, at least 60 flies per replicate) of wild type and humanised 
oxidisable Ref(2)Pox flies subjected to proteotoxic stress (32ᵒC). Survival was plotted as adult lifespan in 
days. (B) Two days old wild type or humanised oxidisable Ref(2)Pox flies were switched to 32ᵒC for 2 days 
or maintained at 25ᵒC and were analysed by western blot for ubiquitin and Ref(2)P. Error bars represent 
s.e.m., n=3 (at least 10 flies per replicate), *P<0.05. 
4.2.9 Oxidation of p62 is impaired in the Amyotrophic Lateral Sclerosis p62 
K102E mutant 
To investigate if the loss of oxidation of p62 could cause age-related diseases we 
looked for known mutations located close to the identified oxidisable cysteines 105 and 
113. One ALS-associated mutation (K102E) was identified in the unstructured region 
and the mechanism of pathology is unknown (Teyssou et al., 2013). We hypothesised 
that the K102E mutation would interfere with degradation of p62 by impairing the ability 
of p62 to be oxidised and form DLC. Lysine 102 is a highly conserved residue and 
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locates closely to the key oxidisable cysteine 105 (Figure 39A) (Le Ber et al., 2013). In 
silico analyses predicted that the K102E mutation can interfere with the sensitivity of 
cysteine 105 to be oxidised by introducing an extra negative charge in the vicinity that 
changes the PKa of the cysteine (Figure 39B). Reactive cysteines are known to be 
close to positive charged residues, such as arginine and lysine, whilst unreactive 
cysteines are located closely to negatively charged residues such as glutamic acid. 
Thus, we predict that the K102E mutation results in less reactive cysteine 105 and 
thereby affecting the potential of p62 to form DLC in response to ROS. Moreover, an 
in silico model of disulphide bond-mediated p62 oligomerisation of the N-terminal PB1 
domain and the unstructured linker region predicted that K102 may be involved in the 
salt-bridge formation with E19 within the PB1 domain (Figure 39C). This salt bridge 
stabilises the protein, and also affects the conformation and orientation of the near 
C105, enabling formation of the disulphide bond between C105 and C113 from another 
p62 subunit (Figure 39C). The K102E mutation disrupts this stabilising interaction and 
results in a conformation change of the loop, making C105 inaccessible to form 
disulphide bonds with a neighbouring p62 molecules (Figure 39C). Thus, the K102E 
mutation could lead to impaired oxidation by two means; changing the electrostatic 
potential around C105 and changing the conformation of the flexible loop between the 
PB1 domain and the ZZ domain, thereby perturbing formation of disulphide bonds with 
neighbouring p62 molecules.  
To test if this mutation indeed would preturb oxidation of p62, as predicted by our 
models, HeLa cells were transfected with FLAG-tagged wild type p62, FLAG-
C105,113Ap62 and FLAG-K102Ep62 and treated with the ROS inducing agents, H2O2 
and PR-619. We found that the K102E mutations resulted in a loss of DLC formation 





Figure 39 The ALS related mutation K102E impairs oxidation of p62. 
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(A) Multiple alignment of p62 sequences (amino acid 100-122) in different species. Increasing conservation 
is shown by light-dark red; cysteine 105 and 113 are indicated by stars and a green box, and a lysine residue 
that is mutated in a sporadic ALS-case is indicated by a diamond and a blue box. (B) Models of the p62 
linker region (amino acids 102-117) containing cysteine residues involved in p62 oxidation of wild type and 
K102E mutant showing electrostatic potential between -1RT (red) and +1RT (blue) mapped to the solvent 
accessible surface. Cysteine 105 is marked by a red circle. (C) In silico analysis p62 oxidation and 
oligomerisation of the N-terminal PB1 domains (residues 3-125) and the potential impact the K102E has on 
the oxidation and oligomerisation. Two of the monomers (A and D) are K102E mutants, while monomers B, 
C and E are wild type. K102E mutation triggers large conformational changes locally, which affect the 
position and orientation of C105 residue (yellow) and impair the disulphide bond between C105 and C115 
(green) from the previous monomer (e.g. K102E mutation in chain D disrupts the disulphide bond between 
C105 from the monomer D and C115 from the monomer C. Thus, equimolar mixture of WT and K102E mutant 
p62 (as would be expected in patients with heterozygous mutation) results in the covalently-linked trimers 
(coloured grey in the figure) and disrupts the larger oligomers. Residue K102 is coloured blue. In wild type 
p62 it interacts with E19 (highlighted as spheres and coloured by heteroatom). In the K102E mutant this 
favourable electrostatic interaction is disrupted, strong electrostatic repulsion triggers the conformational 
changes, and the adjacent K103 (highlighted in the monomer D and displayed as balls and sticks) moves 
towards E19, thus compensating for the loss of favourable interaction, while residue 102 moves outwards. 
(D) Western blot analysis of non-reduced samples of HeLa cells transfected with FLAG-p62, FLAG-
C105,113Ap62 and FLAG-K102Ep62 treated with H2O2 (3mM, 1min) and PR-619 (5µM, 10 min). (D) The ratio 
of DLC to monomeric p62 was quantified and normalised to FLAG-p62. Error bars represent s.e.m., n=3, 
***P<0.001. Alignment and models depicted in A&B and C were created by Drs. Graham Smith and 
Agnieszka Bronowska, respectively.  
4.2.10 Oxidation of p62 is independent of the “charged bridge” 
The K102, C105 and C113 locate in the “charged bridge”, including many charged 
residues. Ciuffa at al. found that the positively charged R106 and R107 residues were 
important for the charged bridge, resulting in stabilisation of PB1 domain-mediated 
oligomers (Ciuffa et al., 2015). In order to assess if other charged residues in the linker 
region containing the oxidisable cysteines could affect oxidation of p62, several 
different mutants were generated; negatively charged to positively charged (E104K); 
positively charged to negatively charged (R106E, R107E); negatively charged to 
neutral (D108A) and positive to neutral (H109A). GFP-tagged p62 plasmids, wild type 
or carrying the previously described mutations, were transfected into HeLa cells and 
treated with the ROS inducing agent PR-619. None of the mutations affected the 
formation of p62 DLC (Figure 40A). This suggest that the formation of p62 DLC does 
not depend on the charged bridge, and that the oxidation of cysteines is dominant and 
potentially aligns the charged bridge. We propose that the formation of p62 DLC via 
the oxidisable cysteines 105 and 113 is an alternative mode for oligomerisation, which 




Figure 40 Mutations in the charged bridge do not affect p62 DLC formation. 
(A) Western blot analysis of non-reduced samples of HeLa cells transfected with GFP-p62, GFP-E104Kp62, 
GFP-R106Ep62, GFP-R107Ep62, GFP-D108Ap62, GFP-H109Ap62 treated with PR-619 (10µM, 10 min).  
4.2.11 The K102E mutation interferes with the ability of p62 to promote 
autophagy 
Considering that oxidation of p62 promotes autophagy and cell survival upon oxidative 
stress as shown previously (Figure 30, 31 & 32), we tested if the K102E mutation 
interferes with autophagy induction. We observed that LC3 lipidation was reduced in 
p62-/- MEFs stably expressing FLAG-K102Ep62 in basal conditions and in response to 
H2O2, this coincided with increased p62 and ubiquitinated protein levels (Figure 41A). 
Furthermore, fewer autophagosomes were observed in p62-/- MEFs stably expressing 




Figure 41 The K102E mutation interferes with the ability of p62 to promote autophagy. 
A) p62-/- MEFs stably expressing FLAG-p62 or the ALS mutant FLAG-K102Ep62 were treated with 1mM H2O2 
for 5 hours and subjected to western blot analyses for LC3, ubiquitin and p62. Ubiquitin and LC3-II levels 
were quantified and normalised to p62-/- MEFs expressing FLAG-p62. (B) Representative confocal 
microscopy images of p62-/- MEFs stably expressing FLAG-p62 or FLAG-K102Ep62 were immunostained 
for p62 and LC3. Error bars represent s.e.m., n=3, **P<0.005, ***P<0.005. 
4.2.12  The ALS related K102E mutation results in impaired p62 oxidation in 
human spinal cord tissue 
Finally, immunochemistry analysis of spinal cord tissue of the K102E patient 
demonstrated an increase in ubiquitin- and p62- positive inclusions compared to other 
sporadic ALS cases (Teyssou et al., 2013), which could be caused by impaired 
autophagy, similar to what we observed in the p62-/- MEFs stably expressing FLAG-
K102Ep62. We analysed spinal cord tissue from a patient with ALS caused by sporadic 
heterozyguos K102E mutation using western blot and compared to sporadic ALS 
(SALS) cases without p62 mutations as well as age-matched controls. We found that 
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in SALS cases total p62 as well as p62 DLC tend to accumulate compared to healthy 
controls (Figure 42A&B), suggesting that the previously described mechanism for p62 
oligomerisation in mouse and tissue culture also applies to human tissue. It also 
suggests that autophagy is impaired in these SALS cases, as described in the literature 
(Section 1.12.3). 
Similar to aged mouse brains and in tissue culture, the main p62 DLC species we 
observe is around 250 kDa. In contrast, in the patient carrying the K102E p62 mutation, 
p62 DLC accumulate in a low molecular weight form, between 100 and 150 kDa, which 
potentially is a p62 dimer or trimer (Figure 42A). Considering that the carrier is 
heterozygous for the K102E mutation, it could be speculated that the K102E interacts 
with wild type p62, allowing the formation of p62 dimers and trimers, but surpressing 
the formation of higher order DLC, suggesting that the K102E mutation is dominant-
negative, as was suggested by our in silico model (Figure 39C) 
We conclude that the K102E mutation interferes with the function of p62 as a sensor 
of oxidation, resulting in impaired autophagy. Therefore, an impairment of the 
mechanism by which p62 associated proteins are degraded in response to oxidative 
stress could be an underlying factor in the ALS pathology caused by the K102E 
mutation.  
 
Figure 42 The ALS related K102E mutation results in impaired p62 DLC formation in human spinal cord 
tissue. 
(A) Spinal cord tissue from ALS patients with either unknown (SALS) or K102E p62 mutation or age-
matched controls (Ctr) were subjected to western blot analysis for p62 in either non-reducing or reducing 
(2.5% β-mE) conditions. The red arrow points to an intermediate DLC of p62 which accumulated in the 





This is the first time that it has been shown that an autophagy receptor can be redox 
regulated in response to ROS. We propose that redox-regulation of p62 is a 
mechanism acquired during evolution of vertebrates to promote autophagy in response 
to oxidative stress. Lower-order species, such as D. melanogaster, do not have this 
mechanism, but we have shown that introduction of the redox-sensitive cysteines 
promotes fly survival in oxidative stress conditions. This mechanism might be 
especially relevant for longer lived species, as the ALS related K102E mutation impairs 
oxidation of p62 and thus may result in neurodegeneration (Figure 43).  
 
Figure 43 Diagram of the proposed role for p62 oxidation in the degradation of autophagy substrates. 
Formation of p62 DLC is triggered by oxidative stress, which promotes degradation of p62 and p62 
substrates (such as poly-ubiquitinated proteins) trough autophagy. The ALS associated K102E mutant 
impairs oxidation of p62.  
We have shown that p62 is increasingly oxidised in mouse brains with age (Figure 
29B), in tissue culture upon ROS treatments (Figure 30) and in human brains (Figure 
42). First of all, we assume that the observed p62 DLC around 250 kDa is a tetramer 
of p62 molecules. However, it is also possible that other proteins interact with p62 via 
disulphide bonds. It would be interesting to test this and purify p62 DLC and identify 
the proteins in the p62 DLC by mass-spectrometry. Unfortunately, this has proven to 
be difficult as p62 is a very aggregate prone protein (data not shown). We propose that 
upon oxidation stress cysteines 105 and 113 form disulphide bonds with cysteine 105 
and 113 of another p62 molecule. Even though, these two cysteines are the most 
important oxidisable cysteines, still a little p62 DLC formation remains in cells 
expressing the FLAG-C105,113p62 (Figure 30A), suggesting that other cysteines 
(even though they are probably less reactive) can form sulphide bonds as well.  
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4.3.1 How can a localised ROS signal result in the formation of p62 DLC? 
Formation of DLC is triggered by ROS, such as H2O2 and in such conditions the 
prosurvival- and autophagy-promoting roles of p62 are most apparent. Interestingly, in 
basal conditions, a little p62 DLC is observed as well (Figures 29B, 30A, 42) and also 
in starvation conditions oxidation of p62 promotes autophagy (Figure 30B-D). 
Interestingly, Atg4, the only other identified redox-regulated protein that is involved in 
autophagy was also shown to be oxidised in starvation conditions, without stressing 
the cells with extracellular ROS (Scherz-Shouval et al., 2007). They convincingly 
demonstrated that starvation induces the formation of H2O2 (Scherz-Shouval et al., 
2007), but how this H2O2 is produced is unclear. One possible mechanism involves the 
direct production of ROS via mitochondria, for example via complex I (Scherz-Shouval 
et al., 2007). How this could be regulated is unclear. Alternatively, local inactivation of 
Prxs can result in a localised ROS signal. At the plasma membrane, phosphorylation 
of Prx1 in response to growth factor stimulation results in its inactivation, allowing the 
build-up of a local H2O2 signal (Woo et al., 2010). Prx1 and Prx2 are cytosolic localised, 
whilst Prx3 and Prx4 are restricted to mitochondria and the ER respectively. As Prx1 
was also able to localise to membranes (Woo et al., 2010) it cannot be excluded that 
these, or other Prxs are present at the site of autophagosome formation. Interestingly, 
Prx1, Prx 2 and Prx 6 have been shown to locate to the autophagosomal membrane 
(Overbye et al., 2007). It would be intriguing to assess if a similar mechanism occurs 
in response to autophagy stimulating conditions such as starvation, where Prxs are for 
example inactivated at the ER-mitochondrial contact site or at the early 
phagophore/autophagosome, resulting in a localised H2O2 signal. Recently, a 
computational model by Travasso et al. suggest that direct oxidation of redox targets 
(p62 in this case) by H2O2 is not likely to happen. Prxs have a much higher rate 
constants in the range of 107–108 M−1 s−1, whilst cysteines of other redox regulated 
proteins range from 9−164 M−1 s−1, and in addition Prxs are very abundant (Travasso 
et al., 2017). According to their model, even locally inactivating Prxs or a locally 
produced high H2O2 signal is not sufficient to directly oxidise less reactive redox targets 
(e.g. p62). They suggest that oxidised forms of Prx (sulfonate or disulphide forms) 
mediate the oxidation of redox targets (Travasso et al., 2017). Thus, it could be 
speculated that the autophagosomal localised Prx1, Prx 2 or Prx 6 function as redox 
relay proteins. The Prxs could act as initial H2O2 sensors and then oxidise target 
proteins. This would involve the formation of a transient DLC between peroxiredoxin 
and p62, as was suggested for Ask1-Prx1 (Jarvis et al., 2012), Stat3-Prx2 (Sobotta et 
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al., 2015) and Dj-1-Prx2 (Fernandez-Caggiano et al., 2016) (Figure 44). Alternatively, 
oxidised Prxs could oxidise Trxs, resulting in less reduction of p62 DLC by Trx (Diego 
Manni, data not shown). 
 
Figure 44 Schematic diagram for a proposed model for Prx-mediated p62 cysteine oxidation.  
Peroxiredoxin (Prx, red) gets oxidised by H2O2 and forms a sulfenic acid (-SOH), which can further resolve 
into a Prx dimer (S-S). Oxidised Prx can then oxidise p62 via a thiol-disulphide exchange, by forming a 
short-lived Prx-p62 DLC intermediate (in brackets), resulting in the formation of p62 DLC. The p62 DLC can 
be reduced via thioredoxins (Trx, Orange). Trx can also be oxidised by oxided Prx. Thus hyperoxidation/ 
inactivation of Prx would most likely result in less H2O2 signal transduction to p62, or less oxidation of Trx 
and thus more reduction of p62, both leading to less p62 DLC. This figure is modified after (Sobotta et al., 
2015). 
4.3.2 A novel role for p62 and the formation of p62 DLC in autophagy 
induction  
p62 is a protein with multiple functions, for example it is involved in several signalling 
pathways and aggregate formation. However, its function is primarily as an autophagy 
receptor in selective autophagy, bridging ubiquitinated cargo to LC3. Our data revealed 
that the formation of p62 DLC promotes autophagy induction. An increased autophagy 
flux (more lipidated Atg8 accumulated upon autophagy inhibition) was especially 
apparent in flies expressing oxidisable Ref(2)Pox (Figure 36), but also in p62-/- MEFs 
re-expressing FLAG-C105,113Ap62 ubiquitinated proteins and p62 accumulated, 
whilst there was less lipidated LC3 and autophagosomes (Figure 30B-E, 31A&B). 
Thus, in addition to its role in the late stage of the autophagy pathway, our data suggest 
that p62 also functions in the early steps of autophagy induction. In Chapter 5 we will 
speculate in more detail how p62 could be involved in autophagy induction and what 
the role of ROS are during autophagy initiation. 
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In addition, to promoting autophagy initiation, the formation of p62 DLC could also 
promote the degradation of ubiquitinated cargo by increased binding to LC3-positive 
membranes. Previously, it has been shown that oligomerisation of p62 is important for 
its targeting to the nascent autophagosome (Wurzer et al., 2015, Itakura and 
Mizushima, 2011). It was proposed that oligomerisation of p62 stabilises its interaction 
with LC3 clusters on the autophagosomal membrane. It was shown that not the affinity 
of binding to individual LC3 molecules was affected, but upon oligomerisation the off-
rate of p62, from LC3 positive vesicles was reduced (Wurzer et al., 2015). Furthermore, 
oligomerisation of p62 also promotes the interaction with ubiquitin and promotes 
specificity towards linear and K63-linked, but not K48-linked ubiquitin chains (Wurzer 
et al., 2015). We have shown that oxidation of p62 promotes aggregate formation (data 
not shown) and as oligomerisation of p62 has been shown to be important for efficient 
recruitment of ubiquitinated cargo to the nascent autophagosome. We propose that 
the formation of p62 DLC functions via the same mechanism as described by Wurzer 
et al. Thus oxidation of p62 has a dual role in autophagy, firstly it promotes autophagy 
initiation and secondly it promotes aggregation, resulting in efficient targeting of 
substrates to the autophagosome.  
4.3.3 How does the formation of p62 and Ref(2)P DLC promotes oxidative 
stress resistance in cells and in flies? 
In cells, as well as in flies, oxidation of p62 results in increases stress resistance. Upon 
oxidative stress less cell death was observed in p62-/- MEFs expressing wild type p62, 
compared to expressing the C105A,113A mutant. We introduced the human p62 linker 
region, including the redox-regulated cysteines into Ref(2)P, thereby creating 
Ref(2)Pox. Flies expressing this humanised Ref(2)Pox showed prolonged survival upon 
oxidative stress. At the moment a control, reintroducing the p62 linker region without 
cysteine 105 and 113 into Ref(2)P is missing and should be included in future studies.  
We showed the increased stress resistance due to the formation of p62 DLC is 
autophagy dependent (Figure 32C) and our data suggests that Nrf2 signalling is not 
involved (Figure 33). Previously, it was shown that in response to arsenic (III) Nrf2 
signalling is induced in a p62-dependent manner (Ichimura et al., 2013). However, we 
do not observe a significant p62 dependence in response to H2O2 (Figure 33B&C). 
Ichimura et al. used p62+/+ and p62-/- MEFs and also used HO-1 mRNA levels as a 
readout, similar to us. Therefore, we think that the stressor As(III) is a different, or a 
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more potent Nrf2 inducer and it would be interesting to test if Nrf2 signalling in response 
to As(III) is dependent on p62 oxidation.  
As we conclude that the increased stress resistance is dependent on autophagy, 
questions remain, such as is there a specific cargo targeted upon p62 oxidation or is 
bulk autophagy induced. The clearance of damaged, misfolded proteins via autophagy 
has been shown to be important for cell survival (Ogata et al., 2006, Chen et al., 2017, 
Tyedmers et al., 2010). We have focused on the clearance of ubiquitinated proteins, 
but different organelles and pathogens are degraded via selective autophagy as well. 
4.3.4 How does the ALS related K102E mutation prevent the formation of 
p62 DLC? 
Lysine 102, which is located very near to cysteine 105, has been identified to be 
mutated into a glutamic acid in a sporadic late-onset ALS patient. Interestingly, this 
mutation prevents the formation of p62 DLC (Figure 39). However, mutating other 
positive charged residues, such as R106 and R107 do not affect p62 DLC formation 
(Figure 40). It is likely that these residues are less important for the reactivity of 
cysteine 105. Therefore, it would be interesting to test if mutating K103 into a negatively 
charged residue such as a glutamic acid affects oxidation as well. If this mutation does 
not affect p62 oxidation, it would suggest that there is something special about lysine 
102. It could be speculated that not only the reactivity of the cysteines plays a role, but 
lysine 102 could be important for an enzymatic form of oxidation, or via for example 
peroxiredoxins. To test this, K102 could be mutated into neutral, negative charged 
residues or other positive charged residues. If only a charge reversal mutations affect 
the formation of p62 DLC, but not other mutations, it would suggest that positive 
charged lysine affects the pKa of the cysteine and the interaction with E19 (Figure 
39B&C). However, if substitutions to other charged residues, or neutral residues also 
affect p62 DLC formation, it would suggest that this lysine affect oxidation of p62 by 
another means and that the cysteine is not oxidised directly by H2O2. Our In silico 
model of p62 oxidation (39C) could be used to test these hypotheses.  
4.3.5 What is the consequence of p62 DLC perturbation? 
We have shown that the formation of p62 DLC is a prosurvival mechanism that is 
acquired in vertebrates and it promotes autophagy induction and thus degradation of 
autophagy substrates during oxidative stress conditions. On the contrary, we have 
shown that if this mechanism is perturbed in humans (K102E mutation in ALS patient) 
it may result in age-related diseases such as neurodegeneration (Figure 39, 41). The 
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K102E mutation showed a similar phenotype to the C105A, C113A mutant, where 
decreased LC3-II levels coincided with increased p62 and ubiquitinated protein levels, 
which was especially apparent in oxidative stress conditions (Figure 41). Teyssou et 
al. performed a careful neuropathological analysis of the K102E patient. The K102E 
p62 mutant carrier was a female who at age 81 was diagnosed with sporadic ALS, with 
a bulbar disease onset and a duration of 10 months. Microscopic analysis revealed 
mild neuronal loss in the spinal anterior horns, in the twelfth nucleus and in the 
substantia nigra (without Lewy bodies). Immunohistochemistry examination showed 
the accumulation of ubiquitin, TDP-43 and p62 positive filamentous and rounded 
inclusions in spinal cord. Furthermore, motor neurons contained intracellular small 
ubiquitin and TDP-43 positive aggregates and increased p62 protein levels were 
observed, which is consistent with our findings (Teyssou et al., 2013)(Figures 41 & 42). 
Interestingly, the K102E mutant patient had a late disease onset. It could be speculated 
that subtle effects on autophagy by the ALS-related K102E mutation predispose 
neurons to a vulnerability, which over time, with age, or a second hit in another 
autophagy or UPS related protein, might be detrimental (Cuervo et al., 2005, Scotter 
et al., 2014). It is not clear why perturbed formation of p62 DLC primarily seem to effect 
motor neurons, potentially they particularly rely on protein and organelle quality control 
and thus are affected most. 
To study the function of p62 DLC formation in more detail, our flies, including the 
previously suggested control (reintroducing the p62 linker region without cysteine 
residues 105 and 113 into Ref(2)P) and a new “ALS” fly (reintroducing the p62 linker 
region with the K102E mutation into Ref(2)P) could be assessed for motor function and 
other ALS related and neurodegenerative pathology. These flies could also be crossed 
with flies expressing mutant human SOD1 or TDP-43 to specifically study ALS (Watson 
et al., 2008, Diaper et al., 2013). 
Promoting autophagy has been shown to prolong life span in flies (Simonsen et al., 
2008, Ulgherait et al., 2014), thus it could be speculated that introducing the oxidisable 
cysteines in Ref(2)P also extends lifespan. It would be interesting to test this and do 




5 CHAPTER 5: OXIDATION OF THE AUTOPHAGY 
RECEPTORS NBR1, TAX1BP1, NDP52 AND OPTN 
5.1 Introduction 
In the previous chapter we described how p62 is oxidised and how this induces 
autophagy, which, as a pro-survival pathway, impacts on cell survival in oxidative 
stress conditions in mammalian tissue culture and in flies and how impaired p62 
oxidation might be causative for late-onset ALS. In this chapter we investigated if the 
oxidation of autophagy receptors is a recurring theme.  
In section 1.3 4 other autophagy receptors, NBR1, TAX1BP1, NDP52 and OPTN have 
been described in great detail. These 4 autophagy receptors were selected because 
they are most widely studied and contain similar functional domains as p62, such as 
LC3- and ubiquitin binding domains and they all can dimerise or oligomerise, even 
though not always to the same extent as p62. NBR1 has a PB1 domain, but this PB1 
domain does not promote oligomerisation of the protein. Instead it uses the first CC 
domain to oligomerise (Kirkin et al., 2009). NDP52 contains a CC domain, which has 
been shown to promote its dimerisation (Kim et al., 2013a), whilst OPTN contains 
multiple CC domains, which most likely promote trimerisation (Agou et al., 2002, Gao 
et al., 2014). Also TAX1BP1 and NBR1 contain multiple smaller CC domains which 
are thought to be important for dimerization as well (Ling and Goeddel, 2000). Data 
published by others suggest that CC domains can be redox regulated. For example 
dimerization of occludin , as well as dimerization of voltage-gated H(+) (Hv) channel 
via its CC domain is redox dependent (Walter et al., 2009, Fujiwara et al., 2013). 
Disulphide bonds formed between two CC domain alpha-helices resulted in 
stabilisation of coiled-coil assembly. Furthermore, mutating the cysteine required for 
redox regulation of this CC domain in the Hv channel did not affect the secondary 
structure of the coiled-coil domain (Fujiwara et al., 2013). These autophagy receptors 
are also distinct from p62 in many other ways, which has been reviewed in section 1.4. 
Oxidation of p62 was shown to be important for oligomerisation and formation of p62 
aggregates (Chapter 4 and data not shown). Therefore, we hypothesise that oxidation 
of these other autophagy receptors promotes dimerization and oligomerisation via 
redox regulated CC domains. As shown in the previous chapter, the oligomerisation of 
p62 is important for autophagy initiation. Other autophagy receptors have been 
suggested to affect autophagy flux as well, although this has not been studied in much 
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detail (Itakura et al., 2012, Wurzer et al., 2015, Mizushima, 2007). In this results 
chapter, tools have been generated to study the role of receptors in regulating 
autophagy induction.  
OPTN and NDP52 have been shown to be required for the degradation of mitochondria 
(mitophagy) (Section 1.5). Recently, antimycin A and oligomycin treatments have been 
used mostly to study PINK1/Parkin mediated mitophagy. antimycin A is a mitochondrial 
complex III inhibitor and results in aberrant ROS production at complex III. Oligomycin 
inhibits complex V (the ATPase) and thereby prevent reverse functioning of the 
ATPase in order to maintain Δψm. Thus, this treatment used to induce mitophagy, 
results in loss of Δψm and ROS production at complex III. We questioned if oxidation 
of autophagy receptors could be important in PINK1/Parkin mediated mitophagy. 
The aim of this chapter is to assess if NBR1, TAX1BP1, NDP52 and OPTN have the 
ability to form DLC’s and generate different tools that can be used to study the role of 
the formation of autophagy receptor DLC’s in starvation induced autophagy and 
selective autophagy, especially mitophagy.  
5.2 Results 
5.2.1 The autophagy receptors NBR1, TAX1BP1, NDP52 and OPTN form DLC 
in response to oxidative stress 
To assess if other autophagy receptors are oxidisable, HeLa cells were treated with 
the oxidants H2O2 and PR-619. Western blot analysis of non-reduced samples were 
probed for 4 autophagy receptors: NBR1, TAX1BP1, NDP52 and OPTN and p62 was 
included as a positive control. Interestingly, we observed that all receptors have the 
ability to form DLC (Figure 45). First of all, NBR1, which is structurally most comparable 
to p62, forms DLC almost as efficiently as p62. In response to PR-619 no monomeric 
species were visible, suggesting that all NBR1 protein is associated with NBR1 DLC. 
H2O2, which is a more transient ROS species, also results in the oxidation of NBR1, 
although slightly less as what is observed for p62. The NBR1 DLC species formed at 
~230 and ~270 kDa could potentially be a trimer a tetramer, however the oligomers 
formed are too large to predict the size. TAX1BP1, NDP52 and OPTN also form DLC, 
in response to H2O2, DLC’s are again less formed compared to p62, suggesting that 
these autophagy receptors are slightly less sensitive to ROS. In response to PR-619, 
all TAX1BP1 protein is in higher order oligomers, which could be TAX1BP1 tetramers 
and higher order species (Figure 45). The main NDP52 DLC species formed are ~200 
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kDa, most likely being a NDP52 tetramer, but also lower order species were observed. 
OPTN seems to form several different sized DLC’s, but the main species are ~200 and 
~270 kDa, which could be OPTN trimers and tetramers. To conclude, all receptors 
tested can form DLC and thus this could be a general mechanism that is required for 
their function. It is also possible that these receptors form disulphides with other 
proteins and this hopefully will be addressed in future experiments, but not in this 
thesis. 
 
Figure 45 NBR1, TAX1BP1, NDP52 and OPTN form DLC in response to oxidative stress. 
HeLa cells were treated with H2O2 (5mM, 1 min) or PR-619 (10µM, 10 min) and analysed by western blot for 





5.2.2 TAX1BP1, NDP52 and OPTN DLC are formed when TrxR is inhibited 
In order to assess if the oxidation of autophagy receptors is reversible, HeLa cells were 
treated with 500 µM H2O2 for different durations. H2O2 treatment is sufficient to produce 
low levels of TAX1BP1, NDP52 and OPTN DLC (Figure 46). This is accompanied by 
PRX hyperoxidation (PRX-SO3) and the formation of PRX-3 dimers (Figure 46). We 
observed that H2O2 treatment triggers a rapid (1 minute) and reversible formation of 
TAX1BP1, NDP52 and OPTN DLC (Figure 46). The OPTN DLC are hard to observe, 
suggesting again that it is less sensitive to ROS. 
In addition, we tested if these DLC can be reduced by the Trx system (Section 1.8.4). 
We treated HeLa cells with H2O2 for the indicated time points in the absence or 
presence of TrxR inhibitors curcumin or auranofin. Curcumin is a natural occurring 
compound that inhibits TrxR (Cai et al., 2012), whilst auranofin is a chemically 
produced potent inhibitor of TrxR. Inhibition of TrxR results in the accumulation of Prx 
dimers and limits the formation of hyperoxidised Prx-SO3. In the presence of curcumin, 
more TAX1BP1, NDP52 and OPTN DLC are formed. Upon TrxR inhibition by auranofin 
TAX1BP1 is all in DLC, and no monomeric band is observed. On the contrary, NDP52 
and OPTN do form DLC, but most NDP52 and OPTN is in the reduced monomeric 
form (Figure 46). This suggests that all three receptors are reducible by thioredoxin, 




Figure 46 TAX1BP1, NDP52 and OPTN are reducible by the thioredoxin antioxidant system. 
HeLa cells were pre-treated with TrxR inhibitors, curcumin (50μM) or auranofin (5μM) for 30 min, then 
treated with H2O2 (500μM) at different time points as shown. Cell were then lysed and immunoblotted in 




5.2.3 Gibson assembly of autophagy receptors in pDEST26 backbone 
Now we have established that, in addition to p62, other autophagy receptors can form 
DLC and that they can be reduced by the thioredoxin system. Next, we were interested 
which cysteines are important for this redox sensing. Furthermore, knowing which 
cysteines are important, gives us the opportunity to create a redox-insensitive mutant, 
which can be used to elucidate the function of the DLC formation by autophagy 
receptors.  
In order to perform cysteine mutagenesis we needed plasmids with the DNA sequence 
of the autophagy receptors. His-tagged OPTN (human) in the pDEST26 backbone was 
purchased from Addgene (Plasmid #23050). This mammalian expression vector 
contains the neomycin resistance gene, which is useful for creating stable cell lines, 
therefore we cloned FLAG-tagged NDP52 into the same backbone. Gibson assembly, 
a cloning strategy that has been developed in the last decade, was used. This method 
allows to combine multiple DNA fragments with overlapping sequences.  
DNA fragments with 20-40 base pair overlap were created by amplifying DNA 
fragments with primers with appropriate overlap using the primers in table 13 (Figure 
47A). After assembly of the fragments the construct was verified by a control digestion 
with SacI (Figure 47B). Finally, the entire insert was sequenced. His-FLAG-NDP52 
was transfected into HeLa PentaKO cells (CRISPR KO for p62, OPTN, NDP52, 
TAX1BP1 and NBR1) (Figure 47C) and western blot analysis was performed to assess 
if the protein is expressed correctly and is oxidised upon H2O2 and PR-619 treatment. 
Indeed, transient overexpressed NDP52 formed DLC, as was detected with a FLAG 
and NDP52 antibody (Figure 47D). The DLC sizes were similar as observed previously 




Figure 47 Gibson cloning of FLAG-NDP52 into pDEST26 (His).  
(A) Agarose gel electrophoreses analysis of the PCR product for pDEST26 (His) and the insert FLAG-
NDP52. The red squares represent the band that were gel-purified and used for Gibson assembly. The 
pDEST26 backbone and the NDP52 insert are depicted in orange and red respectively. The PCR product 
created contain overlapping regions with the insert and backbone. (B) Agarose gel electrophoreses 
analysis of the cloned His-FLAG-NDP52 plasmid digested with SacI to assess correct assembly. (C) HeLa 
wild type and PentaKO cells were analysed by western blot analysis for p62, OPTN, NDP52, TAX1BP1 and 
NBR1. (D) HeLa PentaKO cells were transfected with the His-FLAG-NDP52 plasmid and treated with 5mM 
and 20µM PR-619 and analysed by western blot analysis for FLAG or NDP52 in non-reducing conditions.  
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5.2.4 Analysis of conservation of cysteines in redox regulated autophagy 
receptors 
In p62 we found that two cysteines were required for the formation of p62 DLC. NDP52, 
OPTN, TAX1BP1 and NBR1 contain 13, 7, 19 and 20 cysteines, respectively (Figure 
48), of which 3, 3, 8 and 6 cysteines are part of a zinc finger and predicted to be non-
essential for the formation of DLC. This prediction is based on previous data from p62 
mutagenesis; mutating cysteines in the p62 ZZ domain resulted in more DLC 
formation, potentially because Zinc binding is lost and cysteines become available and 
can form disulphide bonds, or lack of zinc binding results in a conformational change 
that promotes oxidation of other cysteines (Diego Manni, data not shown).  
 
Figure 48 Schematic diagram of the domain structure of p62, NDP52, OPTN, TAX1BP1 and NBR1 
including the cysteines.  
p62 cysteine residues at position 105 and 113 were previously identified to be required for redox regulation 
of p62. Cysteines located in ZZ domains are not shown. The Ubiquitin binding domains are depicted in 
purple, PB1 domains in red, CC domains in blue, LC3-binding domains in green, ZZ domains in orange, KIR 
domain in light blue, TB domains in yellow and the SKICH domain in grey. p62 also contains nuclear 
localisation signals, depicted in black.  
5.2.5 Cysteines at positions 8, 239, 334 and 472 are all important for the 
formation of OPTN DLC 
First single Cys to Ala substitutions of C8, C239, C334 and C472 of OPTN were 
performed and revealed that C334A resulted in less of the ~270 kDa DLC, whilst the 
C472A mutation resulted in the loss of the ~200 kDa DLC (Figure 49A, blue boxes). 
To reduce the formation of OPTN DLC further, a second round of mutagenesis was 
carried out, using the C334A mutation as the basis. Both the C8A and the C472A 
mutation resulted in less DLC formation; C8A mainly affected higher order DLC 
species, whilst C472A again resulted in the loss of the ~200 kDa DLC (Figure 49B). 
Finally, a third and fourth round of mutagenesis was performed to prevent the formation 
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of residual OPTN DLC. Adding the C8A mutation to the C334A, C472A double mutant 
mainly prevented the formation of higher order DLC and mutating Cys 239 on top of 
the triple mutant, resulted in an almost complete loss of OPTN DLC (Figure 49C). This 
quadruple mutant (from now on called 4xCA OPTN) will be used for further functional 
studies (Figure 49D).  
Furthermore, we multiple protein alignments revealed that the 4 cysteines are 




Figure 49 Cysteines at positions 8, 239, 334 and 472 are all important for the formation of OPTN DLC.  
(A) Single, (B) double, (C) triple or quadruple cysteine mutant OPTN plasmids were generated and 
transfected in HeLa PentaKO cells. Cells were treated with 20µM PR-619 for 10 min and analysed by western 
blot for OPTN in either reducing (2.5% β-mE) or non-reducing conditions. (D) Schematic diagram of the 
OPTN structure showing the location of the redox sensitive cysteines.  
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5.2.6 Cysteines located in the CC domain are important for the formation of 
NDP52 DLC 
The same approach was taken to identify cysteines required for NDP52 DLC formation. 
First single Cys to Ala substitutions of C18, C40, C108, C153, C163, C321, C397, 
C400, C406 and C419 were performed. The C153A mutation had the clearest effect 
on NDP52 DLC formation, especially the ~210-230 kDa DLC levels were reduced 
which are potentially tetramers (Figure 50A). A second round of mutagenesis, using 
C153A as the backbone, showed that the C153A,163A double mutation prevented 
NDP52 DLC formation most (Figure 50B). Therefore, this double mutant was used for 
a third round of mutagenesis, as there was still some residual DLC’s left. The C18A 
mutation prevents the formation of the ~150 kDa DLC, however it results in the 
appearance of a different ~130 kDa DLC (Figure 50 B&C, blue boxes). It would be 
interesting to purify these different species to assess their composition. The C153A, 
C163A, C321A triple mutant resulted in an almost complete loss of NDP52 DLC 
formation upon oxidative stress and this NDP52 triple mutant was used to study the 
role of NDP52 oxidation. These three cysteines all localise to the CC domain and it 
would be interesting how cysteines mutations in this domain affects dimerization of 
NDP52 (Figure 50D). Interestingly, we found that the three cysteines we identified to 
be most important for oxidation of NDP52 are acquired very late in evolution and are 




Figure 50 Cysteines at positions 153, 163 and 321 are important for the formation of NDP52 DLC.  
(A) Single, (B) double and (C) triple cysteine mutant NDP52 plasmids were generated and transfected into 
HeLa PentaKO cells. Cells were treated with 20µM PR-619 for 10 min and analysed by western blot for 
NDP52 in either reducing (2.5% β-mE) or non-reducing conditions. (D) Schematic diagram of the NDP52 




5.2.7 Generation of stable cell lines expressing tagged autophagy receptors 
in HeLa PentaKO cells 
To study the role of autophagy receptors in autophagy induction, stable cell lines were 
generated. Because there is a lot of redundancy among the different receptors, we 
decided to use HeLa PentaKO cells to re-express wild type p62, NDP52 or OPTN or 
the respective oxidation mutants. The cysteines essential for redox regulation of NBR1 
and TAX1BP1 remain to be determined and will be included in follow-up research.  
NDP52 and OPTN were cloned in the lentiviral vector pLENTI6/V5-DEST, which has 
a blasticidin selection marker. In order to do so, Gibson assembly was used and 
primers were designed to PCR the pLENTI6/V5-DEST backbone (without overhang), 
so that it could be re-used to insert the different receptors and their mutants. The 
generated PCR fragments were used for Gibson assembly and control digestions were 
performed to test if the generated plasmid was correct (Figure 51A&B). Finally, 
plasmids were send for sequencing and the entire insert was sequenced.  
Because HeLa cells have a good transfection efficiency, we carried out stable 
transfections to generate HeLa PentaKO stably expressing His-FLAG-p62, His-FLAG-
C105,113Ap62, His-FLAG-OPTN, His-FLAG-4XCAOPTN, His-FLAG-NDP52 or His-
FLAG-C153,163,321A-NDP52. After the transfection of HeLa pentaKO, blasticidin 
selection was used to select for the cells which have the plasmid integrated into the 
genome. To test the expression levels of the different proteins western blot analysis 
was performed. Expression levels of p62 and NDP52 were similar to endogenous 






Figure 51 Cloning of OPTN and NPD52 in the lentiviral pLENTI6/V5-DEST plasmid and generation of stable 
cell lines. 
(A) Agarose gel electrophoreses analysis of the PCR products for pLENTI6/V5-DEST (His-FLAG) backbone 
(orange), OPTN wild type and 4xCA mutant inserts (blue) and NDP52 wild type and C153,163,321A mutant 
inserts (red). (B) Agarose gel electrophoreses analysis of the cloned His-FLAG-OPTN and His-FLAG-NDP52 
wildtype and mutant plasmids in the pLENTI6/V5-DEST backbone, digested with EcoRV and NotI, 
respectively. (C) HeLa wild type and PentaKO cells stably expressing His-FLAG-p62, His-FLAG OPTN and 
His-FLAG-NDP52 wildtype and mutants were analysed by western blot analysis for p62, OPTN and NDP52.  
5.2.8 Autophagy receptors are required for autophagy induction 
In chapter 2 we showed that oxidation of p62 regulates autophagy flux and that this is 
important for cell survival and stress resistance in mammalian cells and flies. Here we 
found that autophagy receptors are indeed important to regulate an autophagy 
response in basal and starvation conditions. Autophagic flux in HeLa wild type and 
PentaKO cells was measured in basal conditions and serum starvation conditions 
using Bafilomycin A1 to block autophagosome-lysosome fusion. Interestingly, this 
revealed that in PentaKO cells autophagy flux was decreased in basal conditions, as 
LC3-II accumulated less in PentaKO cells compared to wild type cells and this 
phenotype was even more striking in cells that were serum starved (Figure 52). The 
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HeLa PentaKO cells expressing p62, OPTN and NDP52 (Figure 51) can be used to 
rescue the autophagy defect. HeLa PentaKO cells expressing TAX1BP1 and NBR1 
will need to be generated as well to complete this set. As soon as the most important 
receptor(s) have been identified, oxidation mutants can be tested as well.  
 
Figure 52 Autophagy receptors are required for autophagy initiation. 
HeLa wild type or PentaKO cells were treated Bafilomycin A1 (Baf, 400nM, 4 hours) in either complete (Ctr) 
or serum free medium (SFM) and analysed by western blot for LC3 and p62. Error bars represent s.e.m., 
(n=3), *P<0.05, ***P<0.005, NS= not significant. 
5.2.9 mtKeima can be used to measure PINK1/Parkin mediated mitophagy in 
HeLa PentaKO cells 
p62, OPTN, NDP52, TAX1BP1 and NBR1 have been shown to recruit to damaged 
mitochondria and serve different roles during mitophagy (Section 1.5), however OPTN 
and NDP52, and to a lesser extent TAX1BP1, were shown to be required (Lazarou et 
al., 2015). To test if oxidation of NDP52 and OPTN is required for PINK1/Parkin 
mediated mitophagy we generated HeLa PentaKO stably expressing YFP-Parkin and 
mtKeima. mtKeima is a mitochondrial targeted pH sensitive fluorescence protein, 
which is protease-resistant. Upon a switch to low pH (lysosome) it changes the 
excitation wavelength from 458nm (visualised as green) to 561nm (visualised as red) 
(Figure 53A). HeLa cells and HeLa PentaKO cells stably expressing Parkin-YFP and 
mt-Keima were kindly created by Dr. Michael Lazarou, Monash Univeristy. To test if 
the cell lines can be used to define the level of mitophagy, HeLa wild type and PentaKO 
cells were treated for 3 hours with antimycin A and oligomycin (AO) and live cell 
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imaging was performed. In control conditions Parkin localised to the cytosol and no 
mitophagy events were observed, however upon 3h AO treatment Parkin translocated 
to perinuclear mitochondria. In wild type HeLa cells mitophagy events (red) were 
observed, in contrast to HeLa PentaKO cells (Figure 53B), showing that these cells 
can be used to measure mitophagy events.  
 
Figure 53 mtKeima can be used to measure PINK1/Parkin mediated mitophagy in HeLa PentaKO cells. 
(A) Schematic diagram of the fluorescent mitochondrial targeted Keima (mtKeima). mtKeima has an 
excitation spectrum that is pH sensitive. In neutral pH (cytosol) the protein is predominantly excited with 
458 nm, whereas in an acidic environment (lysosome) the excitation shifts to 561 nm. (B) HeLa wild type 
and PentaKO stably expressing YFP-Parkin and mtKeima were treated with AO (antimycin A and 
oligomycin) for 3 hours and analysed by confocal microscopy.  
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5.2.10 The C153,163,321A mutations in NDP52 impair PINK1/Parkin mediated 
mitophagy 
HeLa PentaKO cells expressing YFP (Yellow Fluorescent Protein)-Parkin and 
mtKeima reintroducing His-FLAG-tagged NDP52 and OPTN and their respective 
oxidation mutants were generated as previously described in section 5.2.7. His-FLAG-
NDP52 protein expression levels were very similar to endogenous NDP52, whilst His-
FLAG-OPTN levels were higher than endogenous levels, however levels between wild 
type and mutant OPTN were similar (Figure 54A). These cell lines were used to test if 
oxidation of NDP52 and OPTN is required for PINK1/Parkin mediated mitophagy. Cells 
were seeded on glass bottom dishes and after 3 hours of AO treatment cells were 
imaged by confocal microscopy. High ratio 550/430 nm signal / cell area was calculated 
as an index for the mitophagy (Katayama et al., 2011). As published previously, 
PentaKO cells had a clear mitophagy defect (Figure 54B). Interestingly, significantly 
less PINK1/Parkin-mediated mitophagy was induced in cells expressing 
C153,163,321A NDP52 mutant compared to wild type, suggesting that oxidation-
sensing properties of NDP52 are required for its function in PINK1/Parkin mediated 
mitophagy. In order to test if NDP52 gets recruited to mitochondria upon mitophagy 
induction, mitochondria were isolated in basal and upon 3h AO treatment and western 
blot analysis in non-reduced and reduced conditions was performed (Figure 54C). 
Upon 3 hours AO treatment the majority of NDP52 is degraded, mostly via autophagy, 
but also by the proteasome (Data not shown). We hypothesised that we could not 
observe NDP52 DLC upon 3h AO treatment, because they are rapidly degraded. 
Therefore, we co-treated cells with the proteasomal inhibitor MG132 and Bafilomycin 
A1 to block autophagy. In these conditions, we could see wild type NDP52 form DLC 
at mitochondria, whilst the C153,163,321A mutant was only able the form lower order 
DLC around 120 and 150 kDa (Figure 54C). Furthermore, increased ubiquitination of 
wild type NDP52 in response to AO treatment was observed (Figure 54C).  
Together this data suggest that NDP52 forms DLC on mitochondria in response to 
mitophagy induction, and this is required for an efficient delivery of the damaged 




Figure 54 The C153,163,321A mutations in NDP52 impair PINK1/Parkin mediated mitophagy. 
(A) HeLa wild type or PentaKO cells stably expressing YFP-Parkin, mtKeima and His-FLAG-NDP52 or His-
FLAG-OPTN and their respective oxidation mutants were analysed by western blot analysis for NDP52 and 
OPTN to check the expression levels. (B) HeLa wild type and PentaKO stably expressing YFP-Parkin and 
mtKeima and His-FLAG-NDP52 or His-FLAG-C153,163,321A-NDP52 were treated with AO for 3 hours and 
high (561/458) signal / cell area values were obtained from confocal images. Error bars represent s.e.m., 
(n=3), *P<0.05, ***P<0.005. In collaboration with Dr. Yoana Rabanal Ruiz. (C) HeLa PentaKO stably 
expressing YFP-Parkin and mtKeima and His-FLAG-NDP52 or His-FLAG-C153,163,321A-NDP52 were 
treated with AO for 3 hours in the absence or presence of MG132 and Bafilomycin A1 (Baf), followed by a 
mitochondrial isolation and western blot analysis for NDP52 in either reducing (2.5% β-mE) or non-reducing 
conditions. The asterisk indicates ubiquitination of NDP52. The mitochondrial protein UQCRC2 was used 




For the first time, we have shown that not only p62, but also four additional autophagy 
receptors, being OPTN, NDP52, TAX1BP1 and NBR1 have the ability to form DLC in 
response to oxidative stress and that these receptors are reducible by the thioredoxin 
system. Three cysteines in NDP52 and four cysteines in OPTN all locating in CC 
domains were shown to be essential for oxidation. In addition, we found that autophagy 
receptors are important for autophagy induction and tools were developed to assess 
which receptors are important and if oxidation of these autophagy receptors is 
important in this process. Furthermore, we have shown that the three oxidisable 
cysteines we identified in NDP52 are important for its function in PINK1/Parkin 
mediated mitophagy.  
5.3.1 Is oxidation of autophagy receptors a reoccurring theme? 
The previous chapter described how oxidation of p62 promotes autophagy and cell 
survival upon oxidative stress conditions and how disrupting this mechanism can result 
in neurodegeneration. p62 is the most studied autophagy receptor, however it is not 
the only one. Very similar receptors with very similar domain structure and function 
have been identified. Autophagy receptors are poorly conserved in contrast to the core 
autophagy machinery. These receptors have in some cases redundant functions, but 
also have their own unique roles (Section 1.3). We were interested to assess if these 
autophagy receptors also have the ability to form DLC in response to oxidative stress. 
Excitingly, we indeed found that all receptors studied (OPTN, NDP52, TAX1BP1 and 
NBR1) had the ability to form DLC. It needs to be elucidated if DLC formation of these 
receptors is functional. Different OPTN DLC species were observed, which could be 
dimers, trimers and tetramers and higher order species. NDP52 DLC could be trimers 
and tetramers. TAX1BP1 and NBR1 DLC formation shows a more similar behaviour to 
p62, where most likely tetramers are formed. Size-exclusion chromatography could 
give us more information about the size of higher-order DLC, as western blot analysis 
only helps predicting the size up to 250 kDa.  
As we first identified OPTN and NDP52 as redox regulated proteins and they are well 
known for their role in mitophagy, we started with a mutagenesis screen to identify 
essential redox regulated cysteines. Interestingly, we found that mutating certain 
cysteines in OPTN and NDP52 resulted in a loss of distinct DLC species and not a 
reduction in all DLC’s as we observed for p62 previously (Diego Manni, data not 
shown). Purifying the different DLC species and assessing their composition could 
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reveal more about their function. The purification of these species was proven to be 
difficult for p62 (Diego Manni, not shown), however OPTN, NDP52, TAX1BP1 and 
NBR1 are less aggregate prone, and therefore potentially easier to purify. When 
purified, 2D sequential non-reducing/reducing (‘diagonal’) SDS-PAGE could be 
performed to identify proteins that are present in the DLC (Sobotta et al., 2015). Mass 
spectrometry of oxidised receptors (comparing wild type and oxidation mutants) could 
help to identify the proteins present in the DLC, whilst including single NDP52 and 
OPTN cysteine mutants would reveal more about what cysteines are important to form 
disulphide bridges with other proteins.  
5.3.2 How is the oxidation status of autophagy receptors regulated? 
As introduced in section 1.8, proteins can be oxidised directly by H2O2, but also 
indirectly via for example Prxs, and they can be reduced via the Trx system. We found 
that autophagy receptors can be reduced via Trx, as inhibiting TrxR results in the 
formation of OPTN, NDP52 and TAX1BP1 DLC. Especially TAX1BP1 seemed very 
sensitive for oxidation in those conditions, as no monomeric TAX1BP1 was observed 
anymore (Figure 46). To confirm if these receptors are indeed reduced by the 
thioredoxin system, co-immunoprecipitations of receptors with different thioredoxin 
and Prxs could be performed. Because these interactions are very transient and hard 
to observe, trapping mutants could be used. 
It would be interesting to asses if the autophagy receptors get oxidised directly by H2O2 
or indirectly via Prxs. As discussed previously in the case of p62 (Section 4.3.1), we 
propose that the autophagy receptors could be indirectly oxidised by H2O2 via Prxs; 
this mechanism involves a physical interaction between the Prxs and the autophagy 
receptors, which allows the transfer of oxidising equivalents between the two (Sobotta 
et al., 2015). If this is the case, hetero-oligomeric species containing for example 
TAX1BP1 and peroxiredoxin should be observed, especially in conditions where TrxR 
is inhibited. Purifying the DLC’s and assessing their composition could reveal more 
about a potential involvement of Prxs in the formation of these DLC’s.  
5.3.3 How can autophagy receptors regulate autophagy? 
We found that autophagy receptors not only function in targeting cargo to the 
autophagosome, but also regulate autophagy flux and induction in starvation (Figure 
52). As we have shown in chapter 3, oxidation of p62 promotes autophagy. It would be 
interesting to assess if other autophagy receptors have a similar role in autophagy 
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initiation. Cell lines have been generated to investigate the role of individual receptors. 
Furthermore, it would be interesting to test in more detail how autophagy flux could be 
regulated by autophagy receptors. Potentially, receptors impact on upstream signalling 
pathways, such as growth factor signalling via AKT or mTORC1 signalling. For 
example, p62 has been suggested to be an integral part of the mTORC1 complex, and 
could affect downstream autophagy initiation (Duran et al., 2011).  
Also a more direct role for in receptors in autophagy initiation could be hypothesised, 
as p62 and NBR1 (other receptors were not tested) have been observed at 
autophagosome formation sites where they form distinct puncta (Kishi-Itakura et al., 
2014, Itakura and Mizushima, 2011). Interestingly, p62 oligomerisation via its PB1 
domain is essential for the recruitment to the ER autophagosome formation site (Kishi-
Itakura et al., 2014). In literature, a role for autophagy receptors in autophagy 
maturation has been proposed. For example, NDP52 was suggested to be involved in 
autophagosome maturation, but not initiation, as autophagosomes accumulate upon 
loss of NDP52 (Verlhac et al., 2015a). Tumbarello et al. suggested that OPTN, NDP52 
and TAX1BP1 are important for autophagosome maturation by linking 
autophagosomes to myoxin VI, which is import for fusion with lysosomes (Verlhac et 
al., 2015a, Verlhac et al., 2015b, Tumbarello et al., 2012). However, they also observed 
that a triple knock-down of NDP52, OPTN and TAX1BP1 reduced autophagosome 
formation in basal and upon autophagy induction induced by proteotoxic stress and 
they hypothesised that the limited targeting of cargo to the autophagosomal membrane 
was causative (Tumbarello et al., 2012). It is not known how targeting of cargo affects 
autophagy flux, but it is an interesting idea that autophagy cargo and autophagy 
initiation come together to make selective autophagy as efficient as possible. This 
hypothesis is supported by work in yeast, where Atg1 (Ulk1/2 orthologue) can be 
activated by receptor bound cargo (protein aggregates and peroxisomes were tested) 
and a scaffold (Atg11) even in nutrient-rich conditions and thus locally overwriting the 
inhibitory mTORC1 signal (Kamber et al., 2015). Work in mammalian cells suggests 
that indeed cargo and receptors recruit and initiate autophagosome formation around 
the cargo. For example, Lazarou et al. showed that upon mitochondrial damage, 
NDP52 and OPTN, are required for the recruitment of ULK1 and DFCP1, two proteins 
involved in autophagosome biogenesis, to mitochondria (Lazarou et al., 2015). By 
using the HeLa PentaKO cells re-expressing the different autophagy receptors we can 
elucidate questions such as which receptors are most important for autophagy 
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initiation, without having problems with redundancy of other receptors and a potential 
role for oxidation of receptors can be investigated.  
5.3.4 Does oxidation of NDP52 promote mitophagy? 
As autophagy receptors function in bridging cargo and the autophagosomal machinery, 
it would be interesting to test if oxidation of autophagy receptors promotes cell survival 
by promoting degradation of distinct intracellular components. Mitochondria are one of 
the main sources for ROS, therefore it would be especially interesting to look into the 
selective degradation of these organelles. OPTN, NDP52, TAX1BP1, NBR1 and p62 
all are recruited to damaged mitochondria, but only OPTN, NDP52 and, to a lesser 
extend TAX1BP1, were shown to be required for mitophagy (Lazarou et al., 2015). 
Excitingly, we found that mutating cysteines 153, 163 and 321 into alanines impacts 
on the role of NDP52 in PINK1/Parkin mediated mitophagy.  
All the reactive cysteines identified are located in CC domains, which is important for 
dimerization. Potentially, the formation of disulphide bridges between NDP52 
molecules result in the alignment of CC domains and triggers dimerization. 
Interestingly, the CC domain of occludin (a transmembrane tight junction protein) was 
shown to be redox sensitive, as disulphide bridges were involved in dimerization 
(Walter et al., 2009). Furthermore, a cysteine in the CC domain in the voltage-gated 
H+ channel forms a disulphide bond which increases the thermal stability of the CC 
domain and promotes dimerization (Fujiwara et al., 2013), showing that CC domains 
can be redox regulated. We will have to rule out that our cysteine to alanine 
substitutions in the CC domains of NDP52 do not impact on the secondary structure 
of these domains. Knowing that cysteine 153, 163 and 321 are only conserved in 
primates, suggests that they are not important for CC domain secondary structure, 
because the other CC domain residues are highly conserved (Appendix, Figure 58).  
In order to conclude that oxidation of NDP52 promotes mitophagy, a few issues need 
to be addressed. For example, it has not been elucidated if PINK1/Parkin mediated 
mitophagy induced by antimycin A and oligomycin is ROS-dependent instead of Δψm-
dependent. In order to address this S3QEL2 can be used in our mtKeima assay. 
antimycin A treatment results in ROS production at respiratory complex III. S3QEL2 is 
an inhibitor that prevents ROS production induced upon antimycin A treatment, without 
affecting the Δψm or the ETC (Orr et al., 2015).  
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We were able to show that upon mitophagy induction NDP52 gets oxidised on 
mitochondria, which suggests that AO treatment does result in ROS production, and 
the recruitment and oxidation of NDP52.  
5.3.5 How could oxidation of NDP52 promote mitophagy? 
Mechanistically, it is not clear how and at what stage oxidation of NDP52 would 
promote mitophagy. First of all, its recruitment to mitochondria could be affected. 
Recruitment of NDP52 to damaged mitochondria is Ub-dependent. Therefore, it would 
be interesting to biochemically assess Ub binding of wild type and the NDP52 oxidation 
mutant, as well as their recruitment to damaged mitochondria. If binding to Ub and 
recruitment to damaged mitochondria is unaffected, recruitment of autophagy initiation 
components, such as ULK1, DFCP1, WIPI1, Atg9 or LC3 could be assessed. ULK1 
and DFCP1 recruitment have been shown to be dependent on NDP52 and OPTN and 
would be a primary target (Lazarou et al., 2015).  
In chapter 4, we showed that oxidation of p62 promotes its oligomerisation and that 
this promotes autophagy induction, resulting in increased oxidative stress resistance. 
We hypothesise that oxidation of NDP52, similarly to p62, results in oligomerisation of 
the protein and that this results in an increased binding avidity to autophagy proteins.  
Most likely, antimycin A and oligomycin treatment would result in a ROS gradient, 
which could result in the formation of NDP52 DLC in the cytosol near damaged 
mitochondria, and this could help the assembly of the mitophagy machinery prior to 
the binding of receptors to mitochondria. In figure 55 a final model speculating a 







Figure 55 Model describing a potential role for oxidation of NDP52 in PINK1/Parkin mediated mitophagy. 
1: Antimycin A and oligomycin treatment results in a loss of mitochondrial membrane potential (Δψm), but 
more importantly ROS production at respiratory complex III. This results in the accumulation of PINK1 at 
the mitochondrial membrane, where it phosphorylates Parkin and Ub. Parkin ubiquitinates outer 
mitochondrial membrane proteins, resulting in 2: the recruitment of NDP52 to the ROS producing 
mitochondrion, where it gets oxidised. 3: Oxidised and oligomerised NDP52 more efficiently recruits 
autophagy initiation components, promoting the formation of an autophagosomal membrane around the 
mitochondrion. 4: Finally, oxidised NDP52 recruits LC3 to promote degradation via fusion with lysosomes. 
5.3.6 Could oxidation of autophagy receptors be implicated in xenophagy? 
Autophagy receptors also have been heavily implicated in xenophagy (Section 1.6). It 
has been established that in response to an infection one of the first host responses is 
the production of ROS by NOXs in macrophages and neutrophils (Robinson, 2008). It 
was shown that Salmonella experiences more oxidative stress in the cytosol, 
compared to the vacuole (van der Heijden and Finlay, 2015). It could be speculated 
that this cytosolic ROS signal produced by the host cell activates autophagy and 
promotes autophagy receptors DLC formation. This formation of DLC potentially could 
more efficiently target bacteria for degradation via autophagy. Recruitment and 
oxidation of the receptors at the bacterial membrane could promote the formation of a 
signalling platform, which promotes an inflammatory response and promotes the 
recruitment of WIPI’s and other autophagy machinery components similar to was 
proposed for mitophagy (Section 1.5, Figure 55). The stable cell lines we created can 
also be used to test if HeLa Penta KO cells re-expressing non-oxidisable autophagy 
receptors cope less well with a Salmonella infection.  
Substrates of oxidation-dependent autophagy can also be identified by subjecting 
HeLa PentaKO cells expressing wild type or non-oxidisable autophagy receptors to a 
proteomics analysis. Proteins that accumulate in cells expressing non-oxidisable 
autophagy receptors could be verified and studied in more detail.  
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We hypothesise that oxidation of autophagy receptors, a mechanism acquired in 
vertebrates, could protect longer lived species against an increasing load of oxidative 
and proteotoxic stress, but also against mitochondrial dysfunction and bacterial 
infections. Future work will focus on characterising the redox-regulated autophagy 
receptors in more depth and to investigate the contribution of oxidation of autophagy 





In this thesis, molecular mechanisms of autophagy and the effect of autophagy 
dysfunction on mitochondrial function and neurodegeneration were studied.  
Long lifespan of evolutionary higher organisms including humans is associated with 
the challenge to maintain viability of post mitotic cells, such as neurons, for many years 
and even decades. Autophagy is increasingly recognized as an important prosurvival 
pathway in oxidative and proteotoxic stress conditions. With age autophagy function 
declines, and is also compromised in several neurodegenerative diseases. We 
identified a novel role for autophagy in the maintenance of mitochondrial health, and 
specifically its role in the maintenance of respiratory complex I. The current consensus 
is that autophagy dysfunction results in proteotoxic stress and this causes disease. 
However, we found that cell death caused by autophagy dysfunction can be rescued 
by preventing ROS production at complex I or bypassing complex I-linked respiration. 
This raises the possibility that via a similar mechanism, autophagy decline with age or 
in patients suffering from autophagy-associated diseases, complex I function becomes 
compromised, which could contribute to the disease symptoms. This new knowledge 
opens up new strategies to battle neurodegeneration. I-BET 762 and S1QEL 2.2 can 
be tested in autophagy deficient mouse models to see if they prevent and/or delay the 
development of a neurodegenerative phenotype at the organism level as well.  
 
Furthermore, we found that vertebrates have evolved mechanisms to respond and 
adapt to the increasing load of proteins damaged by oxidation with age. This involves 
the oxidation of the autophagy receptor p62, which promotes autophagy flux and the 
clearance of autophagy cargo, resulting in increased stress resistance in mammalian 
cells and in flies. Oxidation of p62 as a mechanism to promote autophagy in oxidative 
stress conditions is a completely new concept. In addition, we obtained data revealing 
an important role for redox regulated cysteines in NDP52 for the degradation of 
mitochondria via mitophagy and tools were created to study the role of other autophagy 
receptors in autophagy initiation and selective autophagy. We hypothesise that in 
addition to oxidation of p62, redox regulation of other autophagy receptors, also 
promote autophagy in a oligomerisation-dependent manner. Oligomerised autophagy 
receptors and cargo could function as a platform to recruit autophagy initiation 
components and thereby promote autophagy. Some recent findings suggest that the 
fate of cargo is determined by oligomerisation state of autophagy receptors, instead of 
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for example Ub linkage types (Lu et al., 2017). This raises the possibility that oxidation 
of receptors promote degradation of cargo via autophagy, whilst non-oxidised 
receptors favour degradation of cargo via the proteasome.  
As autophagy deficiency results in neurodegeneration, we studied the effect of an ALS-
related p62 mutant K102E, which affects oxidation of p62 and autophagy induction. 
Based on this data we put forward the idea that lacking this oxidation mechanism of 
p62 can result in age-related neurodegenerative disease. The evolutionary evolved 
oxidation of p62 is a promising therapeutic target to activate autophagy. If we could 
manipulate the p62 protein to function in its oxidised form without ROS being present, 
autophagy initiation could be promoted, which could prevent or delay ALS and 


























Figure 56 Plasmids used or generated in this study.  






Figure 57 Protein sequence alignment of OPTN. 
Multiple alignment of OPTN sequences in different species. Cysteines are indicated by a black star and 
have emerged in vertebrates. Increasing conservation is shown by light-dark red; cysteine residues are 







Figure 58 Protein sequence alignment of NDP52. 
Multiple alignment of NDP52 sequences in different species. Increasing conservation is shown by light-
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